Irish PharmaChem 2008

Fisher Scientific Irelandcelebrates a successful first year

ONE SOURCE. INFINITE SOLUTIONS.

I N A S S O C I A T I O N W I T H P H A R M A C H E M I C A L I R E L A N D

IR

IS

H P

HA

RM

AC

HE

MB

UY

ER

S G

UID

E 2

00

8

Irish Pharmachem Cover 25/09/2008 17:26 Page 1

Invisible Contribution. Visible Success.

Invisible Contribution – Our new plasticiser plays acrucial role in many innovative products. Providing vitalflexibility to the plastic tubing essential for safe medicaldevices that sustain even the smallest patients.

Visible Success – Working closely with customers inmany industries, we develop and optimise solutions.The results of these partnerships are worth seeing.Improved processes and increased quality contributeto the success of our customers. And a better qualityof life for us all. www.basf.com/more

Pharmachem08_w210xd297 6/6/08 10:47 Page 1

FFOORREEWWOORRDDDr Jimmy Devins TD, Minister forScience, Technology and Innovation, onthe Government's mission to keepIreland at the top of the league table forthe pharmaceutical industry well intothe 21st century . . . . . . . . . . . . . . . . . 3

SSEECCTTOORR OOVVEERRVVIIEEWWMatt Moran, PharmaChemical Ireland,reports on the results of a new study intothe pharmachem sector in Ireland . . . . 5

BBIIOOTTEECCHHNNOOLLOOGGYYMichael Gillen, Senior Executive,PharmaChemical Ireland, on howIreland is building a world class biotech-nology industry . . . . . . . . . . . . . . . . . 8

MMEEDDIICCAALL DDEEVVIICCEESS AANNDD DDIIAAGGNNOOSSTTIICCSSSharon Higgins, Director of the IrishMedical Devices Association (IMDA)writes on the development of the sector,both in Ireland and globally . . . . . . . . 11

FFIINNEE CCHHEEMMIICCAALLSSA new set of voluntary guidelines for themanufacture of fine chemical intermedi-ates and active ingredients. . . . . . . . 15

CCOOVVEERR SSTTOORRYYIn June 2008, Fisher Scientific, part ofThermo Fisher Scientific, celebrated asuccessful first year in Dublin, offeringa new level of service when it comes tolaboratory supplies. . . . . . . . . . . . . . 18

RREESSEEAARRCCHH && DDEEVVEELLOOPPMMEENNTTEurope is beginning to lose out to theUS and Asia in R&D terms, accordingto Ronan Collins, CommunicationsManager, IPHA . . . . . . . . . . . . . . . . 21

SSCCIIEENNCCEE FFOOUUNNDDAATTIIOONN IIRREELLAANNDDThe vital role of Science FoundationIreland in delivering on theGovernment’s Strategy for Science,Technology and Innovation. . . . . . . 23

LLAABBOORRAATTOORRIIEESSThe recently launched ‘Labs areVital’ programme will promote thework of Ireland’s 3,000 laboratoryprofessionals . . . . . . . . . . . . . . . . 26

PPHHAARRMMAACCEEUUTTIICCAALL IINNGGRREEDDIIEENNTTSSUnivar Pharma Ingredients is a worldleader in pharmaceutical and chemicaldistribution, and its new site atRathcoole, Co. Dublin, sets the standardfor its European operations . . . . . . . 28

AACCCCRREEDDIITTAATTIIOONN AANNDD SSTTAANNDDAARRDDSSThe important work of the Irish NationalAccreditation Board (INAB) . . . . . . 31

SSUUPPPPLLYY CCHHAAIINNEdward Sweeney, NITL, writes onenhancing shareholder value in thePharmaceutical industry: the supplychain dimension . . . . . . . . . . . . . . . . 32

PPRROOCCEESSSS AANNAALLYYTTIICCAALL TTEECCHHNNOOLLOOGGYYProcess Analytical Technology (PAT) willrevolutionise the way pharmaceuticals aremade, according to ABB . . . . . . . . . . . 34

CCOOUUNNTTEERRFFEEIITT MMEEDDIICCIINNEESSCounterfeit medicines pose a growing

threat to European patients’ health,writes Ronan Collins, CommunicationsManager, IPHA . . . . . . . . . . . . . . . . 39

TTRRAACCEEAABBIILLIITTYYThe EPC Global Network is a technol-ogy solution for its time, with provenbenefits for the healthcare sector,according to Jim Bracken, ChiefExecutive Officer, GS1 Ireland. . . . 40

PPAACCKKAAGGIINNGGGoliath Packaging Systems Ltd sources,supplies, installs and offers after-salesservice on a comprehensive range of end-of-line packaging, materials handling,and washing equipment. . . . . . . . . . . 42

CCLLIINNIICCAALL TTRRIIAALLSSAccording to a new report fromDatamonitor, the paperless clinical trialcould be far closer than you think....46

RREECCRRUUIITTMMEENNTTThe pharmaceutical and chemical sectoris coping well, despite troubled econom-ic conditions, according to BerkeleyRecruitment . . . . . . . . . . . . . . . . . . . 47

EECCOONNOOMMIICC OOUUTTLLOOOOKKThere may be some belt-tighteningahead, but Ireland has the economic andcultural characteristics to ride out thecurrent storm . . . . . . . . . . . . . . . . . . 49

PUBLISHED BY: TARA PUBLISHING CO. LTD.1/2 Poolbeg Street, Dublin 2. Tel: 241 3095 Fax: 241 3010

Email: [email protected] ISDN: 01 241 3050

Managing Director: Fergus Farrell Editorial and Marketing Director: Kathleen Belton

Editorial: John Walshe Advertising Executives: Steven Larkin, David Kelly

Design and Origination by: Rooney Media,

2(B) Ormond Lane, Ormond Road, Drumcondra, Dublin 9

Printed by: Graham & Heslip

T A R AIrish Pharmachem 2008 gratefully acknowledges the

assistance of PharmaChemical Ireland in the

production of this publication.

Every effort has been made to ensure the

accuracy of the information contained in this

publication, but the publisher cannot accept

responsibility for errors or omissions.

LLIISSTTIINNGGSSChemical Suppliers . . . . . . . . 51

General Suppliers . . . . . . . . . 53

Company Listings . . . . . . . . . 61

Useful Refernces . . . . . . . . . . 76

1

Contents 25/09/2008 16:23 Page 1

Festo Ltd.

Unit 5

Sandyford Industrial Estate

Dublin 18

Phone 01 207 55 91

Fax 01 295 56 80

[email protected]

www.festo.com/ie

Reliable? More reliable!

Diagnosis and condition monitoring

Process reliability included!

Project3 25/09/2008 15:50 Page 1

As Minister for Science, Technologyand Innovation, I am very pleasedto contribute to the 2008 IrishPharmaChem Industry Buyers

Guide.Yours is an extremely important industry

and one that has enjoyed extraordinary successin Ireland, particularly over the past two decades.Global pharmaceutical revenues from prescrip-tion drugs stand at over $600 billion, with fore-casts that the total pharmaceutical market willexpand at a compound growth rate of up to 8%in the next five years. By 2010, the market is fore-cast to reach a value of $800 billion, well on theway to an astonishing trillion dollar business.

Ireland is very fortunate to have a major sliceof this enormous market and to have shared inthe substantial growth and success of the indus-try in recent years. The facts speak for themselves: we are thenumber one location in Europe for life sciences, enjoying 48%of the market share in 2004; 13 of the top 15 pharma compa-nies have operations in Ireland; our pharmaceutical exportsamounted to €32 billion in 2005; we have 40,000 workersemployed in life sciences, including 18,000 in pharmaceuticals,and we have 33 FDA approved sites.

Of course, the success of the pharmaceutical industry inIreland did not occur by chance. Successive Irish governmentshave worked over many years to create the conditions, the infra-structure and the business friendly environment necessary toencourage foreign direct investment in this area, which hasalways been viewed as a major source of employment andexports for Ireland.

ADDING VALUE TO THE INDUSTRY

Having secured substantial manufacturing capacity, as I havealready mentioned, Ireland must now turn to the value-addedside of the industry. We can justifiably take pride in our achieve-ments in this regard. What is particularly satisfying is the grow-ing level of research and development taking place in this indus-try, particularly in the areas of process development, formula-tion development and drug discovery development. This is anessential complementary component to the manufacturingprocess and one that will help to underpin and secure the futureof the industry in Ireland in the face of growing competitionfrom other international marketplaces.

As you know, in Government, we continue to put researchand development centre-stage through our Strategy for

Science, Technology and Innovation. Our over-all target is clear – Ireland by 2013 will be inter-nationally renowned for the excellence of itsresearch and will be at the forefront in generat-ing and using new knowledge for economic andsocial progress, within an innovation driven cul-ture.

A HEALTHY RESEARCH CULTURE

We are committed to delivering significantincreases in research capacity, quality and output.This will be accompanied by increased levels ofinvestment in our Higher Education Institutions,combined with renewal and reform. World-classresearch teams will be built and our output ofPhDs will be almost doubled by 2013.

Of course, a healthy research culture has toinvolve companies themselves as active participants. The strat-egy is clear about the types and levels of support that must begiven to the most significant drivers of our economic well-being, namely manufacturing and internationally-traded ser-vices firms.

While different challenges face enterprises in both sectors,we will bring about a transformational change to company atti-tudes to R&D through our development agencies. We willgrow business expenditure on R&D to €2.5 billion by 2013and this achievement will be very much in line with the termsof the EU’s Lisbon goals that will place Ireland in the vanguardof countries addressing ‘knowledge’ issues.

EXPANDING HORIZONS

These are remarkable times both for our country and for yourindustry. Our horizons are expanding continuously as we reg-ularly break out through the boundaries of our previous expec-tations. However, we must avoid complacency and strive tokeep pressing forward relentlessly in order to maintain ourcompetitive advantage.

Our commitment to major expansion of our research anddevelopment base under our Science and Technology strat-egy, our low level of corporation tax, our well educatedworkforce and our wholehearted EU participation will allbe harnessed to keep Ireland at the top of the league tablefor the pharmaceutical industry well into the 21st century.

Dr Jimmy Devins TD, Minister for Science, Technology and Innovation.

MI N I S T E R ’ S FO R E W O R D

LIFE SCIENCES SECTORFLOURISHES IN IRELAND

Dr Jimmy Devins TD, Minister for Science, Technology

and Innovation.

3

Foreword 18/09/2008 16:08 Page 1

Smurfit Kappa 23/09/2008 11:46 Page 1

INDUSTRY FOCUSES ONOPERATIONAL EXCELLENCE

5

Since the first pharmachem companies were estab-lished in Ireland in the 1960s, the sector has con-tinued to grow in prominence, to the point whereit now accounts for over 45% of Ireland’s total

exports, with goods worth over €41.7 billion exported in2006. This phenomenal success story has ensured thatIreland is now firmly established as a preferred locationfor the major international pharmaceutical and life sciencecompanies. The substantial investments made by inter-national pharmaceutical companies in Ireland can bemeasured by a recent study by the IDA, which estimatedthe replacement value of the sector to be approximately$40 billion.

The environment in which these companies are oper-ating is now presenting a number of challenges. The issueof upward pressure in non-pay related costs has been exac-erbated by increased global competition. In addition, reg-ulatory requirements are becoming more stringent. Takenin combination, these and other factors necessitate a newapproach to manufacturing processes.

It was against this background that PharmaChemicalIreland, in conjunction with Enterprise Ireland, Forfásand the IDA, commissioned a study on the industry inIreland, to identify those areas which needed to beaddressed in order to ensure the continued developmentof this key sector.

GLOBAL INFLUENCES ON THE SECTOR

In response to a major upheaval in the global healthcareindustry, driven by a combination of factors, leading inter-national companies are examining how best to maintain andoptimise earnings from their existing product portfolios. Thefactors driving the change are affecting businesses to vary-ing degrees and include:

• The lack of a steady stream of new products enteringthe market / weak new product pipelines;

• Competition between established brands coming offpatent and generic drugs;

• Increased cost pressure from healthcare providers;• Over-capacity in manufacturing networks.

The industry in Ireland will not be immune to these pres-sures and, in facing these challenges, it is imperative that itremains competitive and demonstrates its ability to deliv-er value to the industry.

NEW TECHNOLOGIES

In response to the pressures outlined above, the industry isturning to new technologies, including the manufacture ofdrugs through bio-technology and expansion into thedevelopment of new and more effective drug delivery sys-tems.

These new developments will be important for thepharma manufacturing sector in Ireland and several com-panies have made major investments in recent years bothin primary biotech, as well as in fill and finish operations.Such development requires the highest levels of goodmanufacturing practice, as defined by regulatory agencies,as well as the availability of scientists and engineers with cut-ting-edge education and skills. In both of these key areas,

SE C T O R OV E R V I E W

Matt Moran, PharmaChemical Ireland, reports on the results of a newstudy into the Pharmachem sector in Ireland, which identifies areas

which needed to be addressed in order to ensure the continued development of this key sector.

Matt Moran, PharmaChemical Ireland.

Sector Overview 18/09/2008 16:18 Page 1

6

Ireland has a superb track record that continues to under-pin the attraction of future foreign direct investment to thissector of the Irish economy.

BENCHMARKING METHODOLOGY

Unlike the electronic and automotive industries, bench-marking has only recently been adopted by process indus-tries, including pharmaceuticals. This study undertook acomprehensive examination of chemical and pharmaceuti-cal manufacturing and support processes in 30 sites aroundthe country. The major objectives of the exercise were to:• Enable sites to position themselves against best practice

and thus facilitate learning and improvement;• Identify how Government policy can help resolve

issues affecting business performance;• Internationally benchmark the competitiveness of Irish

sites.

A task force was established comprising PharmaChemIreland, IDA, Forfás, Enterprise Ireland and McKiernanAssociates to direct and oversee the pro-ject. An important aspect of the study wasthe identification of comparable bench-marks of international Pharma sites. Anumber of sources of such data werefound. These are listed in Appendix 2.The exercise was overseen and directedby Jim McKiernan of McKiernanAssociates, based in Basel, Switzerland(www.mckiernan.ch)

DETAILED STUDY FINDINGS: THECOMPETITIVENESS OF PHARMA

IRELAND

Table 1 summarises the main findings ofthe study. Irish sites fared particularlywell in the two key areas of cGMP com-pliance and customer service: in fact,Irish sites could be said to be setting theglobal benchmark standard in these areas.

CGMP COMPLIANCE

The industry track record on cGMP inspections with theIMB, FDA and customer audits is world class and the com-petencies of the companies in this area gives Irish compa-nies a key competitive advantage against industries inother regions around the world.

No pharmaceutical manufacturing site in Ireland hasreceived a warning letter from a regulatory body in the past10 years, which is an exceptional record. In a US study of45 sites (manufacturing APIs, injectables, oral and topicalgrade pharmaceuticals) between 1999 and 2003, 12 sites(27%) were found to have received warning letters or oper-ated under consent decree.

CUSTOMER SERVICE

In the area of customer service, as defined by number of on-time sales, and results of customer inspections and level ofcustomer complaints, it is clear again that the industry inIreland is achieving benchmark standards. As with com-pliance, the challenge to the industry here is to adopt newand innovative processes to maintain this level of customerservice while lowering the cost base.



THE NEXT PHASE

Though the overall performance of the sector is strong, areasfor improvement were identified. An output of the study hasbeen the establishment of a full time operational excellenceworking group within PharmaChemical Ireland. Thisgroup has identified a list of areas for improvement and isnow setting about bringing the entire industry up to iden-tified best practice within the sector.

As far as can be determined, this is the first example inthe world of a benchmarking exercise being conducted ona national pharma sector. PharmaChemical Ireland believesstrongly that the outputs and actions driven by the study willhelp to copper-fasten the relative competitiveness of the Irishpharmachem sector well into the future.

SUMMARY AND NEXT STEPS

This study was intended to form the framework for a plan forthe future development of the industry, and to serve as a spe-cific source of information for the individual companies, assist-ing them in their efforts to achieve the highest standards.

In conclusion, it is clear that Ireland remains a leadinglocation for the manufacture of pharmaceuticals and chem-icals. Even while this sector globally is under severe costpressures, the industry in Ireland can use its proven trackrecord of success to build a platform for sustainability andfuture development.

It is clear that to be successful in this endeavour willrequire a fully-integrated approach, with the involvementof all partners, including the sponsors of this report, theGovernment and educational institutions. This will benecessary to secure the future of those companies alreadyestablished in Ireland and to project the image of Ireland asthe preferred location for the chemical and pharmaceuticalindustry.

Sources:

1 Operational Excellence in the Pharmaceutical Industry,February 2006, Friedli et al, University of St Gallen &APV, Editio Cantor Verlag

2 Benson & McCabe, Pharmaceutical Engineering,July/August 2004

3 Pharmaceutical Manufacturing Research Project,December 2005. Georgetown University, WashingtonDC & Washington University in St Louis, Missouri

0 Benchmarking in the Process Industries, 1999, Ahmad& Benson, I Chem E

Appendix 1Participating Sites

Appendix 2International Benchmarks

1. Pharmaceutical Manufacturing Research Project,December 2005. Georgetown University, WashingtonDC & Washington University in St Louis, Missouri

2. Operational Excellence in the Pharmaceutical Industry,February 2006, Friedli et al, University of St Gallen &APV, Editio Cantor Verlag

3. Benchmarking in the Process Industries, 1999, Ahmad& Benson, I Chem E

4. Benson & McCabe, Pharmaceutical Engineering,July/August 2004


7


GROWING THE IRISH BIOINDUSTRY

8

The biotechnology industry has founda natural home in Ireland. The estab-lishment of the Irish BioIndustryAssociation in 1998 coincided with a

period of unprecedented investment by theIrish government. A series of TechnologyForesight reports in the late 1990s recom-mended that: “the government must immedi-ately invest, on a realistic scale, in a co-ordi-nated biotechnology programme, which buildsstrong links between universities, industry, agri-culture and the financial services sector.”

Since then, Ireland has created a highlystructured supportive environment that pro-vides the right conditions for encouragingstrategic investment in innovation, research and developmentand commercial success in the biotech sector.

Under the Strategy for Science Technology and InnovationProgramme (SSTI), the Irish Bio-technology industry will ben-efit from funding of more than €1.3 billion.

BIOTECH IN IRELAND

Biotechnology will increasingly influence pharmaceuticalresearch and manufacturing; agriculture, food production andsafety; industrial processes and the environment. It willbecome an integral part of the industries that represent thebackbone of Ireland’s new economy.

Over recent years, major biologics investments have beenwon by Ireland. The largest included Wyeth, Eli Lilly, Pfizer,Centocor and Merck Sharp & Dohme. These projects haveincluded both large molecule and cell based vaccines plants.The projects have been focused upon both development andmanufacturing, which is proving to be a key competitive com-petence of Ireland. Industry trends in the direction of per-sonalised, predictive and preventive medicine support thestrategic positioning of Ireland in terms of building out the com-plete industry value chain and focusing from discoverythrough process development and manufacturing to regulatoryand full commercialisation.

BUILDING THE IRISH BIO-ECONOMY

Putting in place the infrastructure to support this developmenthas been a national priority over the last decade. Significantprogress has been achieved consequently, and includes:• Science Foundation Ireland (SFI) which was established

in 2000 with responsibility to invest €1.4billion, which has been allocated for sci-entific research as part of the NationalDevelopment Plan (2007-2013) andthe Strategy for Science, Technologyand Innovation (2006-2013). SFI hasalready invested over €100m in theestablishment of research Centres forScience Engineering and Technology(CSET’s). These include:

1. The Biomedical Diagnostics Institute(BDI) in Dublin City University, whichspecialises in the development of next gen-eration biomedical diagnostic services.

2. The Alimentary Pharmabiotic Centre inUniversity College Cork, which focuses on the discovery,development and commercialisation of proprietary prod-ucts for the treatment of gastro-intestinal disorders andother inflammatory conditions.

3. The Centre for Research on Adaptive Nanostructuresand Nanodevices (CRANN), based in Trinity CollegeDublin, is an internationally recognised centre of excel-lence in nanoscience where there is a convergence of thedisciplines of biology, chemistry and physics.

4. The Regenerative Medicine Institute (REMEDI),based in the National University of Ireland, Galway,is developing gene therapy to promote tissue repair andis currently working in cooperation with Medtronic Inc,a world leader in medical devices, currently focusing oncardiovascular disease.

BIOTECHNOLOGY

Michael Gillen, Senior Executive, PharmaChemical Ireland, on howIreland is building a world class biotechnology industry.

Biotechnology 18/09/2008 14:53 Page 1

9

• Enterprise Ireland (EI), the Irish development agencywhose focus is on accelerating the development of Irishcompanies, has established EI Bio, which is a spe-cialised Biotechnology Commercialisation Group thatsupports the commercialisation of applied bioresearch intotechnologies. Since 2005, EI Bio has invested in excessof €15m in new biotechnology projects.

• NIBRT (National Institute for Bio-processing Researchand Training) is a world-class institute supporting thedevelopment of the bioprocessing industry in Ireland. Theinstitute is based on collaboration between UniversityCollege Dublin, Trinity College Dublin, Dublin CityUniversity and the Institute of Technology Sligo, and pro-vides training and specialist research for the bioprocessingindustry. NIBERT is funded by the IDA.

• The Industrial Development Authority (IDA) has beenparticularly successful in attracting substantial invest-ments into Ireland from global biopharmaceutical com-panies including Wyeth, Schering Plough, Genzyme,Elan, Gilead, and Pfizer.

INNOVATION DRIVEN CULTURE

The vision and objective of the Irish Strategy for Science,Technology and Innovation is to achieve international renownfor the excellence of its research, and to be at the forefront ingenerating and using new knowledge for economic and socialprogress within an innovation driven culture.

The Health and Life Sciences sector is integral to realisingthis objective and is central to Ireland’s National DevelopmentPlan (2007-2013), the key strategy for sustaining Ireland’s eco-nomic growth and contributing to the overarching objectiveof the renewed Lisbon Agenda to make Europe the most com-petitive and the most dynamic knowledge-based economy inthe world.

SUBSTANTIAL INVESTMENTS

Recent substantial investments in Biopharmaceuticals inIreland by Global companies include: Wyeth; ScheringPlough; Elan; GeneMedix; Genzyme; Gilead; Pfizer; MerckSharp &Dohme and Allergan. At the same time, Ireland isgrowing new indigenous biopharma biotechnology industry -

new bio-companies include: Merrion Pharmaceuticals, Opsona,Trinity Biotech, Biotrin.

A strong and innovative R&D environment is attractinginternationally recognised researchers; five new biotechnolo-gy research centres and institutes have been established; andthe number of researchers employed has risen dramatically inline with investment. Strong links between industry, highereducation, state agencies, research institutes and govern-ment are facilitating rapid sustainable development.

BIOPHARMACEUTICALS IN IRELAND

Many of the pharmaceutical companies in Ireland have estab-lished a number of significant operations. For example,Wyeth’s new development is one of the largest integrated bio-pharmaceutical campuses in the world and is the only facili-ty in Europe to manufacture biopharmaceuticals, pharma-ceuticals and vaccines within the same facility. Wyeth’s newfacility in Grangecastle, Co. Dublin, produces Enbrel, whichis a leading biologics blockbuster. The project is Wyeth’s largestcapital investment globally.

Elsewhere, Centocor (J&J) has completed the construc-tion in Ringaskiddy, Co. Cork, of its new biologics launch facil-ity. This is also the largest capital investment ever undertak-en by J&J, as part of a major global biotech investment plan.Eli Lilly is building a new facility in Kinsale, Co. Cork whichwill be central to its corporate plans.

Merck Sharp & Dohme are setting up a human vaccinesand biologics facility in Carlow. The plan includes a formula-tion and sterile filling operation as well as an R&D facility tosupport a number of recently launched vaccines.

Gilead has acquired Nycomed in Cork and is backwardintegrating into full scale manufacturing.

Other organisations have as many as six manufacturingoperations in the country. Nine of the top ten GlobalPharma companies have operations in Ireland and 6 of thetop 10 global drugs are manufactured here. 33 Irish basedplants are approved by the FDA. Indeed, altogether Irelandhas 170 companies employing some 35,000 people in thepharmaceutical, biopharmaceutical, medical devices anddiagnostic sectors.

CREATING THE FUTURE

It is not easy to identify an area of modern scientificresearch and discovery that does not or may not in the futureinclude some aspect of biotechnology. It has been suggest-ed by some experts, for instance, that by 2020, as much as50% of all pharmaceutical products will incorporate someaspect of biotechnology.

Ireland is fully committed, focused and well on the wayto achieving its primary goal of becoming a centre for world-class research, a knowledge-based economy and a global hubfor the biotechnology industry. The results achieved so farare impressive. The environment and culture for business inIreland is progressive and is characterised by a ‘can do’ atti-tude. Biotechnology has much to offer the world; andIreland has much to offer biotechnology.

BIOTECHNOLOGY

Biotechnology 18/09/2008 14:53 Page 2

BRIGHT FUTURE FORMEDICAL DEVICES

11

Ireland’s medical devices and diagnostics sector is asignificant contributor to the Irish economy, interms of exports, direct employment and indirectemployment. The industry accounts for the export of

goods worth over $6 billion annually and employs 24,000people directly and many more indirectly. Many of theworld’s top medical technology companies have investedsignificantly in Ireland and a number of exciting, researchbased, indigenous companies are emerging and competinginternationally.

This industry globally is set to grow and Ireland will con-tinue to be a key player. People everywhere want to livelonger, healthier more fulfilled lives. Every single day, thou-sands of Irish-made products are used around the world todiagnose disease and alleviate pain. Advances in technolo-gy enable earlier detection and offer new, more effectivetreatment options for diseases such as cancer and heart fail-ure. Prevention, diagnosis and treatment of diseases aremore closely linked than ever before to offer highly focused,individualised patient care programmes.

Devices and diagnostic products are becoming eversmaller, smarter, less invasive, simpler to use and morepatient-friendly. More and more devices and diagnostic prod-ucts are developed for home use, such as defibrillators andHIV testing kits. Medical technology products are increas-ingly complex, using new materials and combinations.

The Irish medical devices and diagnostics industry isextremely innovative. While increasing costs are certainlyworrying, we believe that Ireland’s strength lies in its high-ly skilled labour force and in its ability to take a productthrough the development process and to take production toa level where that product can be supplied globally. Theskills required to successfully achieve this should never beunderestimated and are rarely found in other locations, giv-ing Ireland a true competitive edge.

CHANGING GLOBAL MARKET

Without doubt, the global market is changing and Irelandmust adapt to those changes by leveraging the skills that wepossess and using these to create an environment that can-not be rivalled. We believe that it is vital that the manu-facturing base is not only sustained but helped to grow. Todo so, we must lengthen the existing value chain to createan environment in which companies can go end-to-end with

the process of developing innovative products, fromresearch and marketing, right through to production.

Following intensive research and consultation, IMDAlaunched our 2008-2011 Strategy in February 2008. Thisstrategy supports the existing manufacturing base and laysout a framework to leverage this base in order to attractgreater levels of research and development and marketingto this country. The strategy promotes integrated think-ing, calling upon the industry to work together and to thinkstrategically, in order to ensure that Ireland remains thelocation of choice for R&D, manufacturing and market-ing of highly innovative products and services. The fourpillars are:

Manufacturing and Operational Excellence:Sustain the manufacturing base and continue to growinvestment in operations by delivering higher value toinvestors than that available in competing locations globally.

I n n o v a t i o n , R e s e a r c h , D e v e l o p m e n t a n dCommercialisation:Exploit innovation and R&D opportunities in the medicaltechnology sector by nurturing strong interdisciplinary andcross-sectoral collaboration, and thereby maximise thepotential for commercialisation within Ireland.

Shared Services:Increase the value generated in medical technology com-panies operating in Ireland by attracting significant levelsof shared services investment.

Skills and Knowledge:Continue to develop the sector’s highly educated talented

ME D I C A L DE V I C E S AN D DI AG N O S T I C S

Sharon Higgins, Director of the Irish Medical Devices Association (IMDA),reflects on the industry in Ireland and globally, and reports on IMDA’s

strategy for future growth.

Medical Devices 18/09/2008 15:09 Page 1

Soltec 26/09/2008 09:52 Page 1

13

workforce, which is key to meeting the future needs of therapidly changing global industry,

IMDA STRATEGY

The IMDA works to represent and support this industryand does so in a strategic manner. We believe that our strat-egy 2008-2011 will enable the medical devices and diag-nostics sector to develop and grow in a manner consistentwith the development of the global industry and that as aresult, Ireland will retain its position as a world leader in themedical technologies sector.

With the framework in place, it is up to those active inthe medical devices and diagnostics sector to work togeth-er to deliver the objectives of this strategy.

Co-ordinated, open-minded thinking will be the key toensuring that Ireland not only keeps pace with best prac-tice but creates unique attractions for foreign investment andenables indigenous industry to grow to international level.

KEY SECTOR INITIATIVES

Forfás, on behalf of the Expert Group on Future SkillsNeeds published a report examining the trends and driversof change in the industry, which will have the greatestimpact on future skills needs over the period of 2007-2013.Specific recommendations include the establishmentof a Medical Device Manufacturing Centre ofExcellence; increase involvement by clini-cians in medical device innovation; andintroduction of programmes, whichbring together mechanical, electronicand biosciences technologies. IMDAis actively working with stakehold-ers to ensure that the recommen-dations are implemented efficient-ly and effectively.

The IMDA ManufacturingExcellence Skillnets programme inOperational Excellence has beendeveloped with FÁS support to createa training programme that will up-skilloperatives to FETAC level-5, with min-imal disruption to operations. Deliveredthrough blended learning, the programmeminimises costs to the companies by deliveringthe training to several companies at once. This programmeputs operatives on the path to life-long learning and createsa measurable and standardised training.

Enterprise Ireland commissioned a study (supported byIMDA and the Medical Technology Council), to developa technology roadmap outlining opportunities for the med-ical technology sector in Ireland in the medium term (fiveto 10 years hence). This study aims to identify current glob-al trends in the market place by reviewing patents and merg-ers and acquisitions, utilising data therein as a source ofinformation on technologies and their applications. That datais then being cross-referenced against the skills and

expertise of the industry and academic base in Ireland toidentify areas where Ireland can succeed in the future.The final report will be published shortly.

IMDA has lobbied to improve the clinical trialsinfrastructure in this country in order to provide alengthened value chain. We have achieved some successin this area and will continue to work to improve accessto clinicians and to develop linkages between cliniciansand industry.

One of the most high profile successes wasthe first joint Irish Medical Device

Association (IMDA) & Association ofBiomedical and Clinical Engineers

(BEAI) forum, aimed at developingnew products to benefit patientcare globally. Hosted by CorkUniversity Hospital, engineersfrom the medical technologyindustry and hospital basedengineers came together to dis-cuss how to enhance collabora-tion, increase potential for prod-

uct development, improve patientcare and improve product com-

mercialisation activity. The IMDA works to represent

and support this industry and does so ina strategic manner. We believe that our

strategy 2008-2011 will enable the medicaldevices and diagnostics sector to develop and grow in amanner consistent with the development of the globalindustry and that as a result, Ireland will retain its posi-tion as a world leader in the medical technologies sector.

With the framework in place, it is up to those activein the medical devices and diagnostics sector to worktogether to deliver the objectives of this strategy.

Co-ordinated, open-minded thinking will be the keyto ensuring that Ireland not only keeps pace with bestpractice but creates unique attractions for foreign invest-ment and enables indigenous industry to grow to inter-national level.

ME D I C A L DE V I C E S AN D DI AG N O S T I C S

Medical Devices 23/09/2008 16:30 Page 2

www.sartorius.ie

Weighing Solutions...for Laboratory & Industry

LaboratoryWeighing Solutions

ProcessWeighing Solutions

ServiceLeading Edge

• SARTORIUS LTD., UNIT 41, THE BUSINESS CENTRE, STADIUM BUSINESS PARK, BALLYCOOLIN ROAD, DUBLIN 11 •

• Tel: (01) 808 9050 • [email protected] • Fax: (01) 808 9388 • www.sartorius.ie •

Graham Heart 12 23/09/2008 11:56 Page 1

NEW VOLUNTARY MANUFACTURINGSTANDARDS FOR FINE CHEMICALS

15

The Pharmachem Yearbook is the ideal tool tospread the news on the voluntary guidelines forthe manufacture of fine chemical intermediatesand active ingredients.

With the rapid increase in the globalisation of most prod-uct supply chains and the increasing demands from con-sumers for higher quality and safer products, the need forresponsible manufacturing in all industrial sectors hasnever been greater. The incidents currently being report-ed in the US and European public and trade press aboutsub-standard products sourced from foreign suppliers, inparticular China and India, are a sharp reminder of this.

To help minimise exposure risks, high manufacturingand quality standards are necessary, not only for endproducts like food, toys, medicines and crop protectionproducts, but also for the chemical intermediates used intheir manufacture. For example, US chemical distributors,being concerned about how to ensure a safe supply chain,are currently collecting information to support their visionof a Responsible Distribution Process (RDP) and are work-ing through International Council of Chemical TradeAssociations (ICCA) to help spread best practice on a glob-al basis.

In 2006, the ICCA recommended a broad range ofactions as part of its long-term Global Product Strategyand Responsible Care Global Charter, including volun-tary industry actions and cooperative efforts with indus-try groups and both customers and suppliers to thechemicals industry. It said at the time: “The implemen-tation of the strategy at a global level requires a morestructured and far wider process of engagement within the

chemicals industry, with customers and other stake-holders than ever before.”

Announcing the strategy, Andrew Liveris, president andCEO of Dow Chemical, said: “The public expects the chem-icals industry to continuously improve and voluntary ini-tiatives are an important way for us to do that. Voluntaryinitiatives are complementary to laws and regulations and,in some cases, can be much more effective than regulatoryapproaches. They can accomplish a great deal in shorterperiods of time and are less bureaucratic.”

Against this background, the AgrochemicalIntermediates Manufacturers in Europe (AIME), a sub-group of the European Fine Chemicals Group (EFCG), hasdeveloped a set of voluntary guidelines – or a set of mini-mum requirements – for worldwide manufacturers in thecrop protection/agrochemical supply chain, to help main-tain standards and further minimise the risk in the manu-facture of crop protection products which subsequentlyenter the food supply chain.

The voluntary guidelines are based on the experience ofleading European fine chemical custom manufacturersover the last decade in working with almost every crop pro-tection company in the world, and are consistent with theprinciples of Responsible Care and Product Stewardship.

EFCG subsequently adopted these guidelines andextended them to apply to all fine chemical intermediatesand active ingredients (except pharmaceuticals) used in awide range of industrial, professional and consumer prod-uct supply chains. The aim is to help maintain standards andfurther minimise the risk in the manufacture of a range ofdownstream products, other than pharmaceuticals, where

F I N E CH E M I C A L S

Tony Scott, European Fine Chemicals Group, and Dr Uwe Brunk of Saltigoand Chairman of EFCG’s Agrochemical Intermediates Manufacturers inEurope (AIME) subgroup introduce a set of voluntary guidelines for the

manufacture of fine chemical intermediates and active ingredients.

Fine Chemicals 24/09/2008 09:42 Page 1

16

enforceable manufacturing laws are already in place for allactive pharmaceutical ingredients and intermediates destinedfor use in the world’s major markets, such as USA, Europeand Japan.

GUIDELINES

As well as being the voice of European Fine ChemicalManufacturers, EFCG seeks to promote the highest levelof risk management in the manufacture and use of finechemical intermediates and active ingredients on a globalbasis beyond pharmaceuticals. It also works to identify anddeal with the key issues affecting the competitiveness ofmember companies and the safe use of their products.

EFCG members are committed to sustainable devel-opment and continuous improvement in environmental,health and safety (ESH) performance. By adopting thesenew voluntary guidelines, they are extending this commit-ment further to include a set of management policies andpractices used before, during and after manufacturing.

NINE ESSENTIAL AREAS

They are convinced that doing so will bring them and theircustomers real business benefits, while also improvingproduct quality and security of supply throughout the sup-ply chain. To help deliver these benefits, the voluntaryguidelines address nine essential areas in managing the busi-ness, using defined criteria in each case.

The first is ‘Policies’. Products may only be sold for thoseuses where the risks to human health and environment areunderstood and managed, including an audit if decided.Contracts and secrecy agreements must always be binding.

In addition, it is recommended that parties set out whereand how any dispute requiring legal action is to be con-ducted. Clear management and organisational structuresmust exist to provide for efficient normal working and toaddress problems quickly. Know-how is to be protected andIP respected.

Secondly, ‘Business Processes’ must be documentedclearly and follow defined and reproducible guidelines.Regulatory affairs staff should maintain a close working rela-tionship with the authorities, in order to ensure compliance

with the law and to prevent a sudden close down of facilities.Integrated ‘ESH & Quality Management Systems’

should be embedded, communicated to the entire organi-sation and easily audited. Products are to be produced andshipped under the guidelines of the relevant chemical leg-islation, waste streams must be properly managed in com-pliance with local laws and ISO 9001 certification must beauditable.

Auditable ‘Preventative Risk Assessments’ should bemade in production and other parts of the supply chain, suchas supplier quality and reliability, preventative equipmentmaintenance, reaction safety and the identification ofpotential hazards.

Formal, documented raw material purchasing arrange-ments must be put in place on a company basis to improvetraceability and to enhance the quality and security of sup-ply: the resulting counter measures must be implemented,monitored and auditable.

The ‘Qualifications & Training of Staff’, including sub-contractors, is crucial. This should be appropriate to the rel-evant functional activity: for example research, sourcing,production, maintenance, analysis, QA and logistics.

Regular training needs to be provided in health, safetyand environmental precautions and in product quality, espe-cially for substance or product properties and altered riskclassifications. Operating and engineering staff must beupdated regularly on new or altered technical equipmentand training for emergencies must take place regularly.

‘R&D’ staff must be well educated, trained and com-petent to develop and scale up any required capabilitiesthrough innovation and continuous improvement. As wellas respect for IP and know-how, the development of man-ufacturing processes should reflect the EU ESH standardsand a wide range of appropriate analytical equipmentshould be kept available and well maintained by qualifiedstaff.

‘Production Procedures’ are also vital. These includeprocess controls to deliver reproducible product quality, pre-ventative maintenance procedures to ensure high plant reli-ability and reduce the risk of unit failures, keeping properhistorical records on each batch for inspection and/oraudit purposes, procedures to avoid cross-contamination(such as separate storage and analytical capabilities to val-idate cleaning) and proper and auditable measures to pro-tect the health of employees

Likewise, ‘Plant Infrastructure’ must meet certain keyrequirements. These are headed by a secure supply of ener-gy, steam and water, safe filling and trans-filling devices, safeand secure storage facilities, regularly audited fire protec-tion measures (such as firms having their own, on-site firebrigades), audited waste water treatment facility and mon-itored off gas treatment.

Finally, there is ‘Transport’. The key requirementshere are reliable and secure transportation and documen-tation; proper and complete labelling to ease shipment;adherence to relevant transport, packaging and labelling leg-islation; being a member of the official local transport acci-dent information system; and making substance information

F I N E CH E M I C A L S


and first aid instructions available rapidly in case of chem-ical hazards during transportation

These voluntary guidelines are aimed at all manufacturersof ISO-regulated fine chemical intermediates and activeingredients throughout the world. Each manufacturer or cus-tomer may individually decide to follow these guidelineseither in full or partly, or not to follow them at all, basedentirely on their individual decision-making processes.

POTENTIAL BENEFITS

The guidelines have been prepared with several aims inmind:• To address societal concerns about sustainable devel-

opment and the use of chemicals by increasing thetransparency of what we do.

• To help build confidence and trust in an industry thatis essential to improving living standards and thequality of life around the world.

• To share best practice and to promote the highest levelof risk management in the manufacture and use of finechemical intermediates and active ingredients on aglobal basis.

• To enable fine chemical intermediate manufacturers torefer to certain set of standards when advertising theircapabilities.

NEXT STEPS

EFCG wishes to enter into dialogue with anyone who iswilling to help it to raise awareness of the proposed vol-untary guidelines throughout the global fine chemicals com-munity and to promote a process to discuss their appro-

priateness and how they might be developed for a world-wide audience of manufacturers, stakeholders and thepublic at large.

It also wishes to begin to build the global capacity andnetwork of users of the voluntary guidelines and to considerthe development of a quality audit template based on the vol-untary guidelines to facilitate customer audits of theirsuppliers.

F I N E CH E M I C A L S /PA K E X ‘08

FOR MORE INFORMATION,

PLEASE CONTACT:Tony ScottAdvisor – EFCG and AIMEAvenue E. van Nieuwenhuyse 4B-1160 BrusselsBelgiumTel: +44 (0) 1428 641 168E-mail: [email protected]: www.efcg.cefic.org and www.efcg.cefic.org/aime

Dr Uwe BrunkChairman of AIME and EFCG Board MemberHead of Business Line Agro & Specialty ChemcialsSaltigo GmbHKatzbergstr. 140764 Langenfeld/RheinlandTel: +49 (0) 2173 - 2033 763E-mail: [email protected] Web: www.efcg.cefic.org/aime and http://www.saltigo.com

PAKEX Ireland ’08, incorporating Manufacturing &Plant Maintenance & Industrial Environment, takesplace at the RDS, Dublin, on October 21 and 22, 2008,and will incorporate packaging, plant, supply chain,maintenance and industrial environment.

Over 100 companies, many from outside Ireland,will exhibit and many of the technologies being demon-strated will be on display for the first time in Ireland.

The latest professional advice and guidance will beavailable, thanks to the ‘free to attend’ Info Live miniseminars, to help visitors and exhibitors alike stay aheadin today’s highly competitive industrial environment.Manufacturing and process industries now have to runleaner operations, putting an increased burden on main-tenance professionals.

The show now attracts a broad range of visitorsacross a diverse array of industries, including pharma-ceutical, chemical, medical, packaging, handling, logistics,processing, electrical, engineering, industrial machinery,food & drink etc.

Another benefit of visiting Pakex Ireland is the oppor-tunity to network with industry colleagues, allowing youto connect with world class companies to help meet yourprocessing/handling/packaging needs.

For more information, contact: McCann McGuirkPresentations on (01) 4063892 or email [email protected].

17

PAKEX IRELAND ‘08


18

In June 2008, Fisher Scientific, part of Thermo FisherScientific, celebrated its first year of being the newsource for laboratory supplies in Ireland. FisherScientific has proved, within a short space of time, that

it can offer the laboratory customer a new level of service.

SO JUST WHO ARE THERMO FISHER SCIENTIFIC?

Thermo F i sherScientific is theworld leader inserving science,enabling customersto make the worldhealthier, cleanerand safer.

Fisher Scientificis a Thermo FisherScientific brand and provides a complete portfolio of labo-ratory equipment, chemicals, supplies and services used inhealthcare, biotechnology, scientific research, analyticaltesting, safety and education.

LOCAL COMPANY – LOCAL PEOPLE – LOCALSTOCKHOLDING

Customers can be assured that when they contact the office,they will be dealing with people that understand theneeds of their laboratory and are familiar with the Irish lab-oratory market.

Highly expe-r i enced f i e ldsales and cus-tomer servicet e a m s w e r ehandpicked tog i v e F i s h e rScientific’s cus-tomers the confi-dence in know-ing that they willreceive the atten-tion they wouldexpect from a

highly customer-focusedlocal company.

HUGE PRODUCTRANGE – SPOILT FOR

CHOICE?

With more than 100,000products covering every-thing from consumables,chemicals and equip-ment, Fisher Scientificoffers the widest choiceavailable to laboratories,making the company atruly ‘one stop shop’,with premium brands such as Thermo Scientific, Bibby,Grant, Schott, Whatman, Millipore, Nunc, Corning,Nalgene, IKA, Zeiss and Kimberley Clark, amongst others.

The Fisherbrand Series is a name you can trust, withquality you can depend on, and positive proof that low costdoesn’t have to mean low quality!

When choosing a Fisherbrand product, the customer canexpect, at the very least, three basic attributes: Quality.Reliability. Value. As part of Thermo Fisher Scientific,Fisher Scientific draws on global purchasing power toensure it is able to offer superior products with additionalfeatures and benefits not normally found in comparableproducts at similar prices.

The Fisherbrand product range consists of approxi-mately 6,000 product lines, and the range is continuallyevolving and being added to. Fisherbrand covers manyapplication areas that one would expect to find in generaluse in virtually any laboratory, be it research, clinical, ana-lytical or university.

Products range from glass and plastic disposables,paper products and safety general consumables to bench topequipment and accessories.

CHOICE, QUALITY AND VALUE

Fisher Chemical provides customers with choice, quality andvalue from the world leader in serving science. It gives usersconfidence in the specification of the chemicals and reagents,

COV E R ST O R Y

Fisher Scientific celebrates a successful first year in Ireland.

--------Cover Story 23/09/2008 16:44 Page 1

19

along with the stability of supply, backed by consistentlyhigh levels of stock availability, service and delivery.

Customers can rest assured that all Fisher Chemical prod-ucts are manufactured, processedand/or tested in Loughborough, UK.ISO9001: 2000 certification ensuresthat customers can have confidencethat when Fisher Chemical productsarrive at their bench, they will meetthe specification detailed in the cur-

rent catalogue or aspecification agreedwith the customer,prior to ordering.

ONLINE PRESENCE

The Fisher Scientific web site is recognised as one of the bestwithin the lab supplies industry. Here are just a few of thereasons for visiting www.ie.fisher.com.

Techzone is the on-line technical support area. This isbeing constantly updated and added to ensure users canaccess information that will help them to solve issues,whether it be the most suitable product for an applicationor how to find the nearest suitable replacement for anoth-er product.

Users can download MSDS’s, Certificates of Analysis,and protocols, chemical modelling and other informationdesigned to make life easier in the lab.

Viewers can study selection tables and product guidesand look-up FAQ’s. There are a wealth of special offers andpromotions – the Fisher web team aims to keep offers andpromotions not just ‘fresh’ but relevant to the user. Userswill also find fun competitions, with some great prizes, soit’s not all work and no play.

‘Insight 2’ is the Fisher Scientific on-line catalogue, wherethe user can browse products, compare, check real-time stockavailability and have the ability to view ‘new’ products assoon as they are added to the Fisher product range.

Once registered to use the on-line catalogue, Insight 2,the user can viewreal time stockavailability: theprice they see is

the one they willpay, so there is no

need for them tolook up any compli-cated discount sched-ule and work theprice out. Other ben-efits for registereduses include orderhistory download andhot lists, just some ofthe advantages ofpurchasing on-line atwww.ie.fishersci.com.

COV E R ST O R Y

A RECENT ADDITION TO THE FAMILY: THE 2008/2009 FISHER SCIENTIFIC

LIFE SCIENCE CATALOGUE

With over 1,200 pages, the2008/2009 Fisher ScientificLife Science Catalogue is amust for anyone involvedin the life sciences, with acomprehensive selection ofmore than 17,500 essentiallife science products, 2,000of which are brand new.

Always aware of the needfor customer service and sup-port, this catalogue is evenmore user friendly, withproduct groups organisedinto application areas, including: Cell Isolation, CellCulture, Microbiology, Nucleic Acid, ProteinPurification, Amplification and Expression (includingPCR, RTPCR and qPCR techniques), Electrophoresis,Modification, Analysis and Characterisation. A wholenew section dedicated to Healthcare has been included,to satisfy the needs of the busy clinical laboratory.

The equipment and consumables are complementedby a complete range of bioreagents and kits suited to theapplications covered within the catalogue. This formatenables users to easily find and view specific productsrelating to particular techniques and applications.

FOR FURTHER INFORMATION, CONTACT:Fisher Scientific IrelandSuite 3, Plaza 212, Blanchardstown Corporate Park 2, Ballycoolin,Dublin 15.Tel: (01) 885 5854Fax: (01) 899 1855Email: [email protected]: www.ie.fishersci.com

Measom Freer 23/09/2008 11:59 Page 1

TOP OF THE R&D LEAGUE

21

Money invested inp h a r m a c e u t i c a lresearch and devel-o p m e n t ( R & D )

eventually provides patients andphysicians with more and bettertreatment options to best meet indi-vidual patients’ needs.

Globally, the pharmaceuticalindustry accounts for no less than19% of business R&D expenditureand 5.8% of EU manufacturedexports. It is the sector with thehighest ratio of R&D investment tonet sales (15.9%), employing morethan 640,000 people in Europe, ofwhich 107,000 work in R&D units.

This huge investment is neces-sary as the discovery, development,testing and gaining of regulatoryapproval for a new medicine is ahighly complex, lengthy, risky andexpensive process. In fact, severalstudies now put the cost ofresearching and developing a newmedicine at €1 billion. But as thecost continues to increase, so doattrition rates. On average, only 1out of 5,000 to 10,000 promisingsubstances will survive extensivetesting in the R&D phase tobecome approved as a quality, safe and efficient marketableproduct.

THE IRISH EXPERIENCE

In Ireland, pharmaceutical R&D ranges from basic researchto translational research. Much of this investment is spentin collaboration with academic institutions with the supportof Government agencies.

GlaxoSmithKline, Wyeth, Servier Laboratories, BMSand several other companies have developed partnershipswith universities, the most notable being TCD, UCC,NUI, Galway and DCU. Agencies supporting these part-nerships include Science Foundation Ireland (SFI) and IDAIreland.

For example, the Alimentary Pharmabiotic Centre(APC) at UCC, which is supported by SFI, has establisheda joint research partnership with GlaxoSmithKline.Researchers from GSK’s Neurology and Gastro-Intestinal(GI) Centre of Excellence for Drug Discovery work close-

ly with the APC to identify newdrug targets for the treatment ofdebilitating GI disorders, such asinflammatory bowel disease (IBD)and irritable bowel syndrome (IBS).

CLINICAL TRIALS

The pharmaceutical industry is alsoinvolved in a range of clinical trialsin Ireland. In 2006, the IrishMedicines Board approved 122 clin-ical trial applications in Ireland.

According to ICORG, the All-Ireland Co-operative OncologyResearch Group which enablesIrish patients to gain early access tonew cancer treatments, Ireland’spharmaceutical industry providedmedicines worth over €3.5m toIrish cancer patients through thevarious clinical trials they wereinvolved with in 2007.

This demonstrates how valuablethe pharmaceutical industry is toIreland, its health and economy.

EUROPE LOSING GROUND

However that contribution cannotbe taken for granted. For over a

decade, Europe has gradually lost ground as a researchbase, with a steady transfer of R&D activities to other partsof the world, in particular the US, where the environmentis more supportive of pharmaceutical innovation.

Between 1990 and 2007, R&D investment in the UnitedStates grew 5.2 times whilst in Europe it only grew 3.3times. There is rapid growth in the research environmentin emerging economies such as China and India. The cur-rent tendency to close R&D sites in Europe and to open newsites in Asia will show dramatic effects in the next few yearsif nothing is done to maintain the pharmaceutical discoveryexpertise in the EU.

Europe needs to be serious about making innovationwork. It is our belief that if Europe rewards and stimulatesinnovation, industry will not only be able to improvehealthcare in Europe, bringing new innovative medicinesfaster to European patients, it will also contribute to theLisbon objective of economic growth, to more and betterjobs, and therefore guarantee high living standards for cur-rent and future generations of Europeans.

RE S E A R C H & DE V E LO P M E N T

The Pharmaceutical indus-try invests more in R&D

than any other sector, butEurope is beginning to lose

out to the US and Asia,according to Ronan Collins,Communications Manager,

Irish PharmaceuticalHealthcare Association Ltd.

R&D 18/09/2008 14:41 Page 1

Science Foundation Ireland, (SFI) the national foundation for excellence in scientific research is investing in academic researchers and research teams who are most likely to generate new knowledge, leading edge technologies, and competitive enterprises.

SFI has a flexible grants and awards portfolio and several times a year issues calls for proposals from scientists and engineers. SFI also accepts unsolicited proposals throughout the year. SFI’s award programmes include:

Principal Investigator Programmefor outstanding researchers, normally ranging between €50,000 - €250,000 per year for a three to four year period.

Research Professor Recruitment Awardsfor outstanding researchers, with particularly distinguished international reputations, awards normally ranging up to €500,000 per annum for up to two years.

E.T.S. Walton Visitor Awardssupporting leading international scientists who visit Ireland to undertake research for up to one year, normally ranging up to €200,000.

President of Ireland Young Researcher Awards (PIYRA)attracting to Ireland and supporting Irish researchers within five years of completing their PhD, normally up to €1 million over five years.

Undergraduate Research Experience & Knowledge Award (UREKA)supports active research participation by undergraduate

students during the Summer.

Ireland funds great research...maybe it’s your turn!

Apply for an SFI award or learn more about our programmes at www.sfi.ie

Science Foundation Ireland, Wilton Park House, Wilton Place, Dublin 2, Ireland. Tel +353 1 607 3200 fax +353 1 607 3201 email [email protected]

Sci-fi ad (A4).indd 1 05/03/2008 09:27:40

RESEARCH FOR IRELAND’SECONOMIC FUTURE

23

The Irish Government has made a major commit-ment, through the substantial investment set outin the National Development Plan (NDP) 2007-2013, and the Strategy for Science, Technology &

Innovation (SSTI) 2006-2013, to making the transition toa knowledge-economy by funding world-class research inIreland. Building on previous strategies, it provides for aninvestment of €8.2 billion to 2013 which will:

• Double the number of postgraduates; • Promote greater commercialisation of ideas and know-

how of universities and public research institutions;• Increase participation in the fields of science;• Increase translational research activity;• Allocate significant resources to supporting enterprise

R&D, in order to double corporate R&D spend by 2013with a Business Expenditure in Research &Development (BERD) target of $3.9 billion.

The aim of the SSTI is to ensure that Ireland remainsa key location for leading edge research and development,and the quality jobs it can deliver.

Science Foundation Ireland (SFI) is investing in acad-emic investigators and research teams, who are most like-ly to generate new knowledge, leading edge technologiesand competitive enterprises in the fields of science and engi-neering which underpin the broad areas of:

• Biotechnology• Information and communication technology• Sustainable energy and energy efficient technologies.

HIGH QUALITY RESEARCH ENVIRONMENT

Now seven years on from its first grant award, SFI is mov-ing into a new phase of implementation as the organisationfocuses on delivering the ambitious targets set down in theSSTI. Since its establishment in 2001, SFI has approvedover 1,800 awards across all its programmes, representinga substantial investment commitment of over €1.04 billionas it continues to build a high quality research environmentin Ireland.

Ireland is now a place where an active and successfulresearcher has access to grants that are higher than thoseavailable in most countries. To-date in the life sciences area,SFI has made award commitments of over €324m, fund-

ing over 940 Life Science researchers with Ireland, in suchdiverse areas as Agri-Food, Bioinformatics/Systems Biology,Molecular & Cell Biology, Immunology, Microbiology’Neuroscience, Sensors/Devices and Pharma-Chem.

THE ULTIMATE GOAL

The ultimate goal of the investment in SFI is that economicbenefit should, in due course, arise from the actions and pro-jects funded. Those who are performing research at the fron-tiers of knowledge will inevitably discover some newprospect and some of these will be intellectual property,including items that are of a patentable nature. Inventionsand insights from top class researchers have been at the coreof the expansion of industry in the US and elsewhere andthe same should be true of Ireland.

The steps from invention through to commercial activ-ity, however, may be different than those normally occur-ring in major industrial companies. Compared to industri-al research, there is a longer time-lag between frontiersresearch and economic output and we have to recognise this.

It must be noted that the outcome of frontiers researchis richer and more diverse, not concentrated on a singleproduct but rather a multiplicity of products and process-es. We need, therefore, to be patient, understanding andflexible in assessing the Brains to Business process. In thisprocess, SFI works very actively with IDA Ireland andEnterprise Ireland. Indeed, the increased R&D investmentreported by IDA is frequently the consequences of seedfunding by SFI.

SC I E N C E FO U N DAT I O N IR E L A N D

The vital role of Science Foundation Ireland in delivering on theGovernment’s Strategy for Science, Technology and Innovation.

SFI 18/09/2008 15:23 Page 1

Manotherm Limited4 Walkinstown Road, Dublin 12Tel: 01-452 2355Fax: 01-451 6919Email: [email protected]: www.manotherm.ieCo. DownTel: 028 4066 9936Email: [email protected]

Manotherm

Magnehelics

Meters

Matter

SUPPLIERS OF:-

CARBON CAN NOW OFFER A SELECTION OF SOLVENTS IN 200 LITRE DRUMS/ IBC'S EXSTOCK FROM OUR SOLVENT STORAGE AND DRUMMING FACILITY, IN RINGASKIDDY, CORK

A LARGE RANGE OF MATERIALS CAN BE SOURCED TO YOUR SPECIFICATION

Whatever your requirementplease contact:- Carol Deegan Carbon Group, Ringaskiddy, Cork

Mobile: 086 2612 485Office Tel: 021 437 8988

Fax: 021 437 8950 Email: [email protected]: [email protected]

Website: www.carbon.ie

ACETATE ESTERSACIDS & ALKALISANTIFREEZE / GLYCOLSETHANOLETHANOLAMINESEXCIPIENTS

FATS & WAXESFRAGRANCES & FLAVOURSGLYCOL ETHERS / ESTERSGLYMESHYDROCARBON SOLVENTSKETONES

PETROLEUM JELLIES / WHITE OILSPHARMACEUTICAL SPECIALITIESPOLYALKYLENE GLYCOLSPOLYETHYLENE GLYCOLSSALT - ALL GRADESSOLVENTS

UK lo-cal number: 0870 850 4831

BSB .25 23/09/2008 17:15 Page 1

25

FOSTERING STRONG LINKS WITH INDUSTRY

In addition to working with the other agencies, it is crucialfor SFI and its funded researchers to develop strong linkswith industry. It will be key industry partners who pose thequestions and, through partnership with academicresearchers, find the solutions to technological, environ-mental, medical and economical issues. It is these industrypartners who, in association with SFI-funded projects, willcommercialise the outputs of the research. This is where theeconomy benefits and Ireland moves up the value chain.Smaller incremental changes in the existing operations willalso follow, thereby increasing the competitiveness of busi-ness in Ireland.

Significant numbers of SFI funded researchers areactively engaged in collaboration with industrial partners.SFI’s nine Centres for Science, Engineering and Technology(CSETs) and 12 new Strategic Research Clusters (SRCs)are at the leading edge of this process by collaborating withmultinational companies such as GlaxoSmithKline, Proctor& Gamble, Eli Lilly, Merck Sharp & Dohme, ScheringPlough, Pfizer, Abbot, Becton Dickinson, and also withsmaller Irish companies. IDA Ireland and EnterpriseIreland play an important role together with SFI in encour-aging this collaborative process.

Some examples of these collaborative SFI CSETs in theLife Sciences include:

The Alimentary Pharmabiotic Centre (APC) inUniversity College Cork (UCC): its research is focused onthe exploration and exploitation of gut microbiota in healthand disease. The APC has grown in scope, scale andinternational stature since its launch four years ago as anSFI CSET. The APC’s collaborative partners include

Teagasc, Alimentary Health and their partners Proctor &Gamble and GlaxoSmithKline (GSK).

The primary objective of Biomedical DiagnosticsInstitute (BDI), based in Dublin City University, is thedevelopment of novel diagnostic devices, enabling early-stage diagnosis and monitoring of major diseases. Thesedevices are targeted for use at the point-of-care and will ulti-mately enable efficient coupling of diagnosis and treatment(theranostics). The BDI industry partners include: BectonDickinson and Co., Analog Devices Inc., Hospira Inc.,Inverness Medical Innovations Inc., Enfer TechnologiesLtd, and Amic AB.

The REMEDI was established in National Universityof Ireland Galway in 2003 to conduct research in regener-ative medicines, an emerging field that combines the tech-nologies of gene therapy and adult stemcell therapy.REMEDI’s industrial collaborators include MedtronicVascular (Galway).

BUILDING THE TALENT POOL

The Irish Government’s Strategy sets down the goal of see-ing Ireland recognised as an internationally renownedlocation for excellence in scientific research. In order toachieve this, we need to continue to build the talent pool;Ireland needs to ensure that there are sufficient researchersavailable to serve the knowledge-driven economy.

Over the next seven years, a key objective of the IrishGovernment’s Strategy is to double the number of PhDgraduates. To deliver this, SFI will increase the numberof supported Principal Investigators by 30 per annum upto 2013. SFI has developed a suite of competitive awardprogrammes to build this capacity in the Irish researchsystem.

Over the coming years, SFI will continue its efforts tobuild world-class research teams, increase the number ofhigh quality researchers and therefore contribute to increas-ing the output of PhDs, which is a key objective of theStrategy. SFI will be to the forefront in implementing ini-tiatives over the coming seven years, which will provide asolid basis for Ireland's future economic development.See www.sfi.ie for more details

SC I E N C E FO U N DAT I O N IR E L A N D

SFI 24/09/2008 09:47 Page 2

LABS ARE VITAL LAUNCHEDIN DUBLIN

26

Labs are Vital’ is an exciting new initiative dedicatedto creating greater awareness and appreciation ofthe importance of laboratory professionals inIreland’s healthcare system. Every day, laborato-

ry professionals provide critical information that saves livesand helps control the costs of care in our hospitals. It is esti-mated that 60-70% of health care decisions are influenced bylaboratory run tests.

‘Labs are Vital’ will provide a unique platform for pro-fessional associations such as the Academy of MedicalLaboratory Science (AMLS) to work together to:• Highlight the value of the laboratory professional, both

within the healthcare system and to the general public;• Address the issues that laboratories face today, from

workforce changes to reimbursement strategies and lab-oratory utilisation;

• Serve as a community for laboratory professionals toexchange ideas and suggestions, working as a catalyst forpositive change;

• Promote careers in laboratory science among students inIreland.

Launched in the United States by Abbott in 2006, ‘Labsare Vital’ is successfully promoting the valuable work oflaboratory scientists in the United States, the UnitedKingdom, the Netherlands and now in Ireland, whereAbbott employs more than 3,400 people across sevenmanufacturing sites, including the Diagnostic Plants atSligo and Longford.

“The 3000 laboratory professionals working in Irelandmake a very significant contribution to our health care sys-tem, said Kevin O’Connell, President of the Academy ofMedical Laboratory Science (AMLS). “From early diagno-sis, to effective treatment, to maintaining affordable costs –all rely on the continued vitality of our clinical laboratories.‘Labs are Vital’ is an important initiative which will help pro-mote better understanding of the work of laboratories and willalso facilitate peer-to-peer engagement on issues affecting theprofession. The Academy of Medical Laboratory Science isdelighted to be a partner in the ‘Labs are Vital’ programme.”

Dolores Quinn, Marketing and CommunicationsManager, Abbott Diagnostics, echoed his enthusiasm:“‘Labs are Vital’ is a programme whose success is driven bythe active involvement of laboratory professionals andtheir professional organisations. It embraces new media,including social networking sites such as Facebook.com, tocreate awareness of their work and the exciting careeropportunities which exist in the profession. It also supportsthe profession in promoting their work within the widerhealth care system. We are delighted with the enthusiasticresponse from the Academy and other professional bodiesand we look forward to seeing ‘Labs are Vital’ grow fromstrength to strength in Ireland.”

Further information is available on www.labsarevital.com

L A B O R AT O R I E S

The recently launched ‘Labs are Vital’ programme will promote the workof Ireland’s 3,000 laboratory professionals.

Pictured at the launch of ‘Labs are Vital are (l-r): Alex McAllorum(8) and Leah Hennessy (9).

LANCASTER LABS EXPANDS IN IRELAND

LANCASTER Laboratories, one of the largest commer-cial analytical laboratories in the US, is expanding its oper-ation in Dungarvan, Co. Waterford. This investment fol-lows Lancaster’s acquisition in 2007 of Microchem Labs,an Irish company. It will result in the creation of 100 newhigh level positions over the next five years, with the sup-port of IDA Ireland. The majority of these positions willrequire people at PhD, Masters and graduate level.

Lancaster Labs is a leading provider of a compre-hensive array of scientific and validation services requiredby the US Food and Drug Administration (FDA).Following the acquisition of Microchem in Dungarvan,which will also be known as Lancaster LaboratoriesEurope, it has greatly enhanced its ability to support therequirements of companies in Europe and Asia. The ser-vices currently offered by Microchem will complement thepharmaceutical, biopharmaceutical, medical device andenvironmental testing services at Lancaster Laboratories.

‘

Labs 18/09/2008 14:41 Page 1

536 Grants Crescent,

Greenogue Business Park,

Rathcoole,

Co. Dublin

Tel : + 353 1 4019800

Sales Office : + 353 1 4019817

E mail : [email protected]

www.univareurope.com

Univar is Ireland’s leading source of high quality

ingredients to the pharmaceutical sector. Our

brand new site has been designed to meet the

regulatory compliance demands of our

pharmaceutical customers.

We are serious about safety and we are committed

to making a positive impact on environmental

issues in handling fine chemicals.

Univar is the partner of choice for many of the

world’s leading pharmaceutical ingredient

manufacturers.

Whether you are looking for API’S, EXCIPIENTS,

PROCESS CHEMICALS, SOLVENTS, OR

INTERMEDIATES we can provide technical and

regulatory support.

To discuss your specific needs please contact our sales office at +353 1 4019817

Need to re-engineer

your career?

What do you do?

Specialising in Pharmaceutical / Scientific / Technical / Logistics

Manpower offers you dedicated Scientific & Engineering consultants. Professionals who can

truly understand your specific skills and know where the best opportunities for your career lie.

With a Manpower consultant who specialises in Scientific & Engineering recruitment, you can

uncover what you really want out of your career. And more importantly, where to find it.

Call Manpower quoting the reference PCM on 01 - 6455200 or email [email protected]

Manpower Ireland Ltd cares about your privacy and is committed to processingyour personal information in accordance with our Global Data Privacy Principlesand the standards of fair information practices. For further information please visit:http://www.manpower.ie/user_agreement/data_privacy.asp

Univar 23/09/2008 14:57 Page 1

PHARMA INGREDIENTSFOR SUCCESS

28

Univar is best known as a world-leader in chem-ical distribution, serving customers from indus-tries that range from pharmaceutical through tocoatings and chemical manufacturing. The

pharma industry, however, has been a significant focus areafor the company in recent times and Univar PharmaIngredients are determined to build further on their alreadyhighly successful pharma ingredients business, in line withtheir European Pharma industry approach.

SETTING THE STANDARD FOR EUROPE

The new site at Greenogue, Rathcoole Co. Dublin sets thestandard. This outlet has become a blueprint for Univarfacilities across Europe. Thomas Butler, OperationsManager at Univar Ireland, gave PharmaChem Ireland atour of the company’s dedicated pharma ingredient storagefacility in Rathcoole. Thomas and his team ensure every cau-tion is taken in how products are received, stored, and thendistributed around the country.

“We designed the site around the needs of pharmaceu-tical and food customers,” explains Thomas. “This stands toreason, as there has been colossal inward investment in thisbusiness.”

UNIVAR PHARMA INGREDIENTS

“Univar Pharma Ingredients represents a significant por- tion of the business in Ireland,” continues FrankMcLaughlin, Marketing Manager. “Our pharmaceuticalbusiness is the sector where further strategic growth is tar-geted over the coming years.”

Univar’s expertise and long history in the pharmaceu-tical ingredients market allows them to offer customers aunique combination: global cost effective supply of a broadrange of ingredients with specific quality and regulatorystandards required by pharmaceutical manufacturers.

Univar distributes an unrivalled variety of Pharmaingredients, including API’s, excipients, process chemicals,intermediates and vitamins.

“In Ireland, Univar Pharma Ingredients work closelywith world leaders and innovators such as DMV Fonterra,BASF, Shell, Jungbunzlauer, Ineos and Purac,” notesFrank McLaughlin. “We want to be with only the best.”

If proof of Univar’s strong pharma ingredient offering

PHARMACEUTIC AL INGREDIENTS

Univar Pharma Ingredients is a world leader in pharmaceutical andchemical distribution, and its new site at Rathcoole, Co. Dublin, sets the

standard for its European operations.

The management and staff at Univar’s headquarters in Rathcoole,Co. Dublin.

Univar 26/09/2008 15:53 Page 1

29

was needed, look no further than its customer base. Thecommon denominator for every customer is a dedicated and‘best in class’ level of service, expertise, and technology –Univar supports its business not just in Ireland but through-out Europe.

Keeping an eye on trends is crucial for the prolonged suc-cess of Univar Pharma Ingredients. Through watching themarket, they distribute products that are maintained to thehighest standards, through vendor approval and site audits.Indeed, Univar Ireland openly welcomes and encouragesboth customer and supplier visits to their facility.

COMMITMENT TO SAFETY

With such market focus comes a commitment to safety thatsurpasses current industry standards, including their in-house ‘U+ Serious About Safety’ Programme.

When a customer buys from Univar PharmaIngredients, they are not just buying a product, they arebuying a service; not just a reputation, but also a guaran-tee that the product has been verified.

Indeed, Univar’s global reach is an additional benefit forits customers. Univar is the world’s leading chemical dis-tribution company, with a turnover in excess of $8 billion.The business is owned by venture capitalists CVC.

“A lot of our relationships are long term,” explains FrankMcLaughlin. “We have a clearly defined growth strategy:we know where we are going and why we are goingthere.”

HIGHLY TRAINED STAFF

Crucially, personable, knowledgeable, and professionalpeople lead Univar Ireland’s business. Although the phar-ma manufacturing industry is consumed by issues that rangefrom technology to supply chain to globalisation, humanrelationships play a major role in the success and futuredirection of the business. Univar Pharma Ingredients pro-vides more than just products: they offer new businessopportunities, creativity, and windows into new technolo-gies. Univar’s standing is as a result of its employees, sup-pliers, facilities, and its understanding of, and roots in, themarket.

In a fast moving, innovative, and rapidly changing sec-tor, Univar Pharma Ingredients not only provide theanswers, they also have the solutions.

PHARMACEUTIC AL INGREDIENTS

Univar’s new site at Greenogue, Rathcoole, Co. Dublin, has become a blueprint for Univar facilities across Europe.

For more information, contact: Univar Pharma Ingredients,536 Grants Crescent Greenogue Business Park Rathcoole, Co Dublin.Tel: (01) 4019800.Fax: (01) 4019412.Email: [email protected]: www.univareurope.com

Univar 25/09/2008 15:25 Page 2

INAB ACCREDITED CERTIFICATION BODIES

Reg No: 6003 Bord Bia Quality Assurance Board (Dublin)5007 Business Quality Assurance International (BQAI)Ltd. (Galway)8002 Certification Europe Ltd (Dublin)5006 Certification Europe Ltd (Dublin)3001 Certification Europe Ltd (Dublin)3501 Certification Europe Ltd. (Dublin)5005 EQA (Ireland) Ltd (Dublin)7001 ERS (Meath) 6002 IFQC Ltd (Louth)6001 NSAI (Dublin)5001 NSAI (Dublin)6004 Verifier Services Ltd (Dublin)

INAB ACCREDITED INSPECTION BODIES9007 AD Analytical (Dublin)9003 BOC Gases Ireland Ltd. (Dublin)9005 Certification Europe Ltd (Dublin)9006 Clean Technology Centre (Cork)9002 Hibernian General Insurance Ltd (Dublin)9001 Industrial Pressure Testing Ltd. (Cork)9004 OHSS Ltd (Co Dublin)9008 SWS Auditing Services (Cork)

INAB ACCREDITED LABORATORIES018 AGB Scientific Ltd. (Dublin)157 Advanced Micro Services (Cork)126 AGB Scientific Ltd (Dublin)175 Anecto Ltd (Galway)075 Aqualab (Donegal)189 Ascon Ltd. (Co Kildare)029 Aughinish Aluminia Ltd. (Limerick)149 Ballina Beverages (Mayo)005 BHP Laboratories Ltd (Limerick)183 Bodycote Consultus Ltd. (Cork)153 Bon Secours Hospital (Cork)116 Bord Iascaigh Mhara (Dublin)083 Bord Na Mona Environmental Ltd. (Kildare)178 Bristol-Myers Squibb Cruiserath (Dublin)193 Building Envelope Technologies Ltd (Wexford)001 Calibration Specialists Ltd. (Limerick)186 Calibration Technology Ltd. (Limerick)155 Cavan County Council (Cavan)171 Central Meat Control Lab (Kildare)138 City Analysts (Dublin)159 Claymon Laboratories (Co Dublin)174 Coillte Laboratories (Wicklow)108 Complete Laboratory Solutions (Galway)088 Compliance Engineering Ireland Ltd. (Meath)016 Cork County Council (Cork)092 CTL Tástáil Teo. (Galway)141 Dairy Science Laboratory (Kildare) 007 Dairygold Feed Laboratory (Cork)188 Davidson & Hardy (Laboratory Supplies) Ltd. (Dublin)160 Drogheda Concentrates (Louth)079 Dublin City Council (Dublin)177 Edenderry Power Operations Ltd (Offaly)142 Eli Lilly (Cork)166 Enfer Micro Laboratories Ltd (Tipperary)181 Enfer Testing Ltd. (Kildare)172 Enforce Laboratories Ltd (Cork)

185 Enva Ireland Ltd (Cork)111 Environmental Laboratory Services (Cork)113 Environmental Protection Agency (Monaghan)145 Environmental Protection Agency (Mayo)117 Environmental Protection Agency (Cork)119 Euro Environmental Services (Louth)077 Flow Meter Systems Ireland Ltd. (Co Cork)137 Forensic Science Laboratory (Dublin)044 GE Sensing EMEA (Co Clare)162 GeoTesting Ltd (Kildare)047 Hensey Glan-Uisce Teo (Galway)152 Highway Testing Laboratory (Galway)147 Icon PLC (Dublin)179 Identigen Ltd (Dublin)133 IGSL Ltd (Kildare)031 Independent Micro Lab Ltd. (Laois / Waterford)151 Irish Equine Centre Microbiology Unit (Kildare)128 Irish National Greyhound Laboratory (Limerick)164 Isotron Ireland Ltd. (Offaly)066 JVA Analytical Ltd. (Dublin)130 Marine Institute (Co Galway)043 Mason Technology Ltd (Dublin)191The Mater Private Healthcare Group (Dublin)161 Metrology Systems & Services Ltd (Co Cork)163 McAllister Devereux Keating (Cork)030 Medical Bureau Of Road Safety (Dublin)

187 Metlab Int. Ltd. (Cork)004 Microchem Labs (Waterford)182 Monaghan Veterinary Laboratory (Monaghan) 195 Mullingar Midland Regional Hospital (Westmeath)120 MTS Ltd. (Carlow)184 Neptune Laboratory Services Ltd (Galway)176 Occupational Hygiene & Safety Services Ltd (Co Dublin)173 OMAC Laboratories Ltd. (Galway)121 Pesticide Control Laboratory (Kildare)081 Public Analyst’s Laboratory (Cork)099 Public Analyst’s Laboratory (Dublin)009 Public Analyst’s Laboratory (Galway)101 Public Health Laboratory (Dublin)

096 Public Health Laboratory –HSE (Limerick)098 Public Health Laboratory – HSE (Sligo)097 Public Health Laboratory - HSE (Galway)094 Public Health Laboratory – HSE (Waterford)087 Public Health Laboratory – HSE (Cork)089 Q-Lab Ltd. (Wexford)086 Radiological Protection Institute Of Ireland RPII (Dublin)091 Radiological Protection Institute Of Ireland RPII (Dublin)180 Reagecon Diagnostics Ltd (Clare)012 Reagecon Diagnostics Ltd. (Clare)190 Roadbridge Limited (Limerick)165 Roadstone Dublin Ltd. (Dublin)127 Roadstone Dublin Ltd. Slane Laboratory (Meath) 194 Southern Scientific Services Ltd (Kerry)144 Schering Plough (Avondale) Company (Wicklow)196 SM Morris Ltd (Wicklow)146 State Laboratory (Kildare)192 St Vincent’s Hospital Healthcare Group (Dublin)112 Transtest Equipment Ltd. (Co Kildare)106 T.E. Laboratories Ltd. (Carlow)038 Teagasc (Dublin)169 The Drug Treatment Centre Board (Dublin)150 TMS Environment Ltd (Dublin)170 Waterford Regional Hospital – HSE (Waterford)064 Wyeth Nutritionals Ireland (Limerick)

Why use an accredited Laboratory, Certification or Inspection Body?Reduce risk - choose a proven, competent body

Accreditation by the Irish National Accreditation Board (INAB) means that laboratories, certification and inspection bodies have been assessed against internationally recognised standards to demonstrate their competence, impartiality and performance capability.

Log on to WWW.INAB.IE for current accreditation status and a full list of members scopes of accreditation.

Inad A4.indd 1 23/09/2008 17:07:47

THE BENEFITS OF ACCREDITATION

31

Accreditation is an often misun-derstood concept, but it is one ofthe cornerstones of both con-sumer confidence and interna-

tional trade. Frequently confused with cer-tification or standard setting, accreditationactually exists somewhere between thesetwo levels of checks and measures: approv-ing the management of standards which arecreated at an official level, but applied at alocal level.

Standards are set by national standardsbodies, although standards are global, and the NationalStandards Authority of Ireland is a member of theEuropean Committee for Standardisation (CEN) and theInternational Standards Organisation (ISO). The stan-dards are agreed by all stakeholders of the business, andaccreditation is not involved in setting those standards.Instead, it is about measuring how effectively those stan-dards are applied.

In this context, accreditation is different to academicaccreditation. It is there for both the end user and for indus-tries and companies, and it is a major element in the busi-ness carried out by what are known as ConformityAssessment Bodies – whether these bodies are inspecting,certifying or testing a service or a product.

Accreditation began in Ireland in 1985 in laboratories,but it has broadened its remit into areas as diverse as cer-tification of food and energy efficiency. And it is now beingused more and more to facilitate trade between memberstates.

The EC realised that there was a risk of one memberstate insisting on testing the products that it imported, sothey needed a system where there was international accep-tance of the testing that was done, a formal approval sys-tem.

DEMONSTRATING COMPETENCE

To date, accreditation has become far more widely usedacross a variety of sectors, although surprisingly, thisincrease is not being primarily driven by regulation. There

has been consistent growth in accreditationover the past 22 years. It is being applied ina whole range of areas which you might nothave thought of years ago. But, given that20% of the European market is regulated,and 80% is not, it is actually the 80% vol-untary market which is attracted to accred-itation because it needs to be able to demon-strate its competence.

This assessment of competence is a keyelement, in that the work of accreditation isabout assessing the competence of the bod-

ies whose business it is to check how the standards areapplied.

A laboratory which tests water for lead content could beusing an international standard, but INAB have to the checkhow competent that laboratory is at applying that standard.Because INAB is a small organisation, it utilises peerexperts to carry out these checks: it is a system of manag-ing the assessment process through peer expertise, andINAB can call on a wide network of experts worldwide.

QUALITY MANAGEMENT SYSTEMS

A familiar area covered by accreditation is that of qualitymanagement systems, where a company has to ensure con-sistency in its production processes – (the standard is knownas ISO 9001). In order for companies to demonstrate thatthey are complying with the standard, they must be certi-fied by a certification body. This body certifies compliancewith the standard – accreditation assesses the competenceof the body to be able to certify compliance with the stan-dards.

Accreditation is seen as the last level of control over con-formity assessment. Laboratories, inspection bodies orcertification bodies are measuring the conformity of prod-ucts or services. They compete with each other, and are gen-erally dealing with a huge volume of work. It is necessaryto have an accreditation body which levels the playing pitchand assesses how bodies maintain those standards. The IrishNational Accreditation Board fulfils this role.See www.inab.ie for more information.

ACCREDITATION AND STANDARDS

The Irish National Accreditation Board (INAB) is the nationalbody with responsibility for accreditation in accordance with the

relevant International Organisation for Standardisation ISO17000 series of standards and guides and the harmonised EN

45000 series of European standards.

INAB 18/09/2008 14:32 Page 1

ADDING VALUETHROUGH EXCELLENCE

32

The international pharmaceutical business envi-ronment continues to develop at a rapid rate.Increasing interactions between economies, par-ticularly between North America, Europe and

Asia, have raised many important issues regarding trans-port infrastructure, logistics and broader supply chainmanagement (SCM). The potential exists to furtherenhance shareholder value through enhanced trade, pro-vided that these issues are addressed in a logical and sys-tematic manner.

Ireland is a key global location for the pharmaceuticalindustry. Currently 13 of the top 15 companies in the worldhave substantial operations in Ireland, with six out of 10 and12 out of 25 of the world’s top selling drugs produced here.The majority of products are manufactured for globalmarkets.

SCM EXCELLENCE

It must be recognised that a product is delivered to the ulti-mate customer through a series of complex interactionswith several companies along the way. The manufactur-er’s ability to give the customer what they want, when theywant it, at the price and quality that they expect is not justdetermined by the efficiency and effectiveness of themanufacturer’s own operation. Inefficiencies anywhere inthe supply chain will reduce the chances of the manufac-turer successfully competing against other suppliers.Without a proper focus on total supply chain management,therefore, a company will never achieve true competitiveadvantage.

The increasingly international nature of markets andcompanies has resulted in many companies becoming partof large and complex global supply chains. In addition, thepotential benefits associated with emerging electronic com-merce technologies provide the potential to simultaneous-ly improve customer service levels and to reduce supplychain costs. These factors have sharpened the focus on theneed for improvements in all aspects of supply chain per-formance.

So what are the characteristics of SCM in companiesthat might be regarded as world class? The following fourelements appear to be of critical importance for most com-panies in most sectors:

- Identification and measurement of customer servicebecause customer service ‘sets the spec’ for supply chaindesign.

- Integration of supply chain activities and informationbecause many supply chain NVAs are caused by frag-mented supply chain configurations.

- SCM regarded as a senior management functionbecause SCM is a strategic activity.

- Establishment and measurement of supply chain keyperformance indicators (KPI’s) because what getsmeasured gets done!

Recent research by NITL indicates that while pocketsof excellence undoubtedly exist, there is serious room forimprovement. A survey of 776 companies in the Republicof Ireland (including many in the pharma sector) in relationto the factors outlined above showed that:

• Approximately 50% measure customer service formal-ly and those have very limited measurements;

• Companies score low in relation to having the latest sup-ply chain information and communications technology(ICT) and having them integrated across the supplychain;

• Less than 10% have any formal SCM position;• Few companies had clearly defined SCM KPI’s.

SU P P LY CH A I N

Edward Sweeney, National Institute for Transport and Logistics (NITL)writes on enhancing shareholder value in the Pharmaceutical industry:

the supply chain dimension.

NITL 18/09/2008 15:18 Page 1

33

Furthermore, a number of possible barriers to SCM excel-lence have been identified and will be explored as part of theongoing research and associated analysis. These include:

• Inefficiencies are often built into the supply chain.• Communication structures are ineffective and exchange

of information poor.• Culture is inappropriate.• There is an excessive reliance on forecasting and stock-

holding.• Problems are often managed, rather than their causes

eliminated.

CONCLUDING COMMENTS

The potential exists across the pharma industry to signifi-cantly enhance shareholder value through the adoption ofSCM thinking. The regulatory environment in which theindustry operates brings its own particular challenges butthese are not insurmountable: rather, they require that cre-ative SCM strategies be developed, and then executedsuperbly, with strong attention to detail.

SU P P LY CH A I N

ABOUT THE AUTHOR

Edward Sweeney is Director of Learning at the NationalInstitute for Transport and Logistics (NITL), based at theDublin Institute of Technology (DIT). NITL was estab-lished in 1998 as Ireland’s ‘Centre of Excellence’ in supplychain management. Since then, it has provided a range ofeducation, training, consultancy and research supports tocompanies in Ireland and abroad.

At NITL, Edward is responsible for the development andimplementation of the integrated supply chain management(SCM) development programmes and carries out researchand consultancy work on behalf of NITL client companies.He is an engineer by background and has worked and lec-tured in over 20 countries in Europe, North America andAsia. His work has been widely published and he is a reg-ular contributor to business and academic conferences andseminars throughout the world. His most recent book,‘Perspectives on Supply Chain Management and Logistics:Creating Competitive Organisations in the 21st Century’,is available through Blackhall Publishing.

NITL 18/09/2008 15:18 Page 2

PREPARING FOR THE FUTURE

34

Pharmaceutical manufacturers have been providingmedicines for more than 60 years using tried andtested formulations and manufacturing and qualitymanagement processes. In recent years, new inno-

vations in measurement, control and IT technologies havehelped them to manage their processes more efficiently,with higher productivity as a result. In addition to these inno-vations, a specific initiative has also been making its presencefelt. Known as the Process Analytical Technology (PAT)Initiative, its goal is to understand and better control the entiremanufacturing process within the pharmaceutical industry.Processes are actively managed to achieve a high degree ofrepeatability and efficiency, and quality assurance becomescontinuous and real-time activity. ABB is working in part-nership with its customers to deliver a systems approach toPAT. From measurements to process improvement, ABB sup-ports PAT implementation and the delivery of real businessbenefits.

WHAT IS PAT?

Process Analytical Technology (PAT) is a system for design-ing, analysing, and controlling manufacturing processesbased on an understanding of the scientific and engineeringprincipals involved, and identification of the variables whichaffect product quality. The PAT initiative is based on the FDA(The US Food and Drug Administration) belief that: “qual-ity cannot be tested into products; it should be built-in orshould be by design.”

The primary goal of PAT is to provide processes whichconsistently generate products of a predetermined quality.Effective PAT implementation is founded on detailed, science-based understanding of the chemical and mechanical prop-erties of all elements of the proposed drug product.

In order to design a process that provides a consistentproduct, the chemical, physical and biopharmaceutical char-acteristics of the drug and other components of the drug prod-uct must be determined. The role of on-line advanced mea-surement systems is pivotal to realising the benefits of PAT.However, the transformation of process performance toprovide greater efficiency and cost effectiveness, in additionto assured quality, requires much more than the applicationof measurement technologies. Realising such gains alsorequires an integrated measurement, control, workflow man-agement and information environment which meets the

needs of research and development, manufacturing andquality processes within the business.

Using PAT, ABB offers a unique industrial solution so thatits customers in the Life Sciences industry can enhance theirprocesses to deliver the benefits of PAT, from process inves-tigation right through to achieving operational excellence.

THE BENEFITS OF PAT

In a nutshell, the benefits of PAT can be summed up in thefollowing sentences:

PAT improves asset uptime and availability for pharma-ceutical unit operations by up to 40%. Costs are reduced byup to 30%, while fundamental product quality is main-tained. How this is achieved is outlined in the following para-graphs.

BETTER PROCESS UNDERSTANDING:

The physical and chemical processes involved in the man-ufacture of pharmaceuticals are complex and not wellunderstood. However, during both the development andmanufacturing stages, PAT-enabled processes provideaccess to information rich data, in real-time, which can be“mined” to find the critical quality parameters through mul-tivariate analysis. Once these are determined, it is then eas-ier to establish accurate control schemes for the relevantprocess parameters, so that a more robust process can beestablished in a shorter timeframe and right-first time pro-duction is ensured.

PR O C E S S AN A LY T I C A L TE C H N O LO G Y

Process Analytical Technology (PAT) will revolutionise the way pharma-ceuticals are made and will forever change the face of the industry,

according to ABB, who maintain that PAT improves asset uptime andavailability for pharmaceutical unit operations by up to 40%.

Process Analytical & Diagnostics 18/09/2008 17:11 Page 1

End to end solution for PAT implementation. A system for taking advantage of the FDA’s PAT guidance has arrived!

ABB’s IndustrialIT for PAT is a fully integrated PAT solution that

supports online process verification, continuous process improvement

and PAT based product release. The system communicates with ABB

and/or third party analyzers, DCS systems, databases and other manufacturing support

systems. The system is scalable, able to support systems ranging in size from a development

laboratory to a full production facility. To complete the total PAT solution, ABB offers

consultancy, engineering and project management services for the system that meet GAMP4,

ICH Q8 and ICH Q9 guidance. From analyzers and automation to services and support, only

ABB stands ready to implement a total PAT solution for your process today! Call ABB to take

delivery of your PAT solution.

For more information, visit us at www.abb.com/lifesciences, abb.com/analytical

or email [email protected]

© Copyright 2007 ABB USCS 1204

ABB has arrived

with a PAT solution.

Project3 25/09/2008 15:44 Page 1

36

REPEATABLE BATCH TRAJECTORY:

Quality control requires a highly detailed level of processunderstanding. ABB offers a combination of advanced andregulatory control based on robust process models thatdeliver verifiable results. The PAT solutions detect andmanage critical control points in the process so that deviationsfrom a required profile are correctly managed and fed backinto the high performance control zone.

REDUCTION IN OVERALL CYCLE TIME:

Processing to a quality-based endpoint is a key part of the PATquality assurance regime. This eliminates wasted cycle timeassociated with processing using a fixed time-based endpoint,including subsequent reprocessing time, and provides astreamlined workflow through the facility.

REDUCTION IN QUALITY ASSURANCE (QA) COSTS:

Reduction in Out of Specification (OOS) events and conse-quent investigation leads to significant cost savings. PATenabled unit operations reduce the reliance on laboratory test-ing and associated lead times, thus reducing the overhead costsassociated with product quality.

IMPROVEMENT IN OVERALL EQUIPMENT EFFECTIVENESS(OEE):

OEE is the industry accepted tool to measure and monitorproduction performance. It can be applied at the machine,manufacturing cell or plant process level. Making cycletimes repeatable and reducing in-batch down-time throughimproved control and early fault detection delivers a more flex-ible agile asset with much improved OEE.

ABB’S PAT CENTER OF EXCELLENCE (COE)

Following the need to offer an integrated approach to PAT,ABB created a CoE in 2004. Its mandate is to develop ABBproducts and services which will enable customers to reap thebenefits of PAT. The PAT CoE builds on ABB Analytical’sexperience of providing Pharmaceutical PAT FourierTransform Infrared) (FTIR) and Fourier Transform NearInfrared (FT-NIR) analysers to the market for the past 10years, as well as ABB’s position as a leader in Automation andControl, in particular with its 800xA platform.

The PAT CoE leverages ABB’s global resources, whichinclude experienced research and development personnel,application specialists, chemometricians, process engineers, ITengineers, senior validation consultants and advanced processcontrol specialists. Its mandate covers the entire range of PATapplications:• Initial integration with Manufacturing• Excellence programs• Multivariate analysis• Basic and advanced analysers• Data gathering

• Data storage• Data mining• System integration• Connectivity with manufacturing and business systems• Advanced Process Control (APC)

ANALYTICAL AND MEASUREMENT TECHNOLOGIES: THE PLATFORM FOR PAT

At the heart of any PAT system is a series of measurementsmade on real processes under realistic manufacturing condi-tions. Data from conventional process measurement systems(eg, temperature, pressure and flow) give some insight intomanufacturing processes so as to achieve a basic level ofprocess understanding.

However, manufacturing processes are usually too com-plex for simple approaches to be effective in achievingprocess understanding and control. An in-depth degree ofunderstanding and tight control can only be achieved byemploying the correct technologies to measure relevantprocess parameters. These technologies are often based onchemical composition and/or physical form measurements, ieanalytical techniques.

ABB has top class analytical technologies, from FT-IR/NIR spectroscopy right through to mass spectrometry andGas chromatographs. Fully integrated into ABB’s IndustrialIT (IIT) concepts, the systems have unparalleled connectiv-ity capability and provide a robust measurement platform forall PAT applications. Connected to the IIT informationbackbone, the process data developed can be used in every-thing from advanced control to process troubleshooting.

FT-IR/NIR ANALYTICAL SOLUTIONS

FT-NIR is, by far, the most widely used and proven analyt-ical technology for PAT applications. ABB has 10 years ofexperience in supplying off-line, at-line and on-line FT-IR/NIR PAT solutions to the pharmaceutical industry and isa preferred supplier of most of the leading companies. Turn-key analytical solutions are provided for research and devel-opment for scale-up, drug substance, and drug productmanufacturing. Typical drug substance solutions include:• Reaction monitoring• Fermentation monitoring• Crystallisation monitoring• Dryer monitoring• Solvent Recovery monitoring



Typical drug product applications are:• Raw material identification• Blend monitoring• Spray coating monitoring• Fluid bad dryer monitoring• Solid dosage form content uniformity• Moisture in lyophilized solids

Even though the available analytical technology ful-fills a wide variety of measurement needs, there is still avery wide Information Technology gap which is pre-venting the industry from efficiently gathering and usingthis data in real-time for process understanding andcontrol. To be more specific, most of the advanced PATanalysers currently available do not share a common userinterface and data format, and do not offer the connec-tivity required to efficiently exchange this data with plantand business systems. Furthermore, the data is highlyscattered and is not available in real-time in a central loca-tion.

THE INDUSTRIAL IT FOR PROCESS ANALYTICALTECHNOLOGY SUITE:

To address these drawbacks, ABB is currently develop-ing an Industrial IT PAT suite that features an integrat-ed IT platform using proven analytical and automationcore components. This platform is based on the awardwinning 800xA Industrial IT Automation technology).The concept is based around a flexible, modular, scaleableand open architecture which uses OPC – a standard com-munication protocol – to exchange data between modules.

FTSW800 – ANALYSER CONTROL PROCESSSOFTWARE FOR DATA ACQUISITION

This flexible, open architecture process analyser soft-ware is designed for implementing analytical methodsand control sequences. It offers a single platform forthe local control of multiple analysers from spec-troscopy (IR, UV-VIS, Raman etc) to other advancedanalyser types (particle size, acoustics, HPLG, massspectroscopy etc). In addition, it provides unifiedengineering and operator interfaces as well as tools formultivariate analysis and predictions.

DATA STORAGE - PAT DATA MANAGER:

The management of PAT data is highly com-plex, not only because the flow of informationis enormous, but because it also includes a mixof data formats (spectral, vector and scalardata) that makes it difficult for standard his-torians to handle. Furthermore, the centrali-sation of PAT data is not sufficient as itneeds to be combined with the batch infor-

mation coming from the process control system (PCS) and thebusiness systems.

ABB’s PAT data manager is unique in that it stores all thedata in a single distributed database and can handle huge flowsof both scalar and vector data coming from the analysers, thePCS and SCADA systems. It handles the batch structure data,the vector and scalar data, alarms and events, as well as a com-plete audit trail. It can also exchange data with other thirdparty historians.

DATA MINING, VISUALISATION, MULTIVARIATEANALYSIS, AND BATCH MANAGEMENT:

The IndustrialIT for PAT suite includes a wide range of mod-ules to provide an operator workplace, central method con-figuration, multivariate analysis batch configuration andmanagement, as well as asset management for analytical andprocess equipment. The system also has the ability to connectto third party commercial multivariate analysis tools for off-line and real-time predictions.

CONTROL

Controlling processes in a flexible and repeatable mannerrequires process understanding to be realised within regulatoryand advanced control environments, while at the same time tak-ing advantage of a range of process models. This is facilitated bydynamic solutions – predict, control and inferential measurementplatforms which integrate with operator interface, and regulatorycontrol and process data management components.

THE WAY FORWARD

PAT provides an opportunity to move from the current “test-ing to document quality” paradigm to a “continuous qualityassurance” paradigm that can improve a company’s ability toensure that quality has been “built-in” or is “by design”. Notonly that, but it gives companies a greater insight andunderstanding of their processes; it provides the potential forsignificant reduction in production (and development) cycletimes; and it minimises the risk of poor process quality.

PAT will revolutionise the way pharmaceuticals aremade and will forever change the face of the industry. This iswhy ABB’s investment in PAT is the single biggest develop-ment initiative in Life Sciences, and it also presents the com-pany with an exceptional opportunity to become the marketleader in Life Sciences.


PAT solution for the scaled-up process

37


KELLS STAINLESS CELEBRATES 20THANNIVERSARY

38

On June 19, 1988, Kells Stainless Ltd opened itsdoors for business and this year, the companycelebrates 20 years in operation. Although ona newly purchased five-acre site and with a new

name, Kells Stainless personnel already had 18 years ofStainless Steel fabrication experience gained from workingwith Bailie Engineering, a Stainless tank fabrication com-pany which was based in Bailieborough, Co. Cavan.

Founded by key personnel from the former BailieEngineering facility and using plant and equipment pur-chased from the engineering site, Kells Stainless hit theground running and immediately became a major player inthe growing Stainless Steel Vessel manufacturing industry.

MEETING CHALLENGES

Key to Kells’ success over the years has been their ability to pre-dict changes in industry trends and to implement internal changeswithin the organisation to meet every new challenge. These chal-lenges have required substantial investment in personnel,premises, plant and technology and this has kept Kells ahead oftheir competitors and they continue to lead the way in havingstrong industry recognition of quality product and performance.

Flexibility to manufacture Tanks, Vessels and ModularSkid Assemblies for a wide range of industries fromChemical, Food & Beverage to Pharmaceutical and Biotech,has meant that Kells have been able to build up long termworking relationships with their clients and customers allover the world.

INTERNATIONAL CLIENT BASE

Kells have a 40% export market that is supported by a Salesand Design office based in the UK and have recently exhib-ited at Interphex Asia in Singapore, with a view to grow-ing their worldwide market, especially within thePharmaceutical & Biotech sectors.

Recent investment in state of the art fabrication equip-ment and a new 1,000 square metre Clean FactoryAcceptance Test facility, paves the way for future growthfor Kells, and provides them with the ability to meet specificcustomer requirements and to copperfasten Kells Stainless’position as a complete Process Engineering Solutionsprovider.

For more information go to www.kellsstainless.com ore-mail [email protected].

STA I N L E S S ST E E L VE S S E L S

kells stainless 18/09/2008 16:49 Page 1

SECURE SUPPLY CHAIN TOCOMBAT COUNTERFEITERS

39

Today, international traderstake advantage of moreopen borders and new tech-nologies such as the Internet

to conduct their criminal businesswithout any scruples for people'shealth. Though traditionally rare inEurope, this growing threat needs tobe tackled, in particular, by makingthe entire European pharmaceuticalsupply chain as tight and secure aspossible.

Counterfeit medicines are any medicines and active phar-maceutical ingredients (APIs) that are deliberately and fraud-ulently mislabelled by unauthorised parties with respect tosource and/or composition and/or therapeutic quality. They havebeen found to contain toxic substances, no active ingredient, orthe wrong amount of it. Life-saving medicines are increasing-ly targeted, including medicines to treat cancer and heart dis-ease, psychiatric disorders, and infections.

Counterfeiting is attractive because it is a lucrative activi-ty with little risk of being caught. Globalisation has lead torelaxed barriers to trade, thus facilitating the circulation of coun-terfeit products and a plethora of actors are now operating inter-nationally or through the Internet and therefore outside the juris-diction of national regulators.

THE SCALE OF THE PROBLEM

EU statistics released in May 2008 show that over 4m medic-inal products (articles) were seized at EU customs borders in2007. This was an increase of 51% on the 2006 figure. WhileInternet-based sales are the main source of counterfeit medi-cines, these products are being encountered at all stages of thesupply network: manufacture, distribution and entry throughwholesalers, pharmacists and the black market.

The lack of integrity in the supply chain is seen as a facili-tating factor. There is no accurate data on the scale of coun-terfeits in the pharmaceutical sector because they are mainly soldand used in unofficial and uncontrolled settings, thus makingthem difficult to detect. Or where controls and regulations doexist, reporting is sporadic and not centralised.

Strong EU measures to tackle this growing threat, includ-ing a ban on medicine repackaging, a harmonised EU-systemof identification of medicines, and heavier penalties for traf-

ficking in counterfeit medicines arerequired immediately.

The World Health Organisation(WHO) estimates that 8-10% of themedicines in the global medicinesupply chain are counterfeit, reach-ing as high as 25% in some countries.The largest counterfeit market withclose proximity to the EU is Russia,where it is estimated that 12% ofmedicines are counterfeit (Source:

Association of International Pharmaceutical Manufacturers(AIPM) and the Coalition for Intellectual Property Rights(CIPR) 2002).

An in-depth report by the European Alliance for Access to SafeMedicines (EAASM) entitled the Counterfeiting Superhighway(www.eaasm.eu/Media_Centre/News/The_Counterfeiting_Superhighway), examining internet pharmacies and lifesaving medicinespurchased online, revealed that a frightening 62% of medicinespurchased online are fake or substandard. These include medi-cines indicated to treat serious conditions such as cardiovascularand respiratory disease, neurological disorders, and mentalhealth conditions.

DETERMINED ACTION IS NEEDED

It is time for Europe to act as the driving force in the fightagainst this deadly crime. Organised crime gangs are operat-ing on an international scale and playing with human lives inthe name of profit, and these must be dismantled through deter-mined action, systematic prosecution and appropriate sanctions(civil and penal). Penalties in place in Member States today areinadequate.

Patients must also be encouraged to purchase prescriptionmedicines through authorised distribution channels only.Only then can patients be guaranteed to be getting a genuinepharmaceutical product.

Proposals for tougher EU legislation are expected beforethe end of 2008, as part of a new ‘pharmaceutical package’being developed by the European Commission. Options out-lined by the Commission in its public consultation documentin March 2008 include obligatory product sealing and a banon medicine repackaging.

The need for action is urgent, no further time can afford tobe lost if patients’ lives are to be protected.

CO U N T E R F E I T ME D I C I N E S

Counterfeit medicines pose a growing threat to European patients’ health, writes Ronan Collins, Communications Manager,

Irish Pharmaceutical Healthcare Association Ltd.

Conterfeit 18/09/2008 14:38 Page 1

CUTTING DOWN ONMEDICAL ERRORS

40

Patient Safety issues such as medication errors,counterfeit medicines and the inability to achievecomplete traceability of surgical instruments andimplants have challenged the key stakeholders in

the healthcare sector in recent years. Industry has beensearching for practical solutions to deal with the growingthreat of counterfeits and the more effective managementof product recalls.

Concern about patient safety issues has also forced reg-ulators at national and regional level to respond with newlaws requiring more effective tracking of products withinthe supply chain, from manufacturer to patient, and in thecase of implants and instruments, throughout their entirelifecycle.

Healthcare providers are crying out for solutions thatwill help them to reduce the risk of medical errors. Fundingproviders to healthcare, both Government and private, arelooking for information systems which will give themgreater control in order to achieve better value for money.

PEDIGREE LAWS

Once again, the US has led the way with pedigree lawswhich require a chain of custody across the entire phar-maceutical supply. The early laws, for example the Floridapedigree, did not refer to any form of electronic documen-tation but rather naively envisaged paperwork passing frommanufacturer through many other supply chain partners,with each one being required to sign their acceptance andaccountability.

Fortunately these new demands coincided with theadvent of GS1’s RFID division, EPCglobal. As a con-sequence, the manufacturers became heavily involved indefining requirements for deploying RFID and BarCodes in order to deliver an electronic or ePedigree solu-tion. In essence, there was no other practical way to meetsuch onerous regulation. A key reason for choosingEPCglobal was not just the RFID technology but alsoits concept of the EPC Network. The network archi-tecture allows the sharing of critical data via a secureintranet between trusted parties across the entire sup-ply chain: as you might say it’s not the technology, it’sthe data, stupid.

The illustration shows how the network operates.

THE BENEFITS OF SECURE NETWORKS

So how will secure networks based on the EPC global archi-tected standards deliver on the range of requirements out-lined above? Well essentially it will for the following rea-sons:- All pharmaceuticals and medical devices will carry GS1

Data Matrix bar codes and/or RFID tags, which willprovide access to the following common data content– GTIN (Global Trade Item Number), serialisation(unique ID per unit/patient pack), batch number andexpiry date.

- Electronic patient record data held in various databases,such as GP, Laboratory and Radiology Systems and atother treatment centres, will be made available to thepoint of care via the Network using the EPCIS.

- The Network will provide secure access (for trustedparties only) to the following data:

1. The product master data.2. Manufacturing information – batch and expiry etc.3. A complete lifecycle for stakeholders such as the IMB

(Irish Medicines Board), especially important in thecase of a product recall. The latter feature will beachieved because each time a tag or data matrix barcode is captured along the supply chain, this will pro-vide a time and date stamp as well as location confir-mation.

TR AC E A B I L I T Y

The EPC Global Network is a technology solution for its time, with provenbenefits for the healthcare sector, according to Jim Bracken,

Chief Executive Officer, GS1 Ireland.

GS1 23/09/2008 09:57 Page 1

41

Some of the other benefits of these secure networksinclude:

MEDICAL ERRORS

It is widely accepted that hospital patients have a 1 in 9chance of experiencing an adverse event. This can beanything from minor incidents to serious failures causingdeath or significant harm to the patient. Medication errorsalready account for over 20% of all medical errors and con-tinue to increase. With real time availability of clinical data,coupled with the ability to scan patient packs containingproduct ID, batch and expiry information, it will be possi-ble to attack 90% of the root causes of the problem (56%arises at the prescribing/ordering stage and a further 34%at the point of medication).

MEDICAL DEVICE TRACEABILITY

In a similar way, the current medical errors (involvinginstruments and devices – infection caused by cross cont-amination due to unclean instruments and inability totrack individual implants to particular patients) could begreatly reduced through improved Track & Trace capabilitydue to having certainty of identification through scanningand linking to patient records. Given that some implantstoday have a life expectancy of 15 plus years, the accura-cy of identification of the device to the patient is critical.

SUPPLY CHAIN INTEGRITY

By recording every transaction between all the parties acrossthe entire supply chain, from manufacturer to patient, it willbe possible to identify if product goes missing and where andalso to provide a means of product authentication before aproduct is dispensed in a pharmacy. This capability will helpto prevent counterfeit products entering the normal pharmasupply chain, an all too regular occurrence in recent times.

PRODUCT RECALL

At present, it is impossible to effect 100% recall of a prod-uct withdrawn from the market. On average, more than 33%of products are never recovered. Furthermore, the costs ofmanaging a single recall run in to tens of millions of euro.With the visibility provided by the network, virtually 100%of products subject to recall could be located and withdrawn.

RE-IMBURSEMENT FRAUD

Many European Governments have attempted to counteractthis fraud, where the patient is provided with a cheaper(generic) drug in place of the branded one prescribed, butthe Re-imbursement body is charged with the more expen-sive item. By having each patient pack bar-coded or taggedwith a unique identifier, simply by scanning the code, anaudit trail will be established and fraudulent overchargingwill be identified and stopped

EUROPEAN packaging show specialist easyFairs, whichorganises around 20 packaging shows across Europe, bringsthe inaugural easyFairs Packaging Ireland to the RDS,Dublin, on June 17 and 18, 2009, heralding an excitingopportunity for pharmaceutical companies to discover inno-vative new packaging solutions.

The show will mirror the easyFairs model of cost- andtime-effective shows for people who want to do business. It’sa no-nonsense formula that’s proved popular in the UK – theexpo held at Birmingham’s NEC in March attracted 360exhibitors and a record 3,925 visitors – and the Continent.

Many leading packaging companies such as Ashtown,Greiner and pharma specialist Catalent Ireland have alreadycommitted themselves to easyFairs’ Packaging Ireland.The event will showcase the latest packaging design inno-vations, eco-friendly materials and sustainable packagingsolutions, plus packaging machinery, printing systems,robotics automation, and converting technology.

Peter Heath, Managing Director of easyFairs UK, said:“Ireland demands its own packaging show, a place where thethriving packaging community can meet key buyers and deci-sion makers. I’m confident easyFairs’ Packaging Irelandcan grow to become as successful as our shows in the UK andEurope. I envisage the show will comprise mainly Irishexhibitors, with small, niche suppliers exhibiting alongside

larger companies, but also appeal to many European pack-aging suppliers who exhibit at easyFairs’ editions elsewhere.”

And he believes the low-cost, low-fuss easyFairs formulawill prove particularly attractive during today’s challengingeconomic climate: “At times like this, companies are focusedon getting an even better return on their investment.easyFairs’ packaging shows enable exhibitors to do business,develop new contacts and make sales at a fraction of the costof a traditional trade show.”- For further information and stand bookings, contact

Marc Benoit on +0044 208 622 4421 (e-mail:[email protected])

TR AC E A B I L I T Y /PAC KAG I N G IR E L A N D 2009

PACKAGING IRELAND 2009

GS1 23/09/2008 09:57 Page 2

GOLIATH: THE PACKAGING GIANT

42

With direct industry experiencegained through many years ofsuccessful project delivery inIreland, the expertise of its inter-

national partners/suppliers and the skills of its fac-tory trained staff, Tipperary-based GoliathPackaging Systems Ltd is perfectly positioned tomeet the demands of its customers in the phar-maceutical and chemical sectors.

The company recognises the importance of thePharmaChem sector to the Irish economy andconcentrates on this critical market segment viaits trading division, Goliath Pharma.

The Goliath Pharma product range consistsof the following distinct items;• Liquid Filling Systems• Shrink Wrapping & Over Wrapping• Case Erecting, Case Packing & Bag-in-Box

Lining Systems• High Speed Labelling Systems• Case Sealing• Conveying Systems• Pallet Inverting (Fixed, Mobile & Automatic In-line)• Pallet Stacking / Handling• Scissors & Vacuum Lifting Systems• Materials Handling Systems• Pallet Elevating Systems• Palletising Systems (Gantry, Articulated Arm & Layer)• Stretch Wrapping• Strapping Systems (Case & Pallet)• Washing Systems (Pallet, Box, Tray, Drum, Bottle & IBC)• AGV Transport• Warehouse Management Systems (WMS)

In addition, the following complementary (ancillary) items areprovided by Goliath in order to offer a fully integrated turn-keyservice;• Weighing Systems• X-Ray / Metal Detection

Goliath also offers a Project Management / PackagingConsultancy Service to assist in the early determination of cus-tomers’ particular packaging equipment requirements.Goliath serves the following segments of the Irish market:Pharmaceutical; BioTech; Chemical; Healthcare; MedicalDevices; Contract Packing etc.

Goliath is the Irish partner to a number ofinternationally known packaging equipmentsuppliers. The capabilities of the more importantof these international partners (to thePharmaChem sector) are highlighted below.

FILAMATIC

Filamatic has designed and manufactured liquidfilling equipment for over 50 years. Servicing thepharmaceutical, biotech, diagnostic, healthcare,specialty chemical and food industries, Filamaticprovides a wide range of equipment that can becustomised to suit a client’s unique applicationand/or budget. Each unit is custom built to pro-vide increased throughput and faster changeover,while reducing downtime and increasing overallequipment effectiveness.

Filamatic offers a comprehensive equipmentportfolio from easy to use semi-automatic benchtop units to fullyautomatic, integrated packaging systems. The semi-automaticbenchtops are ideal for start-up companies, R&D departments,short production runs and budget conscious projects. The auto-matic range includes Monobloc, In-Line and Molten ProductFillers plus In-Case Filling/Capping Systems. The automatic fill-ing system range can also incorporate a variety of functionsincluding sorting, plugging, stoppering, crimping, capping,induction sealing and/or labelling as necessary. With precisionfilling pumps that can accommodate free-flowing, semi-viscousand viscous products, Filamatic equipment is designed to workwith an array of container types such as bottles, vials, tubes andpails.

PESTER

Pester is a leading international manufacturer and supplier ofshrink wrapping, case packing and palletising equipmentwith a particular focus on the pharmaceutical industry. In busi-ness since 1888 and with over 280 employees, the companyensures that all customers’ packaging requirements are satis-fied with machines of the highest reliability and quality.

With Irish references at P & G, Braun Oral-B, IVAX,Genzyme, GSK and Pfizer, amongst others, Pester has provenitself to be one of the best international providers of validatedequipment in this specialist field.

PACKAGING

Goliath Packaging Systems Ltd sources, supplies, installs and offers after-sales service on a comprehensive range of end-of-line packaging,

materials handling, and washing equipment to the Irish pharmaceutical and chemical marketplace.

Newman Labelling Systems hasbeen a world leader in the supplyof pharmaceutical labelling sys-tems for over 60 years.

Goliath 18/09/2008 16:12 Page 1

TT:: 006677 3377889933 FF:: 006677 3344779944 MM:: 008877 11222222881166iinnffoo@@ggoolliiaatthh..iiee wwwwww..ggoolliiaatthh..iiee

BBEEEECCHHWWOOOODD,, NNEENNAAGGHH,, CCOO.. TTIIPPPPEERRAARRYY

Shrink Wrapping

Banding

Liquid Filling

Case Erecting

Case Packing

Leaflet Dispensing

Bag-In-Box

Case Sealing

Conveying

Labelling Systems

Check Weighing

Metal/X-Ray Detection

ss aa ll ee ss �� ii nn ss tt aa ll ll aa tt ii oonn �� ssee rrvv ii cc ee

Pallet Inverting

Scissors Lifting

Vacuum Lifting

Reel Handling

Drum Handling

Pallet Elevation

Palletising

Stretch Wrapping

Strapping

AGV Transport

Washing Systems

Warehousing

ss aa ll ee ss �� ii nn ss tt aa ll ll aa tt ii oonn �� ssee rrvv ii cc ee

220 x 307mm:Layout 1 18/09/2008 16:56 Page 1

44

NEWMAN LABELLING SYSTEMS

Newman Labelling Systems has been a world leader in the sup-ply of pharmaceutical labelling systems for over 60 years andhas built up an enviable reputation for high quality labellingequipment to meet the specific regulatory demands of the inter-national pharmaceutical industry. The secret behind Newman’ssuccess can be attributed to a combination of accuracy and reli-ability of equipment, quality and speed of validation, quality ofafter-sales service, engineering capability, staff experienceand the stability of the company.

Newman’s products are designed and built to meet and sur-pass the rigorous quality requirements of the pharmaceuticalindustry. In addition, the company provides full validation ser-vice to FDA, European and other national and internationalstandards, enabling easy progress through the necessary qual-ification procedures.

SOCO SYSTEM

Based in Denmark and founded in 1964, Soco System providesa complete range of end-of-line packaging equipment to thePharmaChem sector. Incorporating carton erecting, pick &place, sealing, conveying, palletising and stretch wrapping solu-tions, amongst others, the company enjoys turnover in the regionof €30m per annum.

NEWSMITH

The Newsmith name is synonymous with robust and reliablewashing systems, designed for the particular requirements ofthe PharmaChem industry. Newsmith have been manufacturingwashing equipment since 1968 and have supplied hundreds ofsystems to the PharmaChem sector, including Irish referencesat Organon, Pfizer, UCD and UCC, amongst others.

The Newsmith range includes the Series 80 Rack Washers(laboratory sector), Dynajet Cabinet Washers (trays, containers,pallets on trolleys), Rotary Bin Washers and high speedConveyorised Systems (trays, drums, pallets, IBC’s etc).

TOPPY

Toppy, based in Italy, specialises in providing a complete rangeof pallet inverting, retrieval, transfer and exchange equipment.

The comprehensive product range incorporates both semi andfully automatic systems, plus mobile and fixed options. Today,with a strong base in Europe and over 2,000 global installations,Toppy has proven itself to be a reliable partner for safe and cost-effective pallet exchange and is one of the most important glob-al players in this specialist field.

MJ MAILLIS

MJ Maillis UK, a part of the global Maillis Group is expert inthe supply of automated/integrated strapping and wrapping sys-tems. Based in Nottingham, MJ Maillis has enjoyed many yearsof successful project delivery, with over 2,000 installations.

With wide ranging packaging expertise and an outstand-ing choice of high quality semi-automatic, automatic and highspeed strapping and stretch wrapping solutions, MJ Maillis issuperbly placed to meet all clients’ complete end-of-line pack-aging needs.

JBT

Automated Guided Vehicle Systems by JBT (formerly FMCTechnologies) provide automated material movement for cus-tomers in a variety of industries including pharmaceutical, chem-icals/plastics, warehouse/distribution and manufacturing. JBTis a world leader in AGV supply, with over 20 years’ experience.

JBT engineers develop the most cutting edge AGV tech-nology, in order to continue to provide guided vehicle solutionsto the most unique materials handling challenges.

SUMMARY

Goliath understands the specific needs of the PharmaChem sec-tor. From liquid filling, shrink wrapping, case-packing,labelling, palletising, inverting to high speed washing, via part-nerships with the above international companies, Goliath haspositioned itself as a major provider of packaging equipment tothis discerning sector.

Centrally located in Nenagh, Co. Tipperary, Goliath is lessthan two hours from all of major markets, while trained engi-neers maintain spare parts and service all equipment installedwith annual service contracts (reactive / preventative) availableas preferred.

PACKAGING

CONTACT DETAILS

To discuss your particular packaging equipment needs,please contact Goliath as follows;Goliath Packaging Systems LtdContact: George O’Leary, DirectorBeechwood, Nenagh, Co. Tipperary, Ireland.Tel: (067) 37893Fax: (067) 34794Mobile: 087 1222816 E-mail: [email protected] / [email protected]: www.goliath.ie

Soco System provides a complete range of end-of-line packagingequipment, via Goliath Packaging Systems Ltd.

Goliath 18/09/2008 16:12 Page 2

Chances are, that every day you run your pumping operation, your costs arecreeping up and up: maintenance, servicing, the cost of replacement.So the New Generation N-Pumps could bring a brighter start to your day.

The N-impeller is designed to prevent clogging and maintain higher pumpingefficiency over longer periods.

The Spin-out™ seal protection system prevents particles from damaging the seals.New, improved cooling means the motors operate more efficiently, and at lowertemperatures. And the new Plug-in™ seal system means that if you do have toreplace a seal, it’ll take just a few minutes. Have a nice day. Day after day.Call us for more information, or visit our website.

www.flygt.ie

ITT Water & Wastewater Ireland Limited

50 Broomhill Close, Airton Road, Tallaght, Dublin 24

Tel: 01-452 4444. Fax: 01-452 4795

The N-technique, patented by Flygt, features a self-cleaning impeller

that, together with an integrated relief groove in the pump housing,

ensures sustained high hydraulic efficiency and clog resistance.

Flygt. The New Generation N-Pumps.They might just live forever.

Toyota/Plastic Providers 23/09/2008 17:18 Page 1

CREATING AN ECLINICAL PLATFORM

46

Life sciences companies globally are turning toeClinical solutions in a bid to cut costs during clin-ical trials. On average, life science companiesspend between $12-17m yearly on mailings and

copies of paper case report forms. With the implementationof eClinical solutions, a company could save anywhere from$10-15m a year on paper and postage alone, according to anew report by Datamonitor.

The report, which investigates technology solutions that willbe integral to streamlining the clinical trials process, thus less-ening the burden on life science companies, says firms spendnearly $1 billion to bring a new drug to market, of which $500-700m is spent on clinical trials. Several pharmaceutical com-panies and contract research organisations have alreadydeveloped strategies to use electronic data capture (EDC) for100% of their trials by 2012. Although there are several road-blocks ahead, Datamonitor believes the adoption of EDC willbe rapid through to 2012, at which point it will plateau out. Theindustry will also see an increase in the adoption of clinical tri-als management systems (CTMS) as management becomes agreater issue due to the globalisation of clinical trials.

DATA COLLECTION AND MANAGEMENT

The adoption of EDC and CTMS solutions will be integralin enhancing and transforming the data collection and man-agement aspects of a trial. An efficient eClinical platformwill provide companies with substantial cost and time sav-ings and will play a vital role in changing the researchprocess for the better.

There has been a lot of talk of conducting adaptive trialsas a means to accelerate the drug development process.Through this process, pharmaceutical and biotech companieshave the flexibility to analyse study data before the end of thetrial and change its design in order to either improve thechances for a better positive result or cancel the trial if the drugappears ineffective.

BENEFITS OF EDC/CTMS

EDC allows for a centralised, standard workflow to easily col-lect, clean, validate and manage patient data. It provides real-time, permission-based access to high quality data, which iscritical to a time-sensitive process in which only a limited user-base may be exposed to the information.

CTMS provides a platform to track and manage all non-patient information related to a trial. CTMS allows sponsorsto maximise clinical supply usage, based on patient enrolment

in each treatment arm, which could change mid-trial. eClinical technologies play a vital role in the successful

implementation of an adaptive trial. Adaptive trials requirecontinuous analysis and monitoring of unblinded clinical data,which is performed by a group of statisticians and researcherswho are not allowed to communicate with the rest of the clin-ical research team. eClinical solutions empower sponsors,researchers and statisticians with real-time data, enabling themto make critical modifications to the trial.

An eClinical platform does not consist of just an EDC orCTMS solution, but rather a whole suite of systems.Currently, these systems exist in silos and are connectedthrough point-to-point integrations. To fully leverage thebenefits of these technologies, eClinical solutions must bebuilt on an interoperable framework that will enable life sci-ence companies to run clinical trials in a more efficient man-ner, since many redundancies which currently exist in thepoint solutions would be eliminated. An interoperable plat-form would allow for greater visibility into the clinicalresearch process, and greater collaboration among variousdepartments and stakeholders within an organisation.

SLOW ADOPTION OF EDC

While clinical solutions, particularly EDC, have existed formore than 20 years, adoption of these systems has been muchslower than initially anticipated, due in large part to a lackof support from end-users.

EDC adoption requires a major organisational andprocess paradigm shift. Many researchers and investigatorswho are accustomed to the paper-based system are notready to make that change. Until all stakeholders in the clin-ical trial process are educated on the true features and ben-efits of modern clinical technologies, and are willing to makethe necessary mental and cultural adjustments, implementa-tion of eClinical solutions will remain sluggish.

CL I N I C A L TR I A L S

According to a new report from Datamonitor, the paperless clinical trialcould be far closer than you think.

Clinical Trials 18/09/2008 14:42 Page 1

PHARMACHEM SECTORREMAINS ROBUST

47

The recent downturn inthe Irish economy hashit many manufacturingindustries quite hard but

the pharmaceutical industryremains robust and seems to becoping well with troubled eco-nomic conditions.

The pharmaceutical industrydirectly employs over 17,000 peo-ple in Ireland and 13 out of thetop 15 global companies haveoperations in Ireland. This, com-bined with 26,000 people in themedical technologies industry,would indicate that opportunitiesabound for skilled scientists andengineers.

Foreign investment has beencritical in Ireland’s developmentas a global pharmaceutical cen-tre. The IDA has successfullyattracted global corporations toIreland since 1964, when Bristol Myers Squibb openedtheir Swords plant. Over the intervening 44 years,Ireland has developed into a world leader in the phar-maceutical industry. Given Ireland’s size and location,it has become a major exporter of pharmaceutical prod-ucts, with export values at €29.7 billion, which accountfor 40% of Ireland’s manufactured export goods.

IRELAND AS AN EXPORTER

With a weakening US dollar, strengthening euro, UScredit crunch and a plethora of knock-on global eco-nomic effects, how will this effect Ireland’s position andcompetitiveness as an exporter in the world market?

Undoubtedly, other manufacturing industries havebeen hit hard and have faced shut downs and relocations,but the pharmaceutical industry has remained quitestrong. There are many reasons for this, primarilybeing that the industry is very much knowledge basedand is reliant on a highly educated, highly skilled andexperienced workforce. The expansion, development andinvestment in the R&D function by some of the leadingpharmaceutical companies would suggest that the longterm future of this industry is secure, as companies gen-erally prefer to have their R&D function and manufac-turing functions close to each other.

POTENTIAL PITFALLS

We have seen there are a goodmany reasons for optimism in thepharmaceutical side of things:however, there are a number offactors that could alter that. Onepossible problem is the reductionin the number of science gradu-ates over the coming years andthis is being redressed by gov-ernment and universities. Thec o n t i n u e d d e v e l o p m e n t o feconomies like China, Singaporeand India could destabilise ourposition as global leader, as thesecountries may be able to offermore competitive locations forthe manufacturing function ofthese industries.

Although there are a numberof threats to the future of theindustry, the overall trend would

suggest the future of the pharmaceutical industry inIreland is secure. The length of time the industry hasbeen based in Ireland, the broad range of supportfunctions offered by established companies from a ser-vices, infrastructural and technical point of view, cou-pled by high level of investment, would suggest thefuture of the industry is strong.

BRIGHT FUTURE

The industry has shown a remarkable robustness and hascontinually developed and evolved within a changingmarketplace over the last 40 years. Initial activity wascentred on the production of bulk active materials, buthas been followed by investment in finished product, toa situation where many facilities specialise in productdevelopment for global markets. This level of adapt-ability and growth, coupled with a strong knowledgeablework force, would indicate that the industry should con-tinue to grow.

At Berkley Pharmaceutical, we have found that thedemand for highly skilled and motivated individuals isstill as strong as ever. We are committed to finding thebest candidates in the industry and finding the best pos-sible roles to meet and develop their skill set, helpingto maintain Ireland’s position as global pharmaceuticalleader.

RE C R U I T M E N T

The pharmaceutical andchemical sector is coping

well, despite troubled economic conditions,according to Berkeley

Recruitment.

Recruitment 18/09/2008 14:45 Page 1

With 40 years experience Odenberg offers excellence in best practice design, manufacture,

installation & commissioning and after sales service to meet your individual and productivity needs.

PHARMACEUTICAL SOLUTIONS

HANDLING & PACKAGING EXPERTS

• Conveying & Materials Handling Systems

• End of Line Packaging Systems

• Control & Automation Solutions

Official Integrators for Kuka, PWR and Gudel Robots

2004 Orchard Avenue, Citywest Business Campus, Tel: + 353 1 413 62 00Naas Road, Dublin 24, Fax: + 353 1 457 02 19Ireland. Email: [email protected]

www.odenberg.ie

SRI 23/09/2008 13:05 Page 1

TOWARDS A NEW BEGINNING!

49

The comfort of having 13 of the top 15 pharmacompanies with facilities located in Ireland nowprovides little solace to the sector. The competi-tive advantage that we offered against other

nations (a hardworking, educated English speaking work-force combined with attractive grants and low corporationtax) has been overtaken by EU accession countries withharder working people, cheaper cost bases and even lowercorporation tax, rendering our competitive advantageimpotent. Add to this the growing bases of China, India andAsia, who previously were distanced in term of politics,geography, language, quality, and technical ability.Technology has effectively erased these as barriers todoing business in warp-speed time.

So what’s left for Ireland? David McWilliams, our ownpop economist, recommended that it was the diaspora inSouth America that would save us – grandchildren of Irishemigrants who would revitalise the flagging tiger! That wasonly months ago when we were looking for more workers:by mid ‘08, we are a net exporter of labour.

RATIONALISATION

Losing jobs is not necessarily an evil, as long the process iscontrolled and leads to greater efficiencies. The affected indi-viduals may not feel as strategically orientated, but havingan unprecedented importation of labour, it would be naiveto consider that it could have continued. We are now in a‘national’ rationalisation. An organisation going through a‘rationalisation’ is supported and viewed positively by itsinvestors. A national rationalisation can make us lean andbetter able to compete.

So where is the ‘gold’ for the next generation? IfIreland were to be known for anything, it has to be the inge-nuity of its people. Innovation and creativity have been atour centre as a nation and people since early times: our peo-ple’s ability to succeed against overwhelming odds.

Our one replicable, sustainable competitive advantageis the ingenuity of the Irish bloodstream. Ireland has putpieces on the Ariana rocket and introduced mobile tele-phony to countries 10 times its size.

KNOWLEDGE BASED ECONOMY

The base for our new beginning we already have: ingenu-ity, education and hard-working people. The opportunity

for its deployment is again in the forum of the Government,who are deploying support, both financial and technical, tobring the new dawn, a dawn for Ireland which will be basedon its people’s ability to innovate to a new level, offering aknowledge-based economy.

So while we cut prices to maintain some semblance ofcompetitiveness, we accept the ‘doom & gloom’ of the nowofficial ‘recession’, but we do not have to accept this as ourlot in the long-term. It is anticipated that those manufac-turing entities with big infrastructural investment in Irelandare mandated to be ever-more competitive, but the hope thatwe will ever again attract large manufacturing facilities,allowing newspapers to trumpet ‘1000 new jobs for …” can-not happen. The standard and cost of the style of living wenow enjoy and a newspaper headline like this are mutual-ly exclusive!

So we are ‘transitioning’, and change does not comewithout pain. Europe has been consistently and vainly look-ing for us to temper our rise to glory: we stood steadfast inthe pursuit of further increases! Well, now we have nooption but to comply! Following direction or advice is notour strong point: the carrot has to be replaced by the stick!So live with it we will, but the spirit will rise to create thenext dawn.

EC O N O M I C OU T LO O K

There may be some belt-tightening ahead, but Ireland has the economicand cultural characteristics to ride out the current storm, according to

Helen McGardle, MD, Science Recruitment Ireland.

Economic Outlook 18/09/2008 16:05 Page 1

INVESTING IN THE FUTURE

50

Irish universities are not just centres of learning:they also provide facilities that are of real, tangi-ble benefit to businesses in their drive to increasecompetitiveness through innovation, nowhere

moreso than in the field of life sciences, with knock-oneffects for the pharmaceutical and chemical indus-tries.

UCD

At Univers i ty Co l l ege Dubl in ,NovaUCD supports innovation andtechnology transfer at the college.NovaUCD has supported a num-ber of commercial ventures involv-ing the licensing of UCD technol-ogy to establish new companies.Notable successes include thedevelopment and licensing of aBSE test, which to date has gen-erated €2m in royalty income forUCD.

The Technology Research forIndependent Living (TRIL)Centre is a coordinated collectionof research projects addressingthe consequences of ageing. The TRIL Centre’s missionis to discover and deliver technology solutions whichsupport independent ageing, ideally in a home envi-ronment. Bringing together Intel researchers with inter-disciplinary researchers from University College Dublin,Trinity College Dublin and National University ofIreland, Galway, the TRIL Centre is one of the world'slargest R&D collaborations on this important topic, andhas made Ireland an international centre of excellencefor this work.

TCD

Trinity College Dublin has also made huge advances inmedical research. The Centre for Research on AdaptiveNanostructures and Nanodevices (CRANN) is regard-ed internationally as a flagship nanoscience Institute.The activity at CRANN is the main driver for Ireland tobe ranked 6th globally for research impact. CRANN hasa total research staff of 150 people.

The strengths of the universityin research have greatly benefited

from a strong focus in key areas ofe x c e l l e n c e a n d t h e s e i n c l u d e

immunology, where Trinity has con-tributed significantly at a global level.

For example, research performedby the institute has identified thegenes responsible for childhoodeczema and identified new genes forcoeliac disease. In addition, work has

identified genes that contribute to theimmune response to major infectious

agents, such as TB, malaria and viralhepatitis.

The Biosciences at Trinity are develop-ing rapidly, in terms of quality and scale.

TCD has started the Biosciences complexbuilding project, which will be complete

by 2010, delivering up to 33,000square metres of research and

research-related teaching space.

DCU

Meanwhile, Dublin CityUniversity (DCU) recently launched its ContractResearchers’ Association (DuCRA).

DuCRA endeavours to represent its members throughdiscussion and dialogue with all appropriate third partieswith the aims of improving the professional working envi-ronment of research staff and to enhance the university'sresearch environment for the benefit of all.

DuCRA recently launched a policy document, enti-tled ‘Building Sustainable Research Careers in aKnowledge Based Economy’. This policy documentargues that to create a sustainable, world-class researchinfrastructure in Ireland, the issue of sustainableresearcher careers must be dealt with at a national andan institutional level. This will require a change in thethinking of many stakeholders in government agencies,funding bodies, university management and academicinvestigators alike, changes in the way research inIreland is funded and the development of a formalisedresearcher career structure which is supported by allthese stakeholder groups, according to DuCRA.

RE S E A R C H & DE V E LO P M E N T

Ireland’s universities are at the forefront of research in the healthcareand pharmaceutical sector, with some notable

international achievements.

uni research 18/09/2008 14:50 Page 1

ACIDS & ALKALIS

Albion ChemicalsBASF Ireland LtdBrockley Group LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdEnva Ireland LtdFisher ScientificGoulding Chemicals LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals LtdScientific & Chemical Supplies LtdUnivar Ltd

BIOCHEMICALS

Albion ChemicalsBASF Ireland LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdFisher ScientificNorman Lauder Ltd

BIOCIDES

Albion ChemicalsBASF Ireland LtdCamida LtdChemco Ireland Ltd

CATALYSTS

Albion ChemicalsAllchem PerformanceBASF Ireland LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals Ltd

CHIRAL COMPOUNDS

Allchem PerformanceBASF Ireland LtdCamida Ltd

Corcoran Chemicals LtdNorman Lauder LtdNational Chemical Co. Ltd

EXCIPIENTS

Albion ChemicalsAllchem PerformanceBASF Ireland LtdBetco Marketing LtdBrockley Group LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals LtdUnivar Ltd

FINE CHEMICALS

Albion ChemicalsAllchem PerformanceBASF Ireland LtdBetco Marketing LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdFisher ScientificNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals Ltd

GASES

Albion ChemicalsBASF Ireland LtdCorcoran Chemicals LtdNational Chemical Co. Ltd

HETEROCYCLICS

Albion ChemicalsCamida LtdCorcoran Chemicals LtdNational Chemical Co. Ltd

INORGANIC CHEMICALS

Albion ChemicalsAllchem PerformanceBASF Ireland Ltd

Camida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdEnva Ireland LtdFisher ScientificGoulding Chemicals LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals LtdScientific & Chemical Supplies Ltd

LABORATORY REAGEANTS

BASF Ireland LtdCambio LtdCarbon GroupCorcoran Chemicals LtdFisher ScientificScientific & Chemical Supplies Ltd

MISC. CHEMICALS

Allchem PerformanceBASF Ireland LtdBetco Marketing LtdBrockley Group LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdEnva Ireland LtdFisher ScientificNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals LtdScientific & Chemical Supplies Ltd

OILS, FATS AND WAXES

Albion ChemicalsBASF Ireland LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals Ltd

ORGANIC INTERMEDIATES

Albion ChemicalsAllchem PerformanceBASF Ireland Ltd

IRISH PHARMACHEM 2008

CHEMICAL SUPPLIERS

CH

EM

ICA

LS

UP

PL

IER

S

Ch i l S li /T /JM

51

PC_Chemical Suppliers '08 WIP.qxd 23/09/2008 15:34 Page 1

Betco Marketing LtdCamida LtdCarbon GroupChemco Ireland LtdCorcoran Chemicals LtdNational Chemical Co. LtdTopchem Laboratories LtdUnivar Ltd

ORGANOMETALLICS

BASF Ireland LtdCamida LtdNational Chemical Co. Ltd

REAGENTS

BASF Ireland LtdCambio LtdCamida LtdChemco Ireland LtdCarbon GroupFisher Scientific

Norman Lauder LtdScientific & Chemical Supplies LtdUnivar Ltd

SILANES

Allchem PerformanceBASF Ireland LtdCamida LtdChemco Ireland LtdNorman Lauder LtdNational Chemical Co. LtdP.K. Chemicals Ltd

SOLVENTS

Albion ChemicalsBASF Ireland LtdBetco Marketing LtdBrockley Group LtdCamida LtdCarbon GroupChemco Ireland Ltd

Corcoran Chemicals LtdDalkiaFisher ScientificNorman Lauder LtdNational Chemical Co. LtdScientific & Chemical Supplies LtdSoltec (Ireland) LtdUnivar Ltd

SURFACTANTS

Albion ChemicalsAllchem PerformanceBASF Ireland LtdBrockley Group LtdCamida LtdCarbon GroupCorcoran Chemicals LtdFisher ScientificNorman Lauder LtdNational Chemical Co. LtdUnivar Ltd


C S / /

CH

EM

ICA

LS

UP

PL

IER

S

52

Notes

PC_Chemical Suppliers '08 WIP.qxd 23/09/2008 15:34 Page 2

ACTUATORS

P.J. Boner & Co. LtdFesto LtdFlexachem Manufacturing LtdHanlon O’Grady & Co. LtdSchuf Valve Technology

AERATORS

ITT Water & Waste Water Ireland Ltd

AGITATORS

CPI Technology LtdFlexachem Manufacturing LtdLiancoOdenberg Engineering LtdWrenTech Ltd

AIR FILTRATION/MONITORING

/POLLUTION CONTROL

DalkiaLiancoNederman LtdShaw Scientific Ltd

ALARMS

P.J. Boner & Co. LtdDalkia

ALUMINIUM PRODUCTS

Smurfit Kappa Packaging Solutions Cork

ANALYSIS SERVICES

AnectoB o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesCatalent Pharma SolutionsNorman Lauder Ltd

ANALYTICAL EQUIPMENT

ABB LtdBeamex LtdCalibration TechnologyClassic Technology Ltd

Fisher ScientificNational InstrumentsPollution Control Systems LtdSartorius Mechatronics UK LtdScientific & Chemical Supplies LtdShaw Scientific Ltd

AUTOCLAVES

Fisher ScientificGoliath Packaging Systems LtdScientific & Chemical Supplies LtdShaw Scientific LtdWrenTech Ltd

AUTOMATION

Allchem PerformanceP.J. Boner & Co. LtdCallaghan Engineering Classic Technology LtdEurotherm Ireland LtdFesto LtdFlexachem Manufacturing LtdNational InstrumentsWeber Labelling & Coding

BALANCES

Beamex LtdP.J. Boner & Co. LtdCalibration TechnologyFisher ScientificIrish National Accreditation BoardSartorius Mechatronics UK LtdScientific & Chemical Supplies LtdShaw Scientific LtdWrenTech Ltd

BARCODING/LABELLING/TRACEABILITY

P.J. Boner & Co. LtdCatalent Pharma SolutionsFisher ScientificGoliath Packaging Systems LtdGS1 IrelandNew Era Packaging LtdOdenberg Engineering LtdWeber Labelling & Coding

BARRIERS SAFETY

Odenberg Engineering LtdWrenTech Ltd

BIOTECHNOLOGY

Callaghan EngineeringCambio LtdCatalent Pharma SolutionsCPI Technology LtdFDT Consulting Engineers & Project Managers LtdFisher ScientificFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdNorman Lauder LtdLiancoProsys Sampling Systems LtdShaw Scientific Ltd

BLENDERS

Carbon GroupCPI Technology LtdFisher ScientificKells Stainless LtdLiancoWrenTech Ltd

BLOWERS

Lianco

BPRV

BS&B Safety Systems Ltd

BURSTING / RUPTURE DISCS

BS&B Safety Systems LtdCPI Technology LtdFlexachem Manufacturing Ltd

CABINETS

Festo LtdFisher ScientificLiancoLogstrup (Ireland) LtdProsys Sampling Systems LtdSartorius Mechatronics UK LtdWrenTech Ltd


GENERAL SUPPLIERS

GE

NE

RA

LS

UP

PL

IER

S

53

PC_General Suppliers '08 WIP.qxd 23/09/2008 15:49 Page 1

CAD

AnectoCallaghan EngineeringFDT Consulting Engineers & Project Managers Ltd

CALIBRATION

Astech Ireland LtdBeamex LtdP.J. Boner & Co. LtdCalibration TechnologyClassic Technology LtdDalkiaEurotherm Ireland LtdFlexachem Manufacturing LtdIrish National Accreditation BoardSartorius Mechatronics UK Ltd

CENTRIFUGES

Fisher ScientificGEA Process Technologies Ireland LtdSartorius Mechatronics UK LtdScientific & Chemical Supplies LtdShaw Scientific Ltd

CHEMICAL CONSULTANTS

Callaghan EngineeringEnva Ireland LtdTopchem Laboratories Ltd

CHROMOTOGRAPHY

Fisher ScientificNorman Lauder LtdScientific & Chemical Supplies Ltd

CLEANROOMS

Charpak MedicalClassic Technology LtdDalkiaFisher ScientificSartorius Mechatronics UK LtdWrenTech Ltd

CLEANING SERVICES/EQUIPMENT

Goliath Packaging Systems LtdNederman Ltd

COLD CHAIN PACKAGING

Catalent Pharma Solutions

Cross Technical SolutionsInterpacSmurfit Kappa Packaging Solutions Cork

COMPRESSED AIR/COMPRESSORS

Festo Ltd

COMPUTER SYSTEMS

Eurotherm Ireland Ltd

CONDENSORS

Cross Technical SolutionsGraham Hart (Process Technologies) Ltd

CONDITION MONITORING

Beamex LtdClassic Technology LtdNational InstrumentsSmurfit Kappa Packaging Solutions Cork

CONSTRUCTION

MANAGEMENT

Callaghan Engineering

CONVEYORS

Goliath Packaging Systems LtdLiancoWeber Labelling & CodingWrenTech Ltd

COOLING SYSTEMS

Cross Technical SolutionsGEA Process Technologies Ireland Ltd

DATA ACQUISITION

ABB LtdP.J. Boner & Co. LtdClassic Technology LtdEurotherm Ireland LtdGS1 IrelandNational InstrumentsWeber Labelling & CodingZenith Technologies

DEHUMIDIFIERS

Cross Technical SolutionsSmurfit Kappa Packaging Solutions Cork

DESIGN

P.J. Boner & Co. LtdCallaghan EngineeringFDT Consulting Engineers & Project Managers LtdGEA Process Technologies Ireland Ltd

DISPERSERS

LiancoWrenTech Ltd

DISTILLATION

Fisher ScientificKells Stainless LtdSoltec (Ireland) LtdWrenTech Ltd

DRIERS

Complas Packaging LtdGEA Process Technologies Ireland LtdLiancoProsys Sampling Systems LtdWrenTech Ltd

DRUMS/CONTAINERS

Carbon GroupComplas Packaging LtdFisher ScientificIndustrial Packaging LtdInterpacJohnsen & Jorgensen LtdNorman Lauder LtdPrimepac LtdSoltec (Ireland) LtdWrenTech Ltd

EDUCATION & TRAINING

Calibration TechnologyFDT Consulting Engineers & Project Managers LtdFesto LtdNITL

EFFLUENT MONITORING/TREATMENT

Astech Ireland LtdP.J. Boner & Co. LtdB o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesCarbon GroupEnva Ireland Ltd

54


GE

NE

RA

LS

UP

PL

IER

S


ITT Water & Waste Water Ireland LtdPollution Control Systems LtdProsys Sampling Systems LtdScientific & Chemical Supplies Ltd

ELECTRICAL

Callaghan EngineeringClassic Technology LtdCross Technical Solutions

ELECTRONIC COMPONENTS

Cross Technical Solutions

ENERGY EFFICIENCY/MANAGEMENT

B o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesCallaghan EngineeringCross Technical SolutionsFDT Consulting Engineers & Project Managers LtdFlexachem Manufacturing LtdIrish National Accreditation BoardSustainable Energy Ireland

ENGINEERING SERVICES

ABB LtdAxium ProcessP.J. Boner & Co. LtdClassic Technology LtdCross Technical SolutionsEurotherm Ireland LtdFDT Consulting Engineers & Project Managers LtdFesto LtdGEA Process Technologies Ireland LtdKells Stainless LtdLianco

ENVIRONMENTAL SERVICES/EQUIPMENT

ABB LtdAstech Ireland LtdP.J. Boner & Co. LtdB o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesCross Technical SolutionsEnva Ireland LtdEnvironmental Protection AgencyFDT Consulting Engineers

& Project Managers LtdPollution Control Systems LtdSoltec (Ireland) Ltd

EVAPORATORS

Cross Technical SolutionsFisher ScientificGEA Process Technologies Ireland LtdGraham Hart (Process Technologies) LtdLianco

EXPLOSION PROTECTION /PANELS

BS&B Safety Systems LtdGunnebo Ireland LtdSartorius Mechatronics UK Ltd

EXTRUDERS

LiancoTurboair

FANS

Nederman Ltd

FILLING EQUIPMENT

Goliath Packaging Systems LtdLiancoOdenberg Engineering LtdSartorius Mechatronics UK LtdWrenTech Ltd

FILTERS

Axium ProcessFisher ScientificGEA Process Technologies Ireland LtdITT Water & Waste Water Ireland LtdNederman LtdViking Pump (Europe) Ltd

FILTRATION

Allchem PerformanceAxium ProcessEnva Ireland LtdFisher ScientificGEA Process Technologies Ireland LtdITT Water & Waste Water Ireland LtdLiancoScientific & Chemical Supplies Ltd

FLOW CONTROL

P.J. Boner & Co. LtdDalkiaFesto LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdManotherm LtdHanlon O’Grady & Co. LtdSartorius Mechatronics UK Ltd

FLUID HANDLING

Consolidated Pumps LtdCPI Technology LtdDalkiaFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdHanlon O’Grady & Co. LtdViking Pump (Europe) Ltd

FUME CUPBOARDS

Fisher ScientificProsys Sampling Systems LtdScientific & Chemical Supplies LtdShaw Scientific LtdTurboairWrenTech Ltd

FURNACES

Eurotherm Ireland LtdFisher Scientific

GAS DETECTION

P.J. Boner & Co. LtdFisher Scientific

GAUGES

P.J. Boner & Co. LtdClassic Technology LtdFisher ScientificFlexachem Manufacturing LtdManotherm LtdTORS

GLASSWARE

Fisher ScientificJohnsen & Jorgensen Ltd

GGRRIINNDDIINNGG

Fisher ScientificLianco

55

GE

NE

RA

LS

UP

PL

IER

S



GE

NE

RA

LS

UP

PL

IER

S

HAZARDOUS WASTE

DISPOSAL/TREATMENT

Enva Ireland LtdSoltec (Ireland) Ltd

HEALTH & SAFETY/FIRST AID

Fisher ScientificScientific & Chemical Supplies Ltd

HEAT EXCHANGERS

CPI Technology LtdCross Technical SolutionsFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdGraham Hart (Process Technologies) LtdLiancoHanlon O’Grady & Co. LtdPlate Tek Engineering LtdWrenTech Ltd

HEATERS

Graham Hart (Process Technologies) LtdLianco

HOMOGENISERS

Fisher ScientificGEA Process Technologies Ireland LtdLiancoWrenTech Ltd

HOSES

CPI Technology LtdFlexachem Manufacturing LtdMicro Hydraulics Ltd/Micro Industries LtdNederman Ltd

HUMIDITY/HUMIDIFIERS

P.J. Boner & Co. LtdClassic Technology LtdCross Technical SolutionsSmurfit Kappa Packaging Solutions Cork

HYDRAULICS

Micro Hydraulics Ltd/Micro Industries LtdViking Pump (Europe) Ltd

INCUBATORS

Fisher ScientificScientific & Chemical Supplies LtdShaw Scientific Ltd

INSPECTION EQUIPMENT

ABB LtdBeamex LtdP.J. Boner & Co. LtdNational Instruments

INSTRUMENTATION

Astech Ireland LtdP.J. Boner & Co. LtdCallaghan EngineeringClassic Technology LtdCross Technical SolutionsFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdManotherm LtdNational InstrumentsZenith Technologies

IT

Callaghan EngineeringNational Instruments

INVESTMENT

Science Foundation Ireland (SFI)

LAB EQUIPMENT/SUPPLIES

Astech Ireland LtdCalibration TechnologyClassic Technology LtdFisher ScientificLiancoNational InstrumentsPrimepac LtdProsys Sampling Systems LtdSartorius Mechatronics UK LtdScientific & Chemical Supplies LtdSealpack LtdShaw Scientific LtdWrenTech Ltd

LEGAL/FINANCIAL/INSURANCE

Matheson Ormsby Prentice

LIFTS & HOISTS

Goliath Packaging Systems Ltd

Gunnebo Ireland LtdLiancoWrenTech Ltd

MACHINE TOOLS

Lister Machine Tools Ltd

MAINTENANCE

P.J. Boner & Co. LtdCross Technical SolutionsFesto LtdGunnebo Ireland LtdPlate Tek Engineering Ltd

MATERIALS HANDLING/FORKLIFTS/PALLET TRUCKS

Goliath Packaging Systems LtdHenley Forklift Group LtdInterpacOdenberg Engineering LtdToyota Materials Handling IrelandWrenTech Ltd

MECHANICAL ENGINEERING

SERVICES

Callaghan EngineeringCross Technical SolutionsDalkiaFDT Consulting Engineers & Project Managers LtdFesto LtdGoliath Packaging Systems LtdKells Stainless LtdTurboair

MECHANICAL & PROCESS

ENGINEERING

Callaghan EngineeringDalkiaFDT Consulting Engineers & Project Managers LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdKells Stainless LtdProsys Sampling Systems LtdWeber Labelling & Coding

METERS

P.J. Boner & Co. LtdClassic Technology Ltd

56



LiancoManotherm LtdNational Instruments

MICROSCOPES

Fisher ScientificScientific & Chemical Supplies LtdShaw Scientific Ltd

MILLING

Fisher ScientificFlexachem Manufacturing LtdScientific & Chemical Supplies LtdWrenTech Ltd

MIXERS

CPI Technology LtdFisher ScientificFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdITT Water & Waste Water Ireland LtdKells Stainless LtdScientific & Chemical Supplies LtdWrenTech Ltd

NOISE/ODOUR CONTROL

B o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesFlexachem Manufacturing LtdSmurfit Kappa Packaging Solutions Cork

OEM MANUFACTURING

B. Braun Medical

PACKAGING/DESIGN

AnectoCatalent Pharma SolutionsCharpak MedicalComplas Packaging LtdGoliath Packaging Systems LtdGS1 IrelandIndustrial Packaging LtdInterpacJohnsen & Jorgensen LtdNorman Lauder LtdMeasom FreerNew Era Packaging LtdPrimepac LtdSealpack LtdSmurfit Kappa Ireland

Smurfit Kappa CorkSmurfit Kappa Packaging Solutions Cork

PACKAGING/MACHINERY


PALLETS

Complas Packaging LtdSmurfit Kappa IrelandSmurfit Kappa Packaging Solutions CorkWrenTech Ltd

PIPES/CORES

CPI Technology LtdFlexachem Manufacturing LtdSmurfit Kappa Packaging Solutions Cork

PLASTIC CORES / TUBES

Smurfit Kappa Packaging Solutions Cork

PNEUMATICS

P.J. Boner & Co. LtdFesto LtdFlexachem Manufacturing Ltd

POLLUTION CONTROL

ABB LtdB o r d n a M o n a E n v i r o n m e n t a lConsultancy, Monitoring & LaboratoryServicesPollution Control Systems Ltd

POWDER HANDLING

CPI Technology LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdIndustrial Packaging LtdInterpacLiancoOdenberg Engineering LtdProsys Sampling Systems LtdWrenTech Ltd

POWER SUPPLY

ESB Independent EnergyManotherm Ltd

PRESSURE MEASUREMENTS/SWITCHES/VESSELS

Axium ProcessBeamex LtdBeam Vacuum Systems LtdP.J. Boner & Co. LtdBS&B Safety Systems LtdClassic Technology LtdCross Technical SolutionsGraham Hart (Process Technologies) LtdKells Stainless LtdNational InstrumentsProsys Sampling Systems Ltd

PRESSURE RELIEF

BS&B Safety Systems Ltd

PROCESS CONTROL

Astech Ireland LtdBeamex LtdP.J. Boner & Co. LtdCallaghan EngineeringClassic Technology LtdFDT Consulting Engineers & Project Managers LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdLiancoLogstrup (Ireland) LtdManotherm LtdNational InstrumentsPollution Control Systems LtdWeber Labelling & CodingZenith Technologies

PROCESS & MECHANICAL

ENGINEERING CONTRACTORS

ABB LtdFDT Consulting Engineers & Project Managers LtdGEA Process Technologies Ireland Ltd

PROJECT MANAGEMENT

Axium ProcessCallaghan EngineeringCross Technical SolutionsFDT Consulting Engineers & Project Managers LtdGEA Process Technologies Ireland LtdOdenberg Engineering LtdZenith Technologies

57

GE

NE

RA

LS

UP

PL

IER

S



GE

NE

RA

LS

UP

PL

IER

S

PROTECTIVE CLOTHING/APPARATUS

Albion Chemicals

PUMPS

Beam Vacuum Systems LtdConsolidated Pumps LtdCPI Technology LtdFisher ScientificFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdITT Water & Waste Water Ireland LtdProsys Sampling Systems LtdViking Pump (Europe) Ltd

REACTORS

CPI Technology LtdGEA Process Technologies Ireland LtdKells Stainless Ltd

RECRUITMENT

Berkley PharmaceuticalFDT Consulting Engineers & Project Managers LtdICDS Recruitment ConsultantsKelly ServicesManpower IrelandScience Recruitment IrelandZenith Technologies

R & D

Allchem PerformanceCambio LtdDalkiaFDT Consulting Engineers & Project Managers LtdScientific & Chemical Supplies LtdTopchem Laboratories Ltd

REFRIGERATION/FREEZING

Baku GLS LtdCross Technical SolutionsDalkiaFisher ScientificGEA Process Technologies Ireland Ltd

RENEWABLE ENERGY

Sustainable Energy Ireland

SANITARY TUBING

Micro Hydraulics Ltd/Micro Industries Ltd

SCADA/DCS/MIS

ABB LtdP.J. Boner & Co. LtdCross Technical SolutionsEurotherm Ireland LtdNational InstrumentsZenith Technologies

SCREENS

Lianco

SCRUBBERS

Graham Hart (Process Technologies) Ltd

SEALS & GASKETS

Axium ProcessConsolidated Pumps LtdFlexachem Manufacturing LtdMicro Hydraulics Ltd/Micro Industries Ltd

SIEVING

LiancoScientific & Chemical Supplies Ltd

SOFTWARE

Eurotherm Ireland LtdGEA Process Technologies Ireland LtdLiancoZenith Technologies

SOLVENT RECOVERY/SERVICES

ABB LtdFDT Consulting Engineers & Project Managers LtdSoltec (Ireland) Ltd

STAINLESS STEEL/FITTINGS/PRODUCTS

Axium ProcessFesto LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland Ltd

Micro Hydraulics Ltd/Micro Industries LtdSmurfit Kappa Packaging Solutions Cork

STEAM EQUIPMENT

Flexachem Manufacturing Ltd

STORAGE/BUNDING

Baku GLS LtdGoliath Packaging Systems LtdIndustrial Packaging LtdInterpacJohnston Logistics Ltd

TABLETING EQUIPMENT

Flexachem Manufacturing LtdGEA Process Technologies Ireland LtdLiancoWrenTech Ltd

TANKS

Axium ProcessCeltic Forwarding LtdComplas Packaging LtdCPI Technology LtdEnva Ireland LtdGEA Process Technologies Ireland LtdKells Stainless LtdNorman Lauder LtdMicro Hydraulics Ltd/Micro Industries LtdWrenTech Ltd

TEMPERATURE CONTROL

Beamex LtdP.J. Boner & Co. LtdClassic Technology LtdCross Technical SolutionsEurotherm Ireland LtdFlexachem Manufacturing LtdGEA Process Technologies Ireland LtdManotherm LtdNational InstrumentsSmurfit Kappa Packaging Solutions Cork

TESTING SERVICES

AnectoClassic Technology LtdIrish National Accreditation BoardNorman Lauder Ltd

58



THERMAL IMAGING/THERMOGRAPHY

Cross Technical SolutionsFDT Consulting Engineers & Project Managers LtdManotherm LtdNational Instruments

TRANSPORT & LOGISTICS

Baku GLS LtdCeltic Forwarding LtdC & G Logistics GroupJohnston Logistics LtdKWE (Ireland) LtdNorman Lauder Ltd

TUBE SETS/DISPOSABLES

Micro Hydraulics Ltd/Micro Industries Ltd

VACUUM SYSTEMS

Beam Vacuum Systems LtdCPI Technology LtdFlexachem Manufacturing LtdGoliath Packaging Systems LtdLiancoWrenTech Ltd

VALVES

Beam Vacuum Systems LtdP.J. Boner & Co. LtdBS&B Safety Systems LtdCPI Technology LtdFesto Ltd

Flexachem Manufacturing LtdGEA Process Technologies Ireland LtdLiancoManotherm LtdMicro Hydraulics Ltd/Micro Industries LtdHanlon O’Grady & Co. LtdProsys Sampling Systems LtdSchuf Valve Technology

VALIDATION

ABB LtdAstech Ireland LtdBeamex LtdCallaghan EngineeringCatalent Pharma SolutionsClassic Technology LtdCross Technical SolutionsFDT Consulting Engineers & Project Managers LtdSartorius Mechatronics UK LtdWeber Labelling & CodingZenith Technologies

VENTILATION

Beam Vacuum Systems LtdCallaghan Engineering

VISION SYSTEMS

National Instruments

WAREHOUSE MANAGEMENT

Celtic Forwarding LtdComplas Packaging LtdEurotherm Ireland Ltd

Goliath Packaging Systems LtdJohnston Logistics LtdNorman Lauder LtdSmurfit Kappa Packaging Solutions CorkWeber Labelling & CodingZenith Technologies

WASHING EQUIPMENT


WASTE MANAGEMENT/BALERS/RECYCLING

InterpacNorman Lauder LtdSoltec (Ireland) Ltd

WATER TREATMENT

Axium ProcessCarbon GroupConsolidated Pumps LtdFlexachem Manufacturing LtdITT Water & Waste Water Ireland LtdLogstrup (Ireland) LtdPollution Control Systems LtdSartorius Mechatronics UK Ltd

WEIGHING

Beamex LtdP.J. Boner & Co. LtdCalibration TechnologyFisher ScientificSartorius Mechatronics UK LtdShaw Scientific LtdWrenTech Ltd

59

GE

NE

RA

LS

UP

PL

IER

S


Notes


Irelands only manufacturer of fibre drums

www.industrialpackaging.ie

Killarney Road, Bray, Co WicklowTelephone: +353 1 2864010 Fax: +353 1 2864015

Email: [email protected]

Industrial Packaging Ltd.

Fibre Drums

Plastic Drums

IBCs

Security Tags & Seals

Small Sample Drums/Containers

Your Local ExpertKelly Scientific Resources is the largest - and fastest growing - provider of scientific talent in the worldtoday. With 100+ locations worldwide, we havedeveloped long term partnerships with some of thebiggest names in the scientific industry.

Kelly Scientific Resources in Ireland supports the scientific community by providing scientists andtechnicians in both temporary assignments and permanent contracts at all levels.

Kelly Scientific Resources 21 - 22 Grafton St Dublin 2 p. (01) 6793160 f. (01) 6773048 e. [email protected]

Kelly Scientific Resources Carbery House 67 - 69 South Mall, Cork p. (021) 4905406 f. (021) 4274736 e. [email protected]

Chemists • Microbiologists • Biochemists • Product/ProcessDevelopments • Organic Chemists • CRAs • Scientific /MedicalSales • Environmental Technicians • Research & Development •Molecular Biologists • Regulatory Affairs • Validation • QualityAssurance/Quality Control

Industrial Packaging 23/09/2008 16:53 Page 1

61

COM

PAN

YLI

ST

ING

S


COMPANY LISTINGS

A

ADC BARCODE SOLUTIONSAddress: Unit 1B,

11 Canal Bank,Parkwest IndustrialPark, Nangor Road,Dublin 12.

Tel: (01) 620 9777Fax: (01) 620 9722Email: [email protected]: www.adcbarcodesolutions.comContact: Marketing Manager:

Celine Wogan

AGB SCIENTIFIC LTDAddress: Orion Business

Campus, Northwest Business Park, Ballycoolin, Dublin 15.

Tel: (01) 882 2222Fax: (01) 882 2333Email: [email protected]: www.agb.ie

www.labshop.ieType of Business: Lab supplier.

AIC PLASTIC PALLETS LTDAddress: The Woodlands,

Carrigmore,Ballineen, Co. Cork.

Tel: (023) 47333Fax: (023) 47671Email: info@

aicplasticpallets.comWeb: www.aicplastic

pallets.comContact: Director:

Charles O’Donovan

ALBION CHEMICALSAddress: Unit 405, Greenogue

Business Park, Rathcoole, Dublin 24.

Tel: (01) 401 3500Fax: (01) 405 3501Email: bill.maher@

albionchemicals.ieWeb: www.albionchemicals.co.ukContact: General Manager:

Bill Maher

ALLCHEM PERFORMANCEAddress: Westward House,

Montrose Avenue,Slough, SL1 4TN.

Tel: (0044) 1753 443322Fax: (0044) 1753 443323Email: allchemperformance

@acigroup.bizWeb: www.allchemperformance.comContact: Head of Pharma:

Khalil Sharif

ANECTOAddress: Mervue Business

Park, Co. Galway.Tel: (091) 757 404Fax: (091) 757 387Email: [email protected]: www.anecto.comType of Business: Dangerous goods

packaging testing laboratory.

Contact: Yvonne Kearney

ASTECH IRELAND LTDAddress: Unit 47, Southern

Cross Business Park,Boghall Road, Bray, Co. Wicklow.

Tel: (01) 286 5303Fax: (01) 286 5655Email: [email protected]: www.astechireland.ieContact: Managing Director:

Shay Vella Hancock

ATC AUTOMATION LTDAddress: Unit B7, Centre Point

Business Park, Oak Road,

Dublin 12.Tel: (01) 460 7070Fax: (01) 461 0771Email: [email protected]: www.atc.ieContact: Liam Prendergast

Sales Manager

AXIUM PROCESSAddress: Hendy Industrial

Estate, Hendy, Swansea, SA4 0XP

Tel: (0044) 1792 883882Fax: (0044) 1792 886049Email: [email protected]: www.axiumprocess.comContact: Business

Development Manager:Derek Davies

B

BAKU GLS LTDAddress: Kilrane Business

Park, Rosslare HarbourCo. Wexford.

Tel: (053) 916 1786Fax: (053) 916 1789Email: [email protected]: www.bakugls.comContact: Operations Director:

Leslie Devereaux

BASF IRELAND LTDAddress: Bracetown Business

Park, Clonee,Co. Meath.

Tel: (01) 825 5701Fax: (01) 825 2038Email: [email protected]: www.basf.comType of Distributor ofBusiness: chemicals.Contact: Business Development

Manager, Pharmaceutical Industry:Yvonne Mullins

ABB LTDAddress: Belgard Road,

Tallaght, Dublin 24.

Tel: (01) 405 7300Fax: (01) 405 7327Email: [email protected]: www.abb.comType of Business: Electrical

Engineers.

PC_Listings '08 WIP.qxd 23/09/2008 16:45 Page 1

B. BRAUN MEDICALAddress: 3 Naas Road

Industrial Park, Dublin 12.

Tel: (01) 709 1800Fax: (01) 709 1889Email: [email protected]: www.bbraun.comType of Business: OEM

manufacturing.Contact: Business Unit

Manager: Bill Proctor

BCD ENGINEERINGAddress: Railway Road,

Charleville, Co. Cork

Tel: (063) 30200Fax: (063) 30201Email: richard.keays@

bcdgroup.ieWeb: www.bcdgroup.ieContact: Group Engineering

Sales: Richard Keays

BEAMEX LTDAddress: Newtown Grange

Farm Business Park,Desford Road,Newtown Unthank,Leicestershire LE9 9FL.

Tel: (0044) 1455 821 920Fax: (0044) 1455 821 923Email: beamex.ltd@

beamex.comWeb: www.beamex.comContact: Sales & Service

Director: Alex Maxfield

BEAM VACUUM SYSTEMS LTDAddress: Opus Business Park,

35 Aughrim Road, Magherafelt,Co. Derry,BT45 6BB.

Tel: (0044) 2879 632 424Fax: (0044) 2879 632 425Email: lisa.mcgonigle@

beamvacuums.ieWeb: www.beamvacuums.ie

BERKLEY PHARMACEUTICALAddress: Cork:

Mill House, Carrigrohane, Co. Cork.Dublin:509 The Capel Building, Mary’s Abbey, Dublin 7.

Tel: (021) 455 9092(01) 872 4665

Fax: (021) 455 9095(01) 872 0904

Email: [email protected]: www.berkley.ieContact: Cork:

Ruth ScanlanDublin:Joanna Houston

BETCO MARKETING LTDAddress: Exham House,

The Fingerpost,Douglas, Co. Cork.

Tel: (021) 436 4999Fax: (021) 436 5739Email: [email protected]: www.betco.ieContact: Managing Director:

Diarmuid Halpin

P.J. BONER & CO. LTDINSTRUMENT & WEIGHTINGSPECIALISTSAddress: Unit 35, Western

Parkway Business Centre, BallymountRoad, Dublin 12.

Tel: (01) 450 5050Fax: (01) 450 5183Email: [email protected]: www.pjboner.comContact: Managing Director:

Pat Boner

BORD NA MÓNAENVIRONMENTAL CONSULTANCY,MONITORING & LABORATORYSERVICESAddress: Main Street,

Newbridge, Co. Kildare.

Tel: (045) 439 000Fax: (045) 434 207Email: [email protected]: www.bnm.ie/

environmentalContact: Brand Manager:

Karen Healy

BRIGHTWATERAddress: Dublin:

36 Merrion Square,Dublin 2.Cork: 49 South Mall, Co. Cork

Tel: (01) 662 1000(021) 422 1000

Fax: (01) 662 3900(021) 422 4001

Email: [email protected]@brightwater.ie

Web: www.brightwater.ieContact: Manager,

Pharmaceutical:Adrian Carty

BROCKLEY GROUP LTDAddress: 1 Abbey Street,

Howth, Co. Dublin.Tel: (01) 839 2016Fax: (01) 839 2869Web: www.eirchem.com

www.brockley.euContact: Sales Director:

Pat Short

BS&B SAFETY SYSTEMS LTDAddress: Raheen Business

Park, Raheen, Co. Limerick.

Tel: (061) 484 700Emergency Delivery:086 241 0615Direct Line: 086 838 5556

Fax: (061) 352 240Email: [email protected]: www.bsb.ieType of Business: Pressure relief

devices.Contact: Sales Manager:

Patrick Murphy

BURGOYNE CONSULTANTS LTDAddress: 55 Clontarf Road,

Dublin 3.

CO

MPA

NY

LIS

TIN

GS


62


Tel: (01) 833 2091Fax: (01) 833 2092Email: [email protected]: www.bcl.ieContact: Operations Manager:

Martin Concannon

C

CALIBRATION TECHNOLOGYAddress: Innovation Works,

National Technology Park, Co. Limerick.

Tel: (061) 503 132Fax: (061) 338 065Email: service@

calibrationtech.ieWeb: www.calibrationtech.ieType of Business: Accredited

calibration of all makes of laboratory equipment.

Contact: Operations Manager:Brian Kelly

CALIPER LIFE SCIENCESAddress: 1 Wellfield,

Preston Brook, Runcorn, Cheshire.

Tel: (0044) 1928 711 448Fax: (0044) 1928 791 228Email: lydia.mcintyre@

caliperls.comWeb: www.caliperls.comType of Business: Laboratory

Automation.Contact: Sales Manager

Ireland:Simon Minchin

CALLAGHAN ENGINEERINGAddress: Dublin:

Wentworth House, 19-20 Hogan Place,Lower Grand Canal Street, Dublin 2.Cork: Penrose House,Penrose Quay,Co. Cork.

Tel: (01) 661 4420(021) 455 1646

Fax: (01) 661 4424(021) 455 1770

Email: [email protected]@calleng.ie

Web: www.calleng.ieType of Business: Engineering.

Contact: Dublin - Managing Director:Donal O’CallaghanCork - Senior Electrical Designer: Willie O’Mahony

CAMBIO LTDAddress: 1 The Irwin Centre,

Scotland Road, Dry Drayton, Cambridge, CB23 8AR.

Tel: (0044) 1954 210 200Fax: (0044) 1954 210 300Email: [email protected]: www.cambio.co.ukType of Business: Distribution of

molecular biology research reagents.

Contact: Development Manager: Bethy Booth

A. R. CAMERON LTDAddress: Malahide Road

Industrial Park,Coolock, Dublin 17

Tel: (01) 847 4122Fax: (01) 847 4761Email: [email protected]: Tony Cameron Jr., Sales

CAMIDA LTDAddress: Tower House,

New Quay, Clonmel,Co. Tipperary.

Tel: (052) 25455Fax: (052) 25466Email: [email protected]: www.camida.comContact: Company Secretary:

Deirdre McGrath

CARBON GROUPAddress: Factory Cross,

Ringaskiddy, Co. Cork.Tel: (021) 437 8988

UK Local Lo-Call:(0044) 8708 504 831

Fax: (021) 437 8950Email: [email protected]

[email protected]: www.carbon.ieType of Business: Pharmachemicals.Contact: Area Sales Manager:

Carol Deegan

CASHELS ENGINEERING LTDAddress: Aghamore,

Ballyhaunis, Co. Mayo

Tel: (094) 963 0517Fax: (094) 963 0214Email: [email protected]: www.cashels.netContact: Managing Director:

Peter Cunnane

CATALENT PHARMA SOLUTIONSAddress: Unit 26,

Cherry Orchard Industrial Estate,Dublin 10.

Tel: (01) 620 0600Fax: (01) 626 2815Email: diarmuid.wilson@

catalent.comWeb: www.catalent.comContact: Sales Director

Ireland:Diarmuid Wilson

CELTIC FORWARDING LTDAddress: Dublin:

Celtic House,30 Marlborough Street, Dublin 1.Waterford:Belview Port,Slieverue, Co. Waterford.Limerick:2 Church Street,John’s Square,Co. Limerick.

Tel: (01) 865 6000(051) 851 821(061) 467 969

Fax: (01) 874 6745(051) 851 823(061) 467 972

Email: [email protected]: www.celticfwd.ieType of Business: Shipping.Contact: Director:

Finbarr ClearySales Manager:Gerald KiernanWaterford:DGSATank Division Manager:Patty deCourcey

COM

PAN

YLI

ST

ING

S


63


C & G LOGISTICS GROUPAddress: Westpoint Business

Park, Navan Road,Mulhuddart, Dublin 15.

Tel: (01) 820 8455Fax: (01) 820 8457Email: [email protected]: www.cglogistics.ieContact: General Manager/

Director :Patrick Wogan

CHARPAK MEDICALAddress: 30 St. Peters Road,

Huntingdon, Cambs. UK.

Tel: 0044 1480 434434 Fax: 0044 1480 434545Email: [email protected]: www.charpak

medical.comContact: Director: Paul Smith

CHEMTEK SALES LTDAddress: Estuary House,

New Street, Malahide, Co. Dublin.

Tel: (01) 845 3766/63Fax: (01) 845 3172Email: [email protected]: www.chemtek.ieContact: Director: David Shaw

CLASSIC TECHNOLOGY LTDAddress: Unit 4, Block B,

Johnstown Manor,Johnstown, Naas,

Co. Kildare.Tel: (045) 896 660Fax: (045) 896 713Email: [email protected]: www.classictechnology.ieType of Business: Instrumentation.Contact: Director/Sales:

William KinsellaUKAS Calibration:Patrick Kinsella

COMPLAS PACKAGING LTDAddress: Naas Industrial

Estate, Dublin Road, Naas, Co. Kildare.

Tel: (045) 874 088/9Fax: (045) 874 090Email: [email protected]: www.complas.ieContact: Managing Director:

Patrick Gregory

CONSOLIDATED PUMPS LTDAddress: Knockmeenagh Road,

Newlands Cross,Clondalkin, Dublin 22.

Tel: (01) 459 3471Fax: (01) 459 1093Email: [email protected]: www.consolidatedpumps.comContact: Managing Director:

RK Tolan

CORCORAN CHEMICALS LTDAddress: Kingsbridge House,

17-22 Parkgate Street, Dublin 8.

Tel: (01) 633 0400Fax: (01) 679 3521Email: abyrne@

corcoranchemicals.comWeb: www.corcoranchemicals.comContact: Managing Director:

A. Byrne

CPI TECHNOLOGY LTDAddress: Unit 5, Link Road

Business Park, Ballincollig, Co. Cork.

Tel: (021) 487 4142Fax: (021) 487 8764Email: [email protected]: www.cpitechnology.comContact: Managing Director:

Adrian Giltinan

CRANNAGH & CO.Address: 3 Crannagh House,

Old Clones Road, Beltubet, Co. Cavan.

Tel: (049) 952 2789Fax: (049) 952 2790Email: [email protected]

[email protected]: www.crannaghtrade.euType of Business: International

trade and customs consultants.

Contact: Managing Director:Carol Lynch

CROSS TECHNICAL SOLUTIONSAddress: Unit 22, Kilcarbery

Business Park,Nangor Road,Clondalkin, Dublin 22.

Tel: (01) 405 6777Fax: (01) 413 6932Email: sales@crosstechnical

solutions.ieWeb: www.crosstechnical

solutions.ieType of Business: Specialist

refrigeration.Contact: Director:

David KillaleaGeneral ManagerJason Keating

CURTEC UK LTDAddress: 75 Cannon Street,

London, EC4 5BN.Tel: (0044) 2085 684 445Fax: (0044) 2085 684 446Email: [email protected]: www.curtec.comType of Business: Packaging

Manufacturer.Contact: Eva Klotz

D

DALKIAAddress: 145 Lakeview Drive,

Airside Business Park, Swords, Co. Dublin

Tel: (01) 870 1200Fax: (01) 870 1201Email: [email protected]: www.dalkia.ieContact: Managing Director:

64

CO

MPA

NY

LIS

TIN

GS


CHEMCO IRELAND LTD.Address: Unit 49, Robinhood

Industrial Estate, Longmile Road, Dublin 22.

Tel: (01) 456 9761Fax: (01) 456 9765Email: [email protected]: www.chemco.ieType of Business: Chemical

Distribution.Contact: Operations

Manager: David Hannon


Pat GilroyAssociate DirectorPharmaceutical Division: Fergus ElebertGeneral Manager:Jerome Aguesse

DGP IRELAND LTDAddress: 1 Airways

Technology Park, Kinsale Road, Co. Cork.

Tel: (021) 484 9082Fax: (021) 484 9084Email: [email protected]: www.dgpir.comType of Business: Packaging

manufacturer.Contact: Product Development

Manager:Richard Walsh

DIONEX IRELAND LTDAddress: Unit 9A, Suite 3C,

Plato Business Park, Damastown, Dublin 15.

Tel: (01) 644 0064Fax: (01) 885 1673Email: [email protected]: www.dionex.comType of Business: Scientific analytical

equipment.Contact: Siobhan Curley

E

ENDRESS & HAUSER(IRELAND) LTDAddress: Clane Business Park,

Clane, Co. Kildare.Tel: (045) 868 615Fax: (045) 868 182Email: [email protected]: www.endress.com Type of Business: Process automation

solutions supplier. Contact: Sales Manager:

Tony Donnelly

ENVA IRELAND LTDAddress: Raffeen

Industrial Estate, Ringaskiddy,

Co. Cork.Tel: (021) 438 7200Fax: (021) 438 7299Email: [email protected]: www.enva.ieContact: Sales Manager:

Brian Magrane

ENVIRONMENTALPROTECTION AGENCYAddress: PO Box 3000,

Johnstown CastleEstate, Co. Wexford.

Tel: (053) 916 0600Fax: (053) 916 0699Email: [email protected]: www.epa.ie

ESB INDEPENDENT ENERGYAddress: Dublin:

Woodford Business Park, Santry, Dublin 17.Belfast:33 Clarendon Dock,Laganside, Belfast, BT1 38G.

Tel: (01) 862 8300(028) 9051 1246

Fax: (01) 862 8350(028) 9027 8400

Email: [email protected]: www.esbie.ieContact: Marketing Manager:

John ConlonCustomer Operations Manager: Susan KinaneCommercial Manager:Bob Turley

EUROLECINSTRUMENTATION LTDAddress: Technology House,

Cluan Enda, Dundalk, Co. Louth.

Tel: (042) 933 3423 Fax: (042) 933 1758 Email: [email protected]: www.eurolec-instruments.comType of Business: Electronic

instrumentation.

Contact: Sales/Marketing Executive:Chris Mears

EUROTHERM IRELAND LTDAddress: Unit W4i, Tougher

Business Park, Naas, Co. Kildare.

Tel: (01) 469 1800Fax: (01) 469 1300Email: [email protected]: www.eurotherm.ieContact: Area Engineer:

Rory Lynch

F

FDT CONSULTING ENGINEERS& PROJECT MANAGERS LTDAddress: Fisrst Floor,

170 Walkinstown Road, Dublin 12.

Tel: (01) 429 1900Fax: (01) 429 1901Email: [email protected]: www.fdt.ieType of Business: Consulting

engineers specialising in process engineering, project management & energy efficiency.

Contact: Project Manager:Michael Clancy

FESTO LTDAddress: Unit 5,

Sandyford Park, Sandyford Industrial Estate, Dublin 18.

Tel: (01) 295 4955Fax: (01) 295 5680Email: [email protected]: www.festo.com/ieType of Business: Automation

company specialising in factory and process automation.

Contact: Sales Manager:Brian Reardon

FEHILY TIMONEY & COMPANYAddress: Cork:

Core House,

65

COM

PAN

YLI

ST

ING

S



Pouladuff Road,Co. Cork.

Tel: (021) 496 4133Fax: (021) 496 4464

Dublin:2nd Floor, Mill House, Ashtown Gate, Navan Road, Dublin 15.

Tel: (01) 658 3500Fax: (01) 658 3501Email: [email protected]: www.fehilytimoney.ieContact: Principal:

John Lynch

FLEXACHEMMANUFACTURING LTDAddress: Donnybrook

Commercial Centre,Douglas, Co. Cork.

Tel: (021) 463 6742Fax: (021) 489 1297Email: [email protected]: www.flexachem.comType of Business: Manufacturer/

Distributor.Contact: Commercial Director:

Agnes Mullins

FLUOROCHEM LTDAddress: Wesley Street,

Old Glossop, Derbyshire,SK13 7RY.

Tel: (0044) 1457 868921Fax: (0044) 1457 869360Email: enquiries@

fluorochem.co.ukWeb: www.fluorochem.netContact: Sales Director:

Martin Woolley

G

GEA PROCESS TECHNOLOGIESIRELAND LTDAddress: Ash House,

Lime Tree Avenue,Millennium Park,Naas, Co. Kildare.

Tel: (045) 981 200Fax: (045) 981 232Email: [email protected]: www.geapt.ieContact: Business

Development Manager:Adrian Field

GOLIATH PACKAGINGSYSTEMS LTDAddress: Beechwood, Nenagh,

Co. Tipperary.Tel: (067) 37893Fax: (067) 34794Email: [email protected]: www.goliath.ieType of Business: Supply &

installation of packaging equipment and materials handling systems.

Contact: Director:George O’Leary

GOULDING CHEMICALS LTDAddress: Centre Park Road,

Marina, Co. Cork.Tel: (021) 491 1611Fax: (021) 491 1660Email: [email protected]: www.gouldings.ieType of Business: Chemical

distributor.Contact: Manager Industrial

Chemicals:Matt Pollock

GRAHAM HART(PROCESS TECHNOLOGY) LTDAddress: Friars Ind. Estate,

Bradford Road, Idle,Bradford, BD10 8SW, UK.

Tel: (0044) 1274 617021Fax: (0044) 1274 618614Email: [email protected]: www.graham-hart.comContact: Sales Director:

Stephen Hart

GROWCORP GROUP LTDAddress: 3015 Lake Drive,

Citywest Business Campus, Dublin 24.

Tel: (01) 466 1000Fax: (01) 466 1002Email: [email protected]: www.growcorp.netType of Business: Bioscience investor,

advisor and business incubator.

Contact: Chairman:Michael Donnelly

GS1 IRELANDAddress: The Nutley Building

Merrion Road, Dublin 4.Tel: (01) 208 0671Fax: (01) 208 0670Email: adreena.cullen@

gs1ie.orgWeb: www.gs1ie.orgContact: Marketing Executive:

Adreena Cullen

GUNNEBO IRELAND LTDAddress: Dublin:

601 Western Industrial Estate, Dublin 12.Cork:Unit 4, Hillview Campus,Euro Business Park,Little Island, Co. Cork.

Tel: (01) 458 4836(021) 452 4940

Fax: (01) 458 4835(021) 452 4409

Email: [email protected]@gunnebolifting.com

Web: www.gunnebolifting.comContact: Managing Director:

66

CO

MPA

NY

LIS

TIN

GS


FISHER SCIENTIFICAddress: Suite 3, Plaza 212,

Blanchardstown Corporate Park 2, Ballycoolin, Dublin 15.

Tel: (01) 885 5854Fax: (01) 899 1855Email: fsie.sales

@thermofisher.comWeb: www.ie.fishersci.comType of Business: Laboratory

supplies.Contact: Marketing

Communications Manager:Bob Sharman


Patrick DoyleDirector (Cork):Noel HowardSales Rep (Munster Area): Bryan Davies

H

HAZCHEM TRAINING LTDAddress: G10, Maynooth

Business Campus,Maynooth, Co. Kildare.

Tel: (01) 629 1800Fax: (01) 629 1822Email: [email protected]: www.hazchem.ieContact: Office Manager:

Michelle Cleere

HENLEY FORKLIFTGROUP LTDAddress: Henley Industrial

Park, Killeen Road, Dublin 10.


[email protected]: www.henley.ieType of Business: Forklifts. Specialists

in flameproof forklift trucks.

Contact: Director:Brian O’Connell

HIGHER EDUCATION AUTHORITYAddress: Brooklawn House,

Crampton Avenue, Shelbourne Road, Dublin 4.

Tel: (01) 231 7100Fax: (01) 231 7172Email: [email protected]: www.hea.ieType of Business: Government

agency.Contact: Head of Research

Programme: Dr. Eucharia Meehan

H.R. HOLFELD(ENGINEERING) LTDAddress: 2-4 Merville Road,

Stillorgan, Co. Dublin.

Tel: (01) 288 7361Fax: (01) 283 6293Email: [email protected] of Steam Boiler Business: Supplier.Contact: General Manager:

Oliver Collier

H.R. HOLFELD(HYDRAULICS) LTDAddress: 2-4 Merville Road,

Stillorgan, Co. Dublin.

Tel: (01) 288 7361Fax: (01) 288 7380Email: [email protected] of Process Pump Business: Supplier. Contact: Business

Development & Key Accounts:Emmet Connelly

I

ICDS RECRUITMENTCONSULTANTSAddress: 24 Upper Fitzwilliam

Street, Dublin 2.

Tel: (01) 632 1200Fax: (01) 676 2079Email: [email protected]: www.icds.ieType of Business: Recruitment

consultants.Contact: Recruitment Director:

Anthony McLoughlin

INDUSTRIAL PACKAGING LTDAddress: Killarney Road,

Bray, Co. Wicklow.

Tel: (01) 286 4010Fax: (01) 286 4015Email: [email protected]: www.industrialpackaging.ieType of Business: Manufacturer.Contact: Sales & Marketing

Director: Norman Lee

INTERMEC IRELAND LTDAddress: 19/20, York Road,

Dun Laoghaire,Co. Dublin.

Tel: (01) 205 4200Fax: (01) 205 4201Email: [email protected]: www.intermec.ieContact: General Manager:

Joe Lynch

INTERPACAddress: 67E Heather Road,

Sandyford Industrial Estate, Dublin 18.

Tel: (01) 294 0600Fax: (01) 294 0602Email: [email protected]: www.interpac.ieType of Business: Packaging.Contact: Managing Director:

Ian Sutton

IRISH NATIONALACCREDITATION BOARD, THEAddress: Wilton Park House,

Wilton Place, Dublin 2.

Tel: (01) 607 3003Fax: (01) 607 3109Email: [email protected]: www.inab.ieType of Business: Provides

accreditation of laboratories, certification & inspection bodies .

Contact: Information Officer:Orla Doyle

ITT WATER & WASTEWATER IRELAND LTDAddress: 50 Broomhill Close,

Airton Road, Tallaght, Dublin 24.

Tel: (01) 452 4444Fax: (01) 452 4795Email: [email protected]: www.flygt.ie

www.ittwww.comType of Business: Supplier of

products, systems & services for the transport and treatment of water

67

COM

PAN

YLI

ST

ING

S



and waste water.Contact: Director/General

Manager:Alison Kirwan

J

JOHNSEN & JORGENSEN LTDAddress: Unit 8, Westpoint

Enterprise Park, Clarence Avenue, Trafford Park,Manchester, M17 1QS.

Tel: (0044) 1618 741930Fax: (0044) 1618 741931Email: [email protected]: www.jjpack.comType of Business: Bottle, jar &

stopper suppliers.Contact: Sales Manager:

Matthew Scott

JOHNSTON LOGISTICS LTDAddress: Blackchurch Business

Park, Rathcoole,Co. Dublin.

Tel: + 353 1 401 3333Fax: + 353 1 458 8015Email: [email protected]: www.johnstonlogistics.ieType of Business: Logistics &

distribution.

JVA ANALYTICAL LTDAddress: Unit 1, Longmile

Business Park, Longmile Road, Dublin 12.

Tel: (01) 456 9822Fax: (01) 456 9825Email: [email protected]: www.jva.ieContact: Managing Director:

John Ryan

K

KELLY SERVICESAddress: 20-21 Grafton

Street, Dublin 2.Tel: (01) 679 3111

086 822 0851Fax: (01) 677 3048Email: swiftam@

kellyservices.ieWeb: www.kellyservices.ie

Type of Business: Recruitment agency.

Contact: Country Manager -Ireland:Amanda Swift

KELLS STAINLESS LTDAddress: Oldcastle Road,

Kells, Co. Meath

Tel: (046) 924 1520Fax: (046) 924 1528Email: [email protected]: www.kellsstainless.comType of Business: Stainless

equipment design & fabrication.

Contact: Technical Sales Director: Dara Fay

KWE (IRELAND) LTDAddress: Dublin: Unit 4

Horizon Logistics Park, New Naul Road, Harristown, Swords, Co. Dublin.Cork: Unit 4&5, South RingWest Business Park,Tramore Road,Co. Cork.

Tel: (01) 823 9600(021) 497 5722

Fax: (01) 836 1111(021) 497 5727

Email: [email protected]@ea.kwe.com

Web: www.kwe.comContact: Sales Manager:

Karl O’Reilly

L

NORMAN LAUDER LTDAddress: 2A Richview Office

Park, Clonskeagh,Dublin 14.

Tel: (01) 260 0442Fax: (01) 260 0675Email: [email protected]: www.nll.ieContact: Sales Manager:

Susan Ellis

LENDAC DATA SYSTEMS LTDAddress: Unit 6, Trinity

Enterprise Centre, Pearse Street,Dublin 2.

Tel: (01) 677 6133Fax: (01) 671 0135Email: [email protected]: www.lendac.ie

lrs.lendac.ieContact: Joint Managing

Director: Don Lehane

LENNOX LABORATORYSUPPLIES LTDAddress: John F. Kennedy

Drive, Naas Road, Dublin 12.


[email protected]: www.lennox.ieType of Business: Laboratory

suppliers.Contact: Director:

Gregory Kearns

LIANCOAddress: Rathclaren,

Kilbrittain, Co. Cork.Tel: (023) 49681

087 260 5447Fax: (023) 49677Email: [email protected]: www.lianco.netType of Powder drying, Business: processing,

conveying,and containment.

Contact: Sales Director:Finbar Smith

LISTER MACHINE TOOLS LTDAddress: PO Box 838,

Bluebell Industrial Estate, Dublin 12.

Tel: (01) 450 8866Fax: (01) 450 9836Email: sales@

listermachinetools.comWeb: www.listermachinetools.com

68

CO

MPA

NY

LIS

TIN

GS



Type of Sales of machines, Business: tools & associated

equipment.Contact: Liam Cashe

LOGSTRUP (IRELAND) LTDAddress: Dunmore Road,

Tuam, Co. Galway.Tel: (093) 70900Fax: (093) 70901Email: [email protected]: www.logstrup.comType of Business: MaunfacturingContact: General Manager:

Sean Mulryan

M

MANOTHERM LTDAddress: 4 Walkinstown Road,

Dublin 12.Tel: (01) 452 2355Fax: (01) 451 6919Email: [email protected]: www.manothern.ieType of Business: Distributors of

controls andinstrumentation.

Contact: Managing Director: R.C. Gilbert

MANPOWER IRELANDAddress: Dublin City Centre:

2nd Floor, 8 Harcourt Street,Dublin 2.Dublin North:29 North Street, Swords, Co. Dublin.Dublin West:Unit 7, Tuansgate, The Square, Tallaght, Dublin 24.Dublin South:Unit D12, The Cubes Plaza, Beacon Street Quarter,Sandyford, Dublin 18. Cork:Carbery House,67-69 South MallCo. Cork.

Limerick:1 Michael Street,Co. Limerick.Westmeath:32 Austin Friars Street, Mullingar,Co. Westmeath.

Tel: (01) 645 5200(01) 813 9782(01) 405 7715(01) 293 4666(021) 427 9733(061) 312 230(044) 933 1016

Fax: (01) 645 5299(01) 813 9787(021) 427 9735(061) 312 280(044) 933 1018

Email: [email protected]

Web: www.manpower.ieContact: Managing Director:

Jason KennedyDublin BranchManager: Deborah Mealy

MATHESON ORMSBY PRENTICEAddress: 70 Sir John

Rogerson’s Quay,Dublin 2.

Tel: (01) 232 2000Fax: (01) 232 3333Email: [email protected]: www.mop.ieType of Business: Law firmContact: Helen Middleton,

Associate

MEASOM FREERAddress: 37-41 Chartwell

Drive, Wigston, LeicestershireLE18 2FL, UK.

Tel: (0044) 1162 881588Fax: (0044) 1162 813000Email: [email protected]: www.measomfreer.co.ukContact: Sales Director;

Mark Freer

MICRO HYDRAULICS LTD/MICRO INDUSTRIES IRELANDAddress: Dublin:

2003 Orchard Avenue, Citywest Business Campus,Dublin 24.Cork:Unit 6/7 Cherrywood Business Park,Little Island, Co. Cork.

Tel: (01) 463 9000Fax: (01) 410 5609Email: [email protected]: www.microhydraulics.ieType of Business: Sanitary hose,

tube & accessories.Contact: Sales Representative:

Ralph FitzsimonsSales Representative:Dave O’Donavan

MIELE IRELAND LTDAddress: Broomhill Business

Complex, Broomhill Road, Tallaght, Dublin 24.

Tel: (01) 461 0710Fax: (01) 461 0797Email: [email protected]: www.miele.ieContact: Professional Sales

Manager:Aidan Carey

MSL ENGINEERING LTDAddress: Rushbrooke

Industrial Park, Cobh, Co. Cork.

Tel: (021) 481 5806Fax: (021) 481 2965Email: [email protected] of Business: Mechanical

engineering contractors.

Contact: Managing Director:Maurice McGrath

N

NATIONAL CHEMICAL CO. LTDAddress: NCC House,

42 Lower Leeson St.,Dublin 2.

Tel: (01) 613 1400Fax: (01) 634 0132

69

COM

PAN

YLI

ST

ING

S



Email: [email protected]: www.ncc.ieType of Business: Distributor.Contact: Commercial Director:

Rosanna Duignan

NATIONAL INSTRUMENTSAddress: Measurement House,

Newbury Business Park, London Road,Newbury, Berkshire,RG14 2PS.

Tel: (01) 867 4374Fax: (01) 867 4375Email: [email protected]: www.ni.com/irelandContact: Sales Manager

Ireland:Seamus Casserly

NEDERMAN LTDAddress: Premier Business

Centre, 3013 LakeDrive, Citywest Business Campus, Dublin 24.

Tel: (01) 469 3729Fax: (01) 469 3321Email: ciaran.wilkinson@

nederman.ieWeb: www.nederman.ieType of Business: Fume, Dust &

Materials Handling.Contact: Country Manager:

Ciaran Wilkinson

NEW ERA PACKAGING LTDAddress: Drogheda Industrial

Estate, Donore Road,Drogheda, Co. Louth.

Tel: (041) 987 5600Fax: (041) 983 4481Email: [email protected]: www.newera.ieType of Business: Label printing.Contact: Director:

David Nevin Director:Peter Higgins

NITLAddress: 17 Herbert Street,

Dublin 2.Tel: (01) 669 0806Fax: (01) 661 1943Email: [email protected]

Web: www.nitl.ieContact: Director of Learning:

Edward Sweeney

NORGREN LTDAddress: 137 Slaney Close,

Dublin Industrial Estate, Glasnevin, Dublin 11.

Tel: (01) 830 0288Fax: (01) 830 0082Email: [email protected]: www.ienorgren.comContact: Field Sales Manager :

Dave WhelanTechnical Sales Supervisor: John Lanney

O

OCON CHEMICALS LTDAddress: Unit 5, South Cork

Industrial Estate, Vicars Road,Pouladuff, Co. Cork.

Tel: (021) 431 8555Fax: (021) 431 8560Email: [email protected]: www.oconchemicals.comContact: Managing Director:

Frank Mulcahy

ODENBERG ENGINEERING LTDAddress: 2004 Orchard

Avenue, Citywest Business Campus,Naas Road, Dublin 24.

Tel: (01) 413 6200Fax: (01) 457 0219Email: [email protected]: www.odenberg.ieContact: Business Unit

Manager:Jimmy Deane

HANLON O’GRADY & CO. LTDAddress: Victoria House,

Beaumont Avenue, Churchtown, Dublin 14.

Tel: (01) 295 1101Fax: (01) 298 1790Email: [email protected] of Business: Industrial valves &

controls.Contact: General Manager:

TBA.Office Manager:Rob Arnold

P

PEGLER & LOUDEN IRELANDA DIVISION OF BSS (IRELAND) LTD

Address: Dublin:301 South CircularRoad, White HeatherIndustrial Estate,Dublin 8.


[email protected]: www.fcx-pli.comContact: Joe Melinn

John GeraghtyPat KellyJohn QuinnCork:South Link Park,Ballycurreen RoadGrange, Co. Cork.

Tel: (021) 497 7128Fax: (021) 491 5213Email: Cork:

[email protected]@pli.ie

Web: www.fcx-pli.comContact: Cork:

Pat CroninPat O’BrienColman Hesse

P.K. CHEMICALS LTDAddress: Unit 23, Sandyford

Office Park,Blackthorn Avenue, Foxrock, Dublin 18.

Tel: (01) 295 6977Fax: (01) 295 8338Email: debbie@

pkchemicals.comType of Business: Chemical

distributor.Contact: Accounts

Administrator:Deborah Holmes

PLATE TEK ENGINEERING LTDAddress: IDA Industrial

Estate, Kilmallock Road, Co. Cork.

70

CO

MPA

NY

LIS

TIN

GS



Tel: (063) 21277Fax: (063) 21280Email: [email protected]: www.platetek.ieType of Business: Heat exchangers,

supply, testing and certification.

Contact: General Manager:PJ Greensmith

PM GROUPAddress: Cork:

Loughmahon Technology Park,Blackrock, Co. Cork.Dublin:Killakee House,Belgard Square,Tallaght, Dublin 24.

Tel: (021) 435 8922(01) 404 0700

Fax: (021) 435 8933Email: [email protected]: www.pmg.ieContact: Billy O’Neill

Paul HallamBusiness Development

POLLUTION CONTROLSYSTEMS LTDAddress: Raffeen House,

Ringaskiddy,Co. Cork.

Tel: (021) 437 4237Fax: (021) 437 4236Email: [email protected]: www.biotector.comContact: Managing Director:

Martin Horan

PRIMEPAC LTDAddress: Unit 2, Caulside

Drive, Newpark Industrial Estate, Antrim, BT41 2DU.

Tel: (0044) 2894 428 188Fax: (0044) 2894 428 177Email: [email protected]: www.primepacltd.comType of Business: Manufacturer &

supplier of plastic containers.

Contact: Director:John McGahon

PROSCON LTDAddress: Rushbrooke

Commercial Park,Cobh, Co. Cork.

Tel: (021) 481 1802Fax: (021) 481 1804Email: [email protected]: www.proscon.comContact: Michael Horkan

Business Development Manager

PROSYS SAMPLINGSYSTEMS LTDAddress: Rosehill Business

Centre, Midleton, Co. Cork.

Tel: (021) 461 3890Fax: (021) 461 3891Email: [email protected]: www.prosys.ieContact: Technical Director:

Michael McLoughlin

Q

QUITMANN O’NEILLPACKAGING LTDAddress: St. Brendan’s Road,

Portumna,Co. Galway.

Tel: (09097) 41148/9Fax: (09097) 41459Email: [email protected]: www.qonpack.com

www.quitmannoneillpackaging.comContact: General Manager:

David O’Neill

R

THE RFT GROUPAddress: 6A Old Dunleary

Road, Dun Laoghaire,Co. Dublin.

Tel: (01) 230 2400Email: [email protected]: www.rftgroup.ieType of Business: Recruitment

Agency.Contact: Managing Director:

Gerry Kennedy

S

SARTORIUS MECHATRONICSUK LTDAddress: Unit 41, The Business

Centre, Stadium Business Park, Ballycoolin Road, Dublin 11.

Tel: (01) 808 9050Fax: (01) 808 9388Email: info.ireland@

sartorius.comWeb: www.sartorius.ieType of Business: Laboratory &

process technology provider. Sales & service of laboratory & process weighing equipment.

Contact: Nick Parsons

SCHUF VALVE TECHNOLOGYAddress: Lehenaghmore,

Togher, Co. Cork.Tel: (021) 483 7000Fax: (021) 483 7030Email: [email protected]: www.schuf.comContact: Managing Director:

Wolfgang Frank

SCIENCE FOUNDATIONIRELAND (SFI)Address: Wilton Park House,

Wilton Place, Dublin 2.Tel: (01) 607 3200Fax: (01) 607 3201Email: [email protected]: www.sfi.ieType of Business: Government

funding agency for research.

Contact: Head of Industry - Research Development:Dr. Paul Dodd

SCIENCE RECRUITMENTIRELANDAddress: 40 Grand Canal

Street Upper, Dublin 4.

71

COM

PAN

YLI

ST

ING

S



Tel: (01) 667 5008Fax: (01) 667 6714Email: [email protected]: www.sri.ieType of Business: Specialist science

recruitment agency.Contact: Managing Director:

Helen McGardle

SCIENTIFIC & CHEMICALSUPPLIES LTDAddress: Eastlink House,

Carrigtwohill,Co. Cork.

Tel: (021) 488 2388Fax: (021) 488 2389Email: [email protected]: www.scichem.comType of Business: Laboratory

Suppliers.Contact: Branch Manager:

John Molloy

SEALPACK LTDAddress: Jamestown Industrial

Centre, Jamestown Rd, Inchicore, Dublin 8

Tel: (01) 453 4387Fax: (01) 453 2051Email: [email protected]: www.sealpack.ieContact: Production: Alan Saul

Marketing:Barry SaulSales: Joe Saul

SHAW SCIENTIFIC LTDAddress: Greenhills Industrial

Estate, Walkinstown, Dublin 12.

Tel: (01) 450 4077Fax: (01) 450 4328Email: [email protected]: www.shawscientific.comContact: Seamus Amond

SHELL CHEMICALSAddress: C/o Cork Bulk

Storage Limited,Tivoli Industrial Estate, Co. Cork.

Tel: (021) 491 8184Fax: (021) 491 8184Email: [email protected]: www.shell.com/chemicalsContact: Mark Dalton

Solvents Sales Manager

SIEMENS LTDAddress: Fitzwilliam Court,

Leeson Close, Dublin 2.

Tel: (01) 216 2000Fax: (01) 216 2079Email: [email protected]: www.siemens.ieType of Business: Electrical

engineering.Contact: Sales Engineer:

Liam CotterGeneral Manager:Domhnall Carroll

SIGMA-ALDRICH IRELAND LTDAddress: Airton Road,

Tallaght, Dublin 24.

Tel: (01) 404 1900Fax: (01) 404 1910Email: [email protected]: www.safcsupplysolutions.comContact: Kate Buggle

SMURFIT KAPPA CORKAddress: Sitecast

Industrial Estate, Pouladuff Road,Co. Cork.

Tel: (021) 496 2033Fax: (021) 496 2051Email: tim.odonoghue@

smurfitkappa.ieWeb: www.smurfitkappa.ieType of Business: Packaging supplies.Contact: Regional Sales

Manager: Tim O’Donoghue

SOLTEC (IRELAND) LTDAddress: Zone A,

Mullingar Business Park, Mullingar,Co. Westmeath.

Tel: (044) 933 5133Fax: (044) 934 5248Email: [email protected]: www.soltec.ieContact: Managing Director:

Michael Corcoran

SUSTAINABLE ENERGY IRELANDAddress: Glasnevin,

Dublin 9Tel: (01) 836 9080Fax: (01) 837 2848Email: [email protected]: www.sei.ieType of Business: Energy advice &

information.

T

TOPCHEM LABORATORIES LTDAddress: 70 Western Parkway

Business Park,Ballymount Drive,Dublin 12.


[email protected]: www.topchem.ieType of Business: Chemical synthesis.Contact: Managing Director:

Dr. Donal Coveney

72

CO

MPA

NY

LIS

TIN

GS


SMURFIT KAPPA IRELANDAddress: Ballymount Road,

Walkinstown, Dublin 12.

Tel: (01) 409 0000Fax: (01) 456 4506Email: [email protected]: www.smurfitkappa.ieContact: Marketing Manager:

Daragh Wall

SMURFIT KAPPA PACKAGINGSOLUTIONS CORKAddress: Bolands Industrial

Estate, Mallow Road,Co. Cork.

Tel: (021) 430 7122Fax: (021) 430 7124Email: garrett.quinn@

smurfitkappa.ieType of Business: General packaging.Contact: Plant Manager:

Garrett Quinn


TOYOTA MATERIALSHANDLING IRELANDAddress: Toyota Ireland,

Killeen Road,Dublin 12.

Tel: (01) 419 0200Fax: (01) 419 0325Email: materialhandling@

toyota.ieWeb: www.toyota-forklifts.ieType of Business: Materials handling.Contact: Sales Manager:

Robert O’Reilly

TURBOAIRAddress: 62 Cherry Orchard

Industrial Estate,Dublin 10.

Tel: (01) 626 9500Fax: (01) 623 7002Email: [email protected]: www.turboair.ieContact: Director:

John Jones

U

UNIVAR LTDAddress: 536 Grants Crescent,

Greenogue Business Park, Rathcoole, Co. Dublin.

Tel: (01) 401 9800Fax: (01) 401 9142Email: pharma.sales@

univareurope.comWeb: www.univareurope.comType of Business: Ingredients -

pharma industry including API’s, excipients, process chems, solvents & intermediates.

Contact: Account Manager:John McCluskey

V

VEOLIA ENVIRONMENTALSERVICESAddress: Ballymount Cross,

Ballymount,Dublin 24.Tel: (01) 413 6500Fax: (01) 413 6502Email: [email protected]: www.veolia.ieContact: Ian Mangan

W

WEBER LABELLING & CODINGAddress: Kilcannon Industrial

Estate, Old Dublin Road, Enniscorthy, Co. Wexford.

Tel: (053) 923 3778Fax: (053) 923 3284Email: [email protected]: www.webermarking.comContact: Area Sales Manager:

Richard Smith

WRENTECH LTDAddress: Wrentech House,

Crosshaven Hill,Crosshaven, Co. Cork.

Tel: (021) 483 2644Fax: (021) 483 1363Email: [email protected]: www.wrentech.ieContact: Sales Administrator:

Siobhan Murray

Z

Zenith TechnologiesAddress: Portgate Business

Park, Ringaskiddy,Co. Cork

Tel: (021) 437 0200Fax: (021) 437 0299Email: peter.sheehan@

zenithtechnologies.comWeb: www.zenithtechnologies.comContact: Sales & Marketing

Manager: Peter Sheehan

ZETES BLACKBIRDAddress: The National

Technology Park,Plassey, Co. Limerick.

Tel: (061) 333 188(01) 822 5123

Fax: (061) 333 133Email [email protected]: www.zetes.com/ieType of Business: Systems Integrator

of Supply Chain Automation and Inventory Management Solutions and Services.

Contact: Sales Manager:Barry Long

73

COM

PAN

YLI

ST

ING

S


VIKING PUMP (EUROPE) LTDAddress: R79, Shannon

Industrial Estate, Shannon, Co. Clare.

Tel: (061) 471 933Fax: (061) 475 046Email: coconnell

@idexcorp.comWeb: www.vikingpumpeurope.comContact: Customer Service

Administrator:Claire O’Connell


PublicHoliday

PublicHoliday

SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON TUE WED

SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON TUE WED

1 2 3 4 5 6 7 8 9 10 11 12 13 14

Year Planner 20091 2 3 4 5 6 7 8 9 10 11 12 13 14

1 2 3 4 5 6 7 8 9 10 11 12

1 2 3 4 5 6 7 8 9 10 11 12 13

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

NOV

DEC

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

St.Valentine’sDay

GoodFriday

EasterSunday

PublicHoliday

PublicHoliday

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 17 17

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

St. Patrick’sDay

PublicHoliday

Year Planner 2009 23/09/2008 16:10 Page 1

ChristmasDay

PublicHoliday

THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON

THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON TUE WED THU FRI SAT SUN MON

14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

18 19 20 21 22 23 24 25 26 27 28 29 30

17 18 19 20 21 22 23 24 25 26 27 28 29 30

19 20 21 22 23 24 25 26 27 28

17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

AshWednesday

15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

NOV

DEC

19 20 21 22 23 24 25 26 27 28 29 30 31

13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

19 20 21 22 23 24 25 26 27 28 29 30

15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Father’sDay

Mother’sDay

SummerTimeBegins

St.Stephen’s Day

SummerTimeEnds

16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Year Planner 2009 23/09/2008 16:10 Page 2

76

ACADEMY OF MEDICALLABORATORY SCIENCE Tel: (01) 677 5602 E-mail: [email protected] Web: www.amls.ie

ADVISORY COUNCIL FORSCIENCE, TECHNOLOGY & INNOVATIONTel: (01) 607 3162E-mail: [email protected]: www.sciencecouncil.ie

AN BORD PLEANALATel: (01) 858 8100LoCall: 1890 275 175E-mail: [email protected]: www.pleanala.ie

CHAMBERS IRELANDTel: (01) 400 4300E-mail: [email protected]: www.chambers.ie

COMPANIES REGISTRATION OFFICETel: (01) 804 5200LoCall: 1890 220 226E-mail: [email protected]: www.cro.ie

DEPT. OF CHEMICAL ENGINEERS, UCDTel: (01) 716 1825

DEPT. OF ENTERPRISE,TRADE & EMPLOYMENTTel: (01) 631 2121LOCALL: 1890 220 222E-mail: [email protected]: www.entemp.ie

DEPT. OF THE ENVIRONMENT, HERITAGE& LOCAL GOVERNMENTTel: (01) 888 2000LoCall: 1890 20 20 21E-mail: [email protected]: www.environ.ie

ELECTRICITY SUPPLY BOARDEmergencies CallSave: 1850 37 29 99Web: www.esb.ie

ENTERPRISE IRELANDTel: (01) 808 2000E-mail: [email protected]: www.enterprise-ireland.com

ENVIRONMENTAL HEALTHOFFICERS ASSOCIATIONTel: (01) 276 1211E-mail: [email protected]: www.ehoa.ie

ENVIRONMENTAL PROTECTION AGENCYTel: (053) 916 0600E-mail: [email protected]: www.epa.ie

EUROPEAN FEDERATIONOF BIOTECHNOLOGYTel: (01) 808 2692E-mail: [email protected]

FAS - TRAINING & EMPLOYMENT AGENCYTel: (01) 607 0500E-mail: [email protected]: www.fas.ie

FORFASTel: (01) 607 3000E-mail: [email protected]: www.forfas.ie

HEALTH AND SAFETYAUTHORITYTel: 1890 289 389E-mail: [email protected]: www.hsa.ie

HEALTH RESEARCHBOARDTel: (01) 234 5000E-mail: [email protected]: www.hrb.ie

HIGHER EDUCATIONAUTHORITYTel: (01) 231 7100E-mail: [email protected]: www.hea.ie

IDA - INDUSTRIAL DEVELOPMENT AGENCY Tel: (01) 603 4000E-mail: [email protected]: www.idaireland.com

INSTITUTE OF CHEMISTRY OF IRELANDE-mail: [email protected] www.instituteofchemistry.org

IRISH ASSOCIATION OFDISTRIBUTIVE TRADESTel: (01) 288 7584E-mail: [email protected]: www.rgdata.ie

IRISH BIOINDUSTRY ASSOCIATIONTel: (01) 605 1584E-mail:[email protected]: www.ibec.ie/ibia

IRISH BUSINESS &EMPLOYERS CONFEDERATION (IBEC)Tel: (01) 605 1500 E-mail: [email protected] Web: www.ibec.ie

IRISH CLEANROOM SOCIETYTel: 087 285 9679Web: www.cleanrooms-ireland.ie

IRISH COSMETICS, DETERGENT & ALLIEDPRODUCTS ASSOCIATIONTel: (01) 605 1584E-mail:[email protected]: www.ibec.ie

IRISH EXPORTERSASSOCIATIONTel: (01) 661 282E-mail: [email protected] Web: www.irishexporters.ie

IRISH MEDICAL DEVICES ASSOCIATIONTel: (01) 605 1529E-mail: [email protected]: www.ibec.ie/imda

IRISH MEDICINES BOARDTel: (01) 676 4971E-mail: [email protected]: www.imb.ie

IRISH NATIONAL ACCREDITATION BOARDTel: (01) 607 3003E-mail: [email protected]: www.inab.ie

IRISH PATENTS OFFICE Tel: (056) 772 0111E-mail: [email protected] Web: www.patentsoffice.ie

IRISH PHARMACY UNIONTel: (01) 4936401E-mail: [email protected] Web: www.ipu.ie

IRISH VENTURE CAPITALASSOCIATION Tel: (01) 276 4647E-mail: [email protected] Web: www.ivca.ie

INVEST NORTHERN IRELANDTel: (028) 9023 9060E-mail: [email protected] Web: www.investni.com

MANDATE TRADE UNIONTel: (01) 874 6321E-mail: [email protected] Web: www.mandate.ie

NATIONAL INSTITUTE FOR TRANSPORT & LOGISTICS (NITL)Tel: (01) 669 0806 E-mail: [email protected]: www.nitl.ie

PHARMACHEMICAL IRELANDTel: (01) 605 1584E-mail:[email protected] Web: www.ibec.ie/ipcmf

PHARMACEUTICAL SOCIETY OF IRELAND Tel: (01) 218 4000E-mail: [email protected]: www.pharmaceuticalsociety.ie

REPAKTel: (01) 467 0190E-mail: [email protected] Web: www.repak.ie

SCIENCE FOUNDATION IRELANDTel: (01) 607 3201E-mail: [email protected] Web: www.sfi.ie

TEAGASCTel: (01) 805 9500 E-mail: [email protected]: www.teagasc.ie

US E F U L RE F E R E N C E S

USEFUL REFERENCES

Useful Refs_17.09.08.qxd 23/09/2008 16:12 Page 1

Wrentech House, Crosshaven Hill, Crosshaven, Co. Cork, IrelandTel: 021 483 2644 Fax: 021 483 1363 Mobile: 087 696 3344 E-mail: [email protected]

Your Solutions Provider

Wrentech ad 23/09/2008 17:03 Page 1

Documents

Irish PharmaChem 2008